Processing 00000000.tx.1: Cell adhesion molecules regulate Ca2+-mediated steering of growth cones via cyclic AMP and ryanodine receptor type 3 Noriko Ooashi1, Akira Futatsugi2, Fumie Yoshihara1, Katsuhiko Mikoshiba2, and Hiroyuki Kamiguchi1 1 Laboratory for Neuronal Growth Mechanisms, Brain Science Institute, The Institute of Physical and Chemical Research, Saitama 351-0198, Japan 2 Calcium Oscillation Project, International Cooperative Research Project, Japan Science and Technology Cooperation, Tokyo 108-0071, Japan Correspondence to Hiroyuki Kamiguchi: kamiguchi{at}brain.riken.jp Top Abstract Introduction Results Discussion Materials and methods References  Axonal growth cones migrate along the correct paths during development, not only directed by guidance cues but also contacted by local environment via cell adhesion molecules (CAMs). 

Phrase: "Cell adhesion molecules"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "regulate"

Phrase: "Ca2+-mediated steering of growth cones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0553654:steering [Finding]

Phrase: "via cyclic AMP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0439596:Cyclic [Temporal Concept]
   861   C1511572:Cyclic [Temporal Concept]
   789 E C0031084:Cyclicities [Temporal Concept]

Phrase: "and"

Phrase: "ryanodine receptor type 3 Noriko Ooashi1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   700   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   700   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]

Phrase: "Akira Futatsugi2,"

Phrase: "Fumie Yoshihara1,"

Phrase: "Katsuhiko Mikoshiba2,"

Phrase: "and"

Phrase: "Hiroyuki Kamiguchi1 1 Laboratory for Neuronal Growth Mechanisms,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0022877:Laboratory [Manufactured Object,Organization]
   744   C3244292:laboratory [Functional Concept]

Phrase: "Brain Science Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: "The Institute of Physical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Chemical Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "Saitama 351-0198,"

Phrase: "Japan 2 Calcium Oscillation Project,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1709701:Project [Conceptual Entity]

Phrase: "International Cooperative Research Project,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0700032:research project [Research Activity]
   812   C1709701:Project [Conceptual Entity]

Phrase: "Japan Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology Cooperation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392337:cooperation [Social Behavior]

Phrase: "Tokyo 108-0071,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan Correspondence to Hiroyuki Kamiguchi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "kamiguchi{at}brain.riken.jp Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Axonal growth cones"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   983   C2752547:axonal growth cone [Cell Component]
   901   C0596632:Growth Cones [Cell Component]
   865   C1749784:axon growth [Organ or Tissue Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0206428:Cones [Cell]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793 E C0330095:Cone [Plant]
   793 E C2350017:Cone [Spatial Concept]

Phrase: "migrate along the correct paths"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0232902:migrate [Functional Concept]
   760   C2349182:Correct [Qualitative Concept]
   726   C0919386:PATH [Laboratory Procedure]
   726   C1705483:Path [Intellectual Product]

Phrase: "during development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "directed by guidance cues"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010439:Cues [Idea or Concept]
   770   C0150600:Guidance [Health Care Activity]
   770   C1959633:Guidance [Clinical Attribute]
   737   C0439851:Direct [Qualitative Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "but"

Phrase: "also"

Phrase: "contacted by local environment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0014406:Environment [Spatial Concept]
   770   C0205276:Local [Spatial Concept]
   737   C0332158:contact [Functional Concept]
   737   C0337611:Contact [Population Group]
   737   C1705415:Contact [Idea or Concept]

Phrase: "via cell adhesion molecules (CAMs)."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.2: Asymmetric Ca2+ elevations in the growth cone cytosol induce both attractive and repulsive turning in response to the guidance cues (Zheng, J.Q. 

Phrase: "Asymmetric Ca2+ elevations in the growth cone cytosol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0702240:elevations [Spatial Concept]
   711 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "both attractive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346874:Attractive [Qualitative Concept]

Phrase: "and"

Phrase: "repulsive turning in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0541749:turning [Finding]

Phrase: "to the guidance cues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010439:Cues [Idea or Concept]

Phrase: "(Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "J.Q."
Processing 00000000.tx.3: 2000. 

Phrase: "2000."
Processing 00000000.tx.4: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.5: 403:8993; 

Phrase: "403"

Phrase: ":"

Phrase: "8993"

Phrase: ";"
Processing 00000000.tx.6: Henley, J.R., K.H. 

Phrase: "Henley,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.7: Huang, D. 

Phrase: "Huang,"

Phrase: "D."
Processing 00000000.tx.8: Wang, and M.M. 

Phrase: "Wang,"

Phrase: "and"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.9: Poo. 

Phrase: "Poo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015733:poo [Body Substance]
Processing 00000000.tx.10: 2004. 

Phrase: "2004."
Processing 00000000.tx.11: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.12: 44:909916). 

Phrase: "44"

Phrase: ":"

Phrase: "909916"

Phrase: ")."
Processing 00000000.tx.13: Here, we show that CAMs regulate the activity of ryanodine receptor type 3 (RyR3) via cAMP and protein kinase A in dorsal root ganglion neurons. 

Phrase: "Here,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "regulate"

Phrase: "the activity of ryanodine receptor type 3 (RyR3)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C1753335:ryanodine receptor activity [Molecular Function]
   800   C0459205:Type of activity [Intellectual Product]
   774   C1152633:receptor activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "via cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "protein kinase A in dorsal root ganglion neurons."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.14: The activated RyR3 mediates Ca2+-induced Ca2+ release (CICR) into the cytosol, leading to attractive turning of the growth cone. 

Phrase: "The activated RyR3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   888   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   888   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   840   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0441731:Type 3 [Classification]
   840   C1753335:ryanodine receptor [Molecular Function]
   804   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   804   C0332307:Type [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "Ca2+-induced Ca2+ release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(CICR"

Phrase: ")"

Phrase: "into the cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "leading to attractive turning of the growth cone."
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   770   C0596632:growth cone [Cell Component]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0206428:Cone [Cell]
   744   C0220844:growth [Physiologic Function]
   744   C0330095:Cone [Plant]
   744   C0332152:Leading [Temporal Concept]
   744   C0541749:turning [Finding]
   744   C1522538:Leading [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2346874:Attractive [Qualitative Concept]
   744   C2350017:Cone [Spatial Concept]
   744   C2911660:Growth [Activity]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.15: In contrast, the growth cone exhibits repulsion when Ca2+ signals are not accompanied by RyR3-mediated CICR. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "repulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683283:repulsion [Mental Process]

Phrase: "when"

Phrase: "Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accompanied by RyR3-mediated CICR."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   793   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   793   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   770   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0441731:Type 3 [Classification]
   770   C1753335:ryanodine receptor [Molecular Function]
   744   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0332307:Type [Qualitative Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.16: We also propose that the source of Ca2+ influx, rather than its amplitude or the baseline Ca2+ level, is the primary determinant of the turning direction. 

Phrase: "We also"

Phrase: "propose"

Phrase: "that"

Phrase: "the source of Ca2+ influx,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "rather than"

Phrase: "its amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]

Phrase: "or"

Phrase: "the baseline Ca2+ level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "the primary determinant of the turning direction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.17: In this way, axon-guiding and CAM-derived signals are integrated by RyR3, which serves as a key regulator of growth cone navigation. 

Phrase: "In this way,"

Phrase: "axon-guiding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0181090:Guide [Professional or Occupational Group]
   827   C0302614:Guide [Medical Device]
   827   C1706050:Guide [Manufactured Object]

Phrase: "and"

Phrase: "CAM-derived signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "integrated by RyR3,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   820   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   820   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   790   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0441731:Type 3 [Classification]
   790   C1753335:ryanodine receptor [Molecular Function]
   753   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "which"

Phrase: "serves as a key regulator of growth cone navigation."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0596632:growth cone [Cell Component]
   762   C1817513:growth regulator [Cell Function]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0182953:REGULATOR [Medical Device]
   742   C0206428:Cone [Cell]
   742   C0220844:growth [Physiologic Function]
   742   C0330095:Cone [Plant]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1704734:Regulator [Medical Device]
   742   C1704735:Regulator [Conceptual Entity]
   742   C2350017:Cone [Spatial Concept]
   742   C2827562:Navigation [Activity]
   742   C2911660:Growth [Activity]
Processing 00000000.tx.18: Abbreviations used in this paper: AM, acetoxymethyl ester; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C1273517:used [Finding]
   770   C1547566:Paper [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "AM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014898:Ester [Organic Chemical]

Phrase: "acetoxymethyl ester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014898:Ester [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.19: BAPTA, 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; 

Phrase: "BAPTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043775:BAPTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2-bis(o-aminophenoxy"

Phrase: ")"

Phrase: "ethane-N,N,N',N'-tetraacetic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.20: [Ca2+]c, cytosolic free Ca2+ concentration; 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "cytosolic free Ca2+ concentration"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0086045:Concentration [Mental Process]
   812   C0332296:free [Functional Concept]
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1383501:Cytosolic [Cell Component]
   812   C1446561:Concentration [Quantitative Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ";"
Processing 00000000.tx.21: CAM, cell adhesion molecule; 

Phrase: "CAM,"

Phrase: "cell adhesion molecule"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:Molecule [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.22: CCD, charge-coupled device; 

Phrase: "CCD,"

Phrase: "charge-coupled device"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1455741:Charge coupled device [Medical Device]
   827   C0025080:Device [Medical Device]
   827   C0699733:Device [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.23: CG-1, Calcium Green-1; 

Phrase: "CG-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0753494:calcium green 1 [Indicator, Reagent, or Diagnostic Aid]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0332583:Green [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "Calcium Green-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0753494:calcium green 1 [Indicator, Reagent, or Diagnostic Aid]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0332583:Green [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.24: CGRP, calcitonin gene-related peptide; 

Phrase: "CGRP,"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]
   812   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0017337:Gene [Gene or Genome]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C0770558:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C2825090:Calcitonin [Pharmacologic Substance]
   812   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   779 E C0163712:Relate [Organic Chemical]
   756 E C0115656:Thyrocalcitonin [Organic Chemical,Pharmacologic Substance]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "calcitonin gene-related peptide"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]
   812   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0017337:Gene [Gene or Genome]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C0770558:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C2825090:Calcitonin [Pharmacologic Substance]
   812   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   779 E C0163712:Relate [Organic Chemical]
   756 E C0115656:Thyrocalcitonin [Organic Chemical,Pharmacologic Substance]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: ";"
Processing 00000000.tx.25: CICR, Ca2+-induced Ca2+ release; 

Phrase: "CICR,"

Phrase: "Ca2+-induced Ca2+ release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.26: DIC, differential interference contrast; 

Phrase: "DIC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1979874:Contrast [Qualitative Concept]

Phrase: "differential interference contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1979874:Contrast [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.27: DRG, dorsal root ganglion; 

Phrase: "DRG,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
  1000   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   901   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   901   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   827   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   827   C0040452:Root [Body Part, Organ, or Organ Component]
   827   C0205095:Dorsal [Spatial Concept]
   827   C0242726:Root [Plant]
   827   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   827   C1318154:Root [Body Part, Organ, or Organ Component]
   827   C1705917:Root [Idea or Concept]

Phrase: "dorsal root ganglion"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
  1000   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   901   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   901   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   827   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   827   C0040452:Root [Body Part, Organ, or Organ Component]
   827   C0205095:Dorsal [Spatial Concept]
   827   C0242726:Root [Plant]
   827   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   827   C1318154:Root [Body Part, Organ, or Organ Component]
   827   C1705917:Root [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.28: FLIP, focal laserinduced photolysis; 

Phrase: "FLIP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031751:photolysis [Molecular Function]

Phrase: "focal laserinduced photolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031751:photolysis [Molecular Function]

Phrase: ";"
Processing 00000000.tx.29: IgSF, immunoglobulin superfamily; 

Phrase: "IgSF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]
   861   C1883220:Superfamily [Conceptual Entity]

Phrase: "immunoglobulin superfamily"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]
   861   C1883220:Superfamily [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.30: MAG, myelin-associated glycoprotein; 

Phrase: "MAG,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0129439:Myelin Associated Glycoprotein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           myelin glycoprotein
  1000   C1416969:MYELIN-ASSOCIATED GLYCOPROTEIN [Gene or Genome]
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "myelin-associated glycoprotein"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0129439:Myelin Associated Glycoprotein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           myelin glycoprotein
  1000   C1416969:MYELIN-ASSOCIATED GLYCOPROTEIN [Gene or Genome]
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: ";"
Processing 00000000.tx.31: NP-EGTA, o-nitrophenyl EGTA; 

Phrase: "NP-EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "o-nitrophenyl EGTA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0250426:o-nitrophenyl EGTA [Organic Chemical]
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0439114:O NOS [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.32: PKA, protein kinase A; 

Phrase: "PKA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.33: RyR, ryanodine receptor.  

Phrase: "RyR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419778:RYR [Gene or Genome]

Phrase: "ryanodine receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1753335:ryanodine receptor [Molecular Function]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.34: Introduction Top Abstract Introduction Results Discussion Materials and methods References  During neuronal development and regeneration, the growth cone navigates the axon toward its target by monitoring environmental cues along its path. 

Phrase: "Introduction Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References  During neuronal development"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C1657987:neuron development [Cell Function]
   770   C0243107:development [Physiologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0678723:Development [Organism Function]
   770   C1514811:Reference [Idea or Concept]
   770   C1527148:Development [Functional Concept]
   770   C1706462:Reference [Conceptual Entity]

Phrase: "and"

Phrase: "regeneration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "the growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "navigates"

Phrase: "the axon toward its target"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004461:Axon [Cell Component]

Phrase: "by monitoring environmental cues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0010439:Cues [Idea or Concept]

Phrase: "along its path."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919386:PATH [Laboratory Procedure]
  1000   C1705483:Path [Intellectual Product]
Processing 00000000.tx.35: Such environmental cues can be diffusible, substrate-bound or cell surface molecules, which serve as either attractants or repellents upon binding to relevant receptors expressed on the growth cone surface (Tessier-Lavigne and Goodman, 1996; Huber et al., 2003). 

Phrase: "Such environmental cues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010439:Cues [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "diffusible, substrate-bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0332297:bound [Spatial Concept]
   827   C1145667:Bound [Activity]
   827   C1167622:Bound [Molecular Function]
   827   C1689898:% bound [Quantitative Concept]
   827   C2349209:Bound [Conceptual Entity]

Phrase: "or"

Phrase: "cell surface molecules,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0699040:Cell surface [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0205148:Surface [Spatial Concept]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "which"

Phrase: "serve as either attractants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1622714:attractant [Molecular Function]

Phrase: "or"

Phrase: "repellents upon binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0544309:Repellents [Hazardous or Poisonous Substance]

Phrase: "to relevant receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "expressed on the growth cone surface"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0596632:growth cone [Cell Component]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0205148:Surface [Spatial Concept]
   753   C0206428:Cone [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C0330095:Cone [Plant]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2350017:Cone [Spatial Concept]
   753   C2911660:Growth [Activity]

Phrase: "(Tessier-Lavigne"

Phrase: "and"

Phrase: "Goodman,"

Phrase: "1996"

Phrase: "; Huber et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.36: Many guidance molecules, including netrin-1, NGF, brain-derived neurotrophic factor, and myelin-associated glycoprotein (MAG), influence the direction of axon extension through cytosolic Ca2+ signals in the growth cone (Song and Poo, 1999; Hong et al., 2000). 

Phrase: "Many guidance molecules,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "netrin-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0258174:netrin-1 [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1334908:netrin 1 [Gene or Genome]
  1000   C1442814:Netrin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "NGF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417719:NGF [Gene or Genome]

Phrase: "brain-derived neurotrophic factor,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "myelin-associated glycoprotein (MAG),"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0129439:Myelin Associated Glycoprotein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           myelin glycoprotein
  1000   C1416969:MYELIN-ASSOCIATED GLYCOPROTEIN [Gene or Genome]
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "influence"

Phrase: "the direction of axon extension"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449738:Direction [Spatial Concept]

Phrase: "through cytosolic Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "in the growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "(Song"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "and"

Phrase: "Poo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015733:poo [Body Substance]

Phrase: "1999"

Phrase: "; Hong et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.37: It has also been shown that a focal and unilateral elevation of cytosolic free Ca2+ concentration ([Ca2+]c) in the growth cone is sufficient to induce its turning to the side with elevated [Ca2+]c (Zheng, 2000). 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a focal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205234:Focal [Spatial Concept]
   928 E C1883677:Focality [Qualitative Concept]

Phrase: "and"

Phrase: "unilateral elevation of cytosolic free Ca2+ concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c) in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "the growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "its turning to the side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0541749:turning [Finding]

Phrase: "with elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c (Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.38: Interestingly, extracellular gradients of netrin-1 or MAG, which normally induce attractive or repulsive growth cone turning, respectively, increase [Ca2+]c that is highest on the side of the growth cone facing the source of the netrin-1/MAG gradients (Hong et al., 2000; Henley et al., 2004). 

Phrase: "Interestingly,"

Phrase: "extracellular gradients of netrin-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0812409:gradients [Quantitative Concept]
   726 E C0439182:% gradient [Quantitative Concept]

Phrase: "or"

Phrase: "MAG,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0129439:Myelin Associated Glycoprotein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           myelin glycoprotein
  1000   C1416969:MYELIN-ASSOCIATED GLYCOPROTEIN [Gene or Genome]
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "which normally"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "attractive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346874:Attractive [Qualitative Concept]

Phrase: "or"

Phrase: "repulsive growth cone turning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0541749:turning [Finding]

Phrase: "respectively,"

Phrase: "increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "highest on the side of the growth cone"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C1522410:Highest [Qualitative Concept]
   725   C0424639:growth height [Finding]
   711 E C0205250:High [Qualitative Concept]
   711 E C1299351:High [Qualitative Concept]
   711 E C2700149:HIGH [Intellectual Product]

Phrase: "facing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015450:Face [Body Location or Region]
   966   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "the source of the netrin-1/MAG gradients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0449416:Source [Finding]
   739   C1705919:Source [Idea or Concept]

Phrase: "(Hong et al.,"

Phrase: "2000"

Phrase: "; Henley et al.,"

Phrase: "2004"

Phrase: ")."
Processing 00000000.tx.39: This observation indicates that a [Ca2+]c gradient across the growth cone can trigger turning to the side with higher [Ca2+]c (attraction) as well as to the side with lower [Ca2+]c (repulsion). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicates"

Phrase: "that a [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c gradient across the growth cone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]

Phrase: "can"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "turning to the side"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0441987:Side [Spatial Concept]
   770   C0541749:turning [Finding]
   737 E C1709743:Turn [Spatial Concept]

Phrase: "with higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c (attraction"

Phrase: ")"

Phrase: "as well as to the side"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205170:Well [Qualitative Concept]
   753   C0441987:Side [Spatial Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "with lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c (repulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683283:repulsion [Mental Process]

Phrase: ")."
Processing 00000000.tx.40: What, then, determines the growth cone responses to the [Ca2+]c gradient? 

Phrase: "What,"

Phrase: "then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "determines"

Phrase: "the growth cone responses to the [Ca2+"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "]c gradient?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]
Processing 00000000.tx.41: An important distinction might be the amplitude of Ca2+ signals, with high-amplitude signals mediating attraction and low-amplitude signals mediating repulsion (Nishiyama et al., 2003; Henley et al., 2004; Wen et al., 2004). 

Phrase: "An important distinction"

Phrase: "might"

Phrase: "be"

Phrase: "the amplitude of Ca2+ signals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "with high-amplitude signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "attraction"

Phrase: "and"

Phrase: "low-amplitude signals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   827   C2346753:Amplitude [Spatial Concept]
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "repulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683283:repulsion [Mental Process]

Phrase: "(Nishiyama et al.,"

Phrase: "2003"

Phrase: "; Henley et al.,"

Phrase: "2004"

Phrase: "; Wen et al.,"

Phrase: "2004"

Phrase: ")."
Processing 00000000.tx.42: An earlier study showed that baseline [Ca2+]c is a determinant of the growth cone responses to [Ca2+]c increases: normal baseline [Ca2+]c (130 nM) favors attraction, and low baseline [Ca2+]c (60 nM) favors repulsion (Zheng, 2000). 

Phrase: "An earlier study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that baseline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "a determinant of the growth cone responses to [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1521761:Determinant [Functional Concept]

Phrase: "]c increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: ":"

Phrase: "normal baseline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0168634:baseline [Biomedical or Dental Material]
   861   C1442488:Baseline [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c (130 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "favors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "attraction,"

Phrase: "and"

Phrase: "low baseline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0168634:baseline [Biomedical or Dental Material]
   861   C1442488:Baseline [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c (60 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "favors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "repulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683283:repulsion [Mental Process]

Phrase: "(Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.43: However, because cytosolic Ca2+ signals above some threshold level activate the ryanodine receptors (RyRs) on the internal Ca2+ stores (for review see Bouchard et al., 2003), high-level Ca2+ signals are likely to trigger secondary Ca2+ influx to the cytosol via RyRs, a process called Ca2+-induced Ca2+ release (CICR). 

Phrase: "However,"

Phrase: "because"

Phrase: "cytosolic Ca2+ signals above some threshold level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1710082:Signal [Phenomenon or Process]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the ryanodine receptors (RyRs) on the internal Ca2+ stores"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   754 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   754 E C1753335:ryanodine receptor [Molecular Function]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Bouchard et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: ","

Phrase: "high-level Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "secondary Ca2+ influx to the cytosol"

Phrase: "via RyRs,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   983 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   983 E C1753335:ryanodine receptor [Molecular Function]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "Ca2+-induced Ca2+ release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(CICR"

Phrase: ")."
Processing 00000000.tx.44: Therefore, it is possible that the differential turning responses of the growth cone to Ca2+ signals depend primarily on the source of Ca2+ influx rather than the amplitude or the baseline level of Ca2+ signals. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the differential turning responses of the growth cone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0871261:responses [Organism Attribute]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]

Phrase: "to Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "depend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0725813:depend [Medical Device]

Phrase: "primarily on the source of Ca2+ influx"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449416:Source [Finding]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1705919:Source [Idea or Concept]

Phrase: "rather than"

Phrase: "the amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]

Phrase: "or"

Phrase: "the baseline level of Ca2+ signals."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0168634:baseline [Biomedical or Dental Material]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1442488:Baseline [Quantitative Concept]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.45: Answering this question is an important step for identifying downstream Ca2+ effectors and understanding the precise mechanisms of growth cone navigation. 

Phrase: "Answering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706817:Answer [Intellectual Product]

Phrase: "this question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "is"

Phrase: "an important step for identifying downstream Ca2+ effectors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1261552:Step [Conceptual Entity]
   744   C1704379:Step [Functional Concept]
   744   C1705117:Step [Quantitative Concept]
   744   C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the precise mechanisms of growth cone navigation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.46: Whilst guided by molecular guidance cues, a migrating growth cone also makes adhesive contact with its environment via cell adhesion molecules (CAMs). 

Phrase: "Whilst"

Phrase: "guided by molecular guidance cues,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0010439:Cues [Idea or Concept]
   760   C0150600:Guidance [Health Care Activity]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1959633:Guidance [Clinical Attribute]
   726   C0181090:Guide [Professional or Occupational Group]
   726   C0302614:Guide [Medical Device]
   726   C1706050:Guide [Manufactured Object]

Phrase: "a migrating growth cone also"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0596632:growth cone [Cell Component]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0206428:Cone [Cell]
   812   C0220844:growth [Physiologic Function]
   812   C0330095:Cone [Plant]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2350017:Cone [Spatial Concept]
   812   C2911660:Growth [Activity]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "adhesive contact with its environment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0332158:Contact with [Functional Concept]
           contact
   760   C0337611:Contact [Population Group]
   760   C1705415:Contact [Idea or Concept]

Phrase: "via cell adhesion molecules"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "(CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.47: CAMs expressed by neurons can be divided into three large families: integrins, cadherins, and the immunoglobulin superfamily (IgSF) members. 

Phrase: "CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "expressed by neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "can"

Phrase: "be"

Phrase: "divided into three large families"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0424972:Large family [Family Group]
   760   C0015576:Families [Family Group]
   760   C0205449:Three [Quantitative Concept]
   760   C0332849:Divided [Functional Concept]
   760   C0549177:Large [Quantitative Concept]
   760   C1704727:Family [Conceptual Entity]

Phrase: ":"

Phrase: "integrins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "cadherins,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006631:Cadherins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1413274:cadherin [Gene or Genome]

Phrase: "and"

Phrase: "the immunoglobulin superfamily (IgSF) members."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680022:members [Population Group]
   793 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.48: Cadherins and the majority of IgSF CAMs interact homophilically, i.e., with the same type of molecules present on adjacent cells (Takeichi, 1991; Brummendorf and Rathjen, 1994). 

Phrase: "Cadherins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006631:Cadherins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1413274:cadherin [Gene or Genome]

Phrase: "and"

Phrase: "the majority of IgSF CAMs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0680220:majority [Social Behavior]

Phrase: "interact"

Phrase: "homophilically,"

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "with the same type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "of molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "present on adjacent cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0150312:Present [Quantitative Concept]
   770   C0205117:Adjacent [Spatial Concept]
   770   C0449450:Present [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Takeichi,"

Phrase: "1991"

Phrase: "; Brummendorf"

Phrase: "and"

Phrase: "Rathjen,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.49: In contrast, integrins interact heterophilically, i.e., with extracellular matrix molecules, such as laminin (Letourneau et al., 1994). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "interact"

Phrase: "heterophilically,"

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "with extracellular matrix molecules,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "such as laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Letourneau et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.50: Upon ligand binding, different sets of CAMs expressed at the growth cone are likely to influence its turning response to guidance cues. 

Phrase: "Upon ligand binding,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1517880:Ligand Binding [Molecular Function]
   861   C0023688:Ligand [Chemical]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "different sets of CAMs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036849:Set [Mental Process]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]

Phrase: "expressed at the growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0596632:growth cone [Cell Component]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0206428:Cone [Cell]
   760   C0220844:growth [Physiologic Function]
   760   C0330095:Cone [Plant]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2350017:Cone [Spatial Concept]
   760   C2911660:Growth [Activity]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "influence"

Phrase: "its turning response to guidance cues."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.51: For example, growth cone attraction to netrin-1 is converted to repulsion by laminin (Hopker et al., 1999). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "growth cone attraction to netrin-1"

Phrase: "is"

Phrase: "converted to repulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0683283:repulsion [Mental Process]

Phrase: "by laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Hopker et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.52: Furthermore, neuropilin-1 forms a cis-dimer with L1, an IgSF CAM, on the growth cone membrane and mediates repulsive turning against semaphorin 3A (Castellani et al., 2000). 

Phrase: "Furthermore,"

Phrase: "neuropilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0100804:Neuropilin-1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1334905:NEUROPILIN 1 [Gene or Genome]
   861   C0287275:Neuropilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a cis-dimer with L1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596448:dimer [Chemical Viewed Structurally]

Phrase: "an IgSF CAM,"

Phrase: "on the growth cone membrane"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C2245784:growth cone membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0596632:growth cone [Cell Component]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "repulsive turning against semaphorin 3A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0541749:turning [Finding]

Phrase: "(Castellani et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.53: This repulsive response is converted to attraction by trans binding L1 with neuropilin-1 (Castellani et al., 2002). 

Phrase: "This repulsive response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "converted to attraction"

Phrase: "by trans binding L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441918:L1 [Finding]
   827   C1179698:L1 [Body Location or Region]
   827   C1416177:L1 [Gene or Genome]

Phrase: "with neuropilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0100804:Neuropilin-1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1334905:NEUROPILIN 1 [Gene or Genome]
   861   C0287275:Neuropilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Castellani et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.54: These results raise the possibility that CAMs influence the Ca2+ signals that mediate growth cone steering in response to guidance cues. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "influence"

Phrase: "the Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "growth cone steering in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0553654:steering [Finding]

Phrase: "to guidance cues."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010439:Cues [Idea or Concept]
Processing 00000000.tx.55: In this paper, we report two major findings: (1) the primary determinant of the turning direction is the source of Ca2+ influx to the growth cone cytosol. 

Phrase: "In this paper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "two major findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]

Phrase: ":"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "the primary determinant of the turning direction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521761:Determinant [Functional Concept]

Phrase: "is"

Phrase: "the source of Ca2+ influx"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "to the growth cone cytosol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1383501:Cytosol [Cell Component]
   734   C0596632:growth cone [Cell Component]
Processing 00000000.tx.56: RyR-mediated CICR triggers attractive turning, whereas Ca2+ signals without CICR induce repulsive turning. 

Phrase: "RyR-mediated CICR"

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "attractive turning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0541749:turning [Finding]

Phrase: "whereas"

Phrase: "Ca2+ signals without CICR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "repulsive turning."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0541749:turning [Finding]
Processing 00000000.tx.57: Consistent with this in vitro result, the RyR is also implicated in axon guidance in vivo. 

Phrase: "Consistent with this in vitro result,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the RyR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419778:RYR [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "implicated in axon guidance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C2984268:Axon guidance [Cell Function]
   797 E C0598948:axonal guidance [Cell Function]
   770   C0004461:Axon [Cell Component]
   770   C0150600:Guidance [Health Care Activity]
   770   C1959633:Guidance [Clinical Attribute]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.58: (2) CAMs influence growth cone steering by regulating the RyR activity via cAMP and protein kinase A (PKA). 

Phrase: "(2) CAMs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "influence"

Phrase: "growth cone steering by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0553654:steering [Finding]

Phrase: "regulating"

Phrase: "the RyR activity via cAMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "protein kinase A (PKA)."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.59: Growth cones migrating on an L1 or N-cadherin substrate have active RyRs and make an attractive turn in response to Ca2+ signals, whereas growth cones on a laminin substrate show the opposite behavior. 

Phrase: "Growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0596632:Growth Cones [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cones [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0330095:Cone [Plant]
   827 E C2350017:Cone [Spatial Concept]

Phrase: "migrating on an L1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0232902:migrating [Functional Concept]
   770   C0441918:L1 [Finding]
   770   C1179698:L1 [Body Location or Region]
   770   C1416177:L1 [Gene or Genome]

Phrase: "or"

Phrase: "N-cadherin substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1710236:Substrate [Manufactured Object]
   734   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1413277:N-CADHERIN [Gene or Genome]

Phrase: "have"

Phrase: "active RyRs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   884 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   884 E C1753335:ryanodine receptor [Molecular Function]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "an attractive turn in response to Ca2+ signals,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "whereas"

Phrase: "growth cones on a laminin substrate"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0596632:Growth Cones [Cell Component]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0206428:Cones [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
   719 E C0330095:Cone [Plant]
   719 E C2350017:Cone [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the opposite behavior."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.60: Our results indicate that axon-guiding and CAM-derived signals merge at the level of RyRs, which serve as key regulators of growth cone navigation.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that axon-guiding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0181090:Guide [Professional or Occupational Group]
   827   C0302614:Guide [Medical Device]
   827   C1706050:Guide [Manufactured Object]

Phrase: "and"

Phrase: "CAM-derived signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "merge at the level of RyRs,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   762 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762 E C1753335:ryanodine receptor [Molecular Function]
   748   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   748   C1547707:Level [Geographic Area]
   748   C1881786:Merge [Activity]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "serve as key regulators of growth cone navigation."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0596632:growth cone [Cell Component]
   750   C1817513:growth regulator [Cell Function]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0182953:regulators [Medical Device]
   744   C0206428:Cone [Cell]
   744   C0220844:growth [Physiologic Function]
   744   C0330095:Cone [Plant]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2350017:Cone [Spatial Concept]
   744   C2827562:Navigation [Activity]
   744   C2911660:Growth [Activity]
   711 E C1704734:Regulator [Medical Device]
   711 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.61: Results Top Abstract Introduction Results Discussion Materials and methods References  Ca2+-induced growth cone turning on different substrates Spatially restricted Ca2+ signals in a growth cone of a dorsal root ganglion (DRG) neuron were produced by focal laserinduced photolysis (FLIP) of a caged Ca2+ compound, o-nitrophenyl EGTA (NP-EGTA) compounded with Ca2+ in the cytosol. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Ca2+-induced growth cone turning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0541749:turning [Finding]

Phrase: "on different substrates Spatially restricted Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1710082:Signal [Phenomenon or Process]

Phrase: "in a growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "of a dorsal root ganglion (DRG) neuron"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0027882:Neuron [Cell]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   741 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "produced by focal laserinduced photolysis (FLIP) of a caged Ca2+ compound,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0031751:photolysis [Molecular Function]
   739   C0205198:Compound [Qualitative Concept]
   739   C0205234:Focal [Spatial Concept]
   739   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1706082:Compound [Chemical]
   706   C0337189:Cage [Manufactured Object]
   706   C0441239:Cage [Medical Device]

Phrase: "o-nitrophenyl EGTA (NP-EGTA)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0250426:o-nitrophenyl EGTA [Organic Chemical]
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0439114:O NOS [Intellectual Product]

Phrase: "compounded with Ca2+"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205198:compounded [Qualitative Concept]
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   756 E C1706082:Compound [Chemical]

Phrase: "in the cytosol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]
Processing 00000000.tx.62: Time-lapse images of [Ca2+]c using Calcium Green-1 (CG-1) demonstrated a focal and transient elevation of [Ca2+]c in response to a single laser pulse that photolyzed NP-EGTA (Fig. 1 A). 

Phrase: "Time-lapse images of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Calcium Green-1 (CG-1)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0753494:calcium green 1 [Indicator, Reagent, or Diagnostic Aid]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0332583:Green [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "demonstrated"

Phrase: "a focal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205234:Focal [Spatial Concept]
   928 E C1883677:Focality [Qualitative Concept]

Phrase: "and"

Phrase: "transient elevation of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in response to a single laser pulse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "photolyzed"

Phrase: "NP-EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.63: This type of experimental manipulation has been used extensively to study the physiological roles of Ca2+ signals in axon growth and guidance (Gomez and Spitzer, 1999; Gomez et al., 2001; Wen et al., 2004). 

Phrase: "This type of experimental manipulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "extensively to"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the physiological roles of Ca2+ signals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "in axon growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1749784:axon growth [Organ or Tissue Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "guidance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150600:Guidance [Health Care Activity]
  1000   C1959633:Guidance [Clinical Attribute]

Phrase: "(Gomez"

Phrase: "and"

Phrase: "Spitzer,"

Phrase: "1999"

Phrase: "; Gomez et al.,"

Phrase: "2001"

Phrase: "; Wen et al.,"

Phrase: "2004"

Phrase: ")."
Processing 00000000.tx.64: Consistent with a previous study (Zheng, 2000), repetitive FLIP of NP-EGTA on one side of the growth cone resulted in attractive turning on both L1 and N-cadherin substrates (Fig. 1, B and D; and Fig. 2 A). 

Phrase: "Consistent with a previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "repetitive FLIP of NP-EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0031751:photolysis [Molecular Function]

Phrase: "on one side"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205092:one side [Spatial Concept]
   861   C0441987:Side [Spatial Concept]

Phrase: "of the growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "resulted in attractive turning"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0541749:turning [Finding]
   770   C2346874:Attractive [Qualitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "on both L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "and"

Phrase: "N-cadherin substrates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1710236:Substrate [Manufactured Object]
   734   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1413277:N-CADHERIN [Gene or Genome]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"

Phrase: "and"

Phrase: "Fig. 2 A"

Phrase: ")."
Processing 00000000.tx.65: The attractive turning was sometimes preceded by lamellipodial protrusion (Fig. 1 B, 3 min) and filopodial elongation (not depicted), as reported previously (Lau et al., 1999; Cheng et al., 2002). 

Phrase: "The attractive turning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0541749:turning [Finding]

Phrase: "was"

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "preceded by lamellipodial protrusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332152:preceded [Temporal Concept]
   770   C0333056:protrusion [Anatomical Abnormality]

Phrase: "(Fig. 1 B,"

Phrase: "3 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "filopodial elongation"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "depicted"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(Lau et al.,"

Phrase: "1999"

Phrase: "; Cheng et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.66: In contrast, the same FLIP treatment caused repulsive turning on a laminin substrate (Fig. 1 F and Fig. 2 A). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the same FLIP treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "repulsive turning on a laminin substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0541749:turning [Finding]

Phrase: "(Fig. 1 F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Fig. 2 A"

Phrase: ")."
Processing 00000000.tx.67: As a control, simultaneous loading of 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), a fast Ca2+ chelator, completely negated the turning responses to NP-EGTA photolysis, indicating that Ca2+ released from NP-EGTA, but not byproducts of photolyzed NP-EGTA, was responsible for growth cone turning (Fig. 2 and see Fig. 7). 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "simultaneous loading of 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1708715:Loading [Activity]

Phrase: "2-bis(o-aminophenoxy"

Phrase: ")"

Phrase: "ethane-N,N,N',N'-tetraacetic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]

Phrase: "(BAPTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043775:BAPTA [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "a fast Ca2+ chelator,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007974:chelator [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C1664784:Chelator [Eukaryote]

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "negated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Negated [Functional Concept]

Phrase: "the turning responses to NP-EGTA photolysis,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "indicating"

Phrase: "that Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "released from NP-EGTA,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "not byproducts of photolyzed NP-EGTA,"

Phrase: "was"

Phrase: "responsible for growth cone turning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.68: These results indicate that, depending on the substrates, focal Ca2+ signals in growth cones induce either attractive or repulsive turning. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that,"

Phrase: "depending on the substrates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0725813:depend [Medical Device]
   737   C1710236:Substrate [Manufactured Object]

Phrase: "focal Ca2+ signals in growth cones"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0596632:Growth Cones [Cell Component]
   799   C0206428:Cones [Cell]
   766 E C0330095:Cone [Plant]
   766 E C2350017:Cone [Spatial Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "either attractive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346874:Attractive [Qualitative Concept]

Phrase: "or"

Phrase: "repulsive turning."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0541749:turning [Finding]
Processing 00000000.tx.69: The three substrates (L1, N-cadherin, and laminin) did not influence the subpopulations of surviving neurons as shown in a previous study (Nishimura et al., 2003), excluding the possibility that the differential turning behavior of growth cones was dependent on neuronal cell types. 

Phrase: "The three substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "(L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "N-cadherin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the subpopulations of surviving neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1257890:Subpopulation [Population Group]

Phrase: "as"

Phrase: "shown in a previous study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205156:Previous [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1552607:previous [Temporal Concept]
   760   C2603343:Study [Research Activity]
   726   C1547282:Show [Intellectual Product]

Phrase: "(Nishimura et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: ","

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the differential turning behavior of growth cones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1523628:turning behavior [Individual Behavior]
   748   C0004927:Behavior [Individual Behavior]
   748   C2707008:Behavior [Clinical Attribute]

Phrase: "was"

Phrase: "dependent on neuronal cell types."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.70: View larger version (29K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.71: Ca2+-induced growth cone turning on different substrates. 

Phrase: "Ca2+-induced growth cone turning on different substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0541749:turning [Finding]
Processing 00000000.tx.72: (A) A localized and transient [Ca2+]c elevation is produced by single FLIP of NP-EGTA in a chick DRG growth cone. 

Phrase: "(A)"

Phrase: "A localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "and"

Phrase: "transient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040704:Transient [Population Group]
  1000   C0205374:Transient [Temporal Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "is"

Phrase: "produced by single FLIP of NP-EGTA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0031751:photolysis [Molecular Function]
   742   C0037179:Single [Population Group]
   742   C0087136:single [Finding]
   742   C0205171:Single [Quantitative Concept]
   742   C0205234:Focal [Spatial Concept]

Phrase: "in a chick DRG growth cone."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0596632:growth cone [Cell Component]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0206428:Cone [Cell]
   799   C0220844:growth [Physiologic Function]
   799   C0330095:Cone [Plant]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2350017:Cone [Spatial Concept]
   799   C2911660:Growth [Activity]
Processing 00000000.tx.73: Shown is the time course of the Ca2+ signal (CG-1 F/F0 in pseudocolor). 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "the time course of the Ca2+ signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0449247:Time course [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C0750729:Course [Temporal Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "(CG-1 F/F0 in pseudocolor"

Phrase: ")."
Processing 00000000.tx.74: Each image was acquired by a 10-ms exposure starting at the indicated time point after the laser shot. 

Phrase: "Each image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "acquired by a 10-ms exposure starting"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]
   748   C0439661:Acquired [Temporal Concept]
   748   C2349943:Ms. [Conceptual Entity]
   748   C3245488:acquired [Intellectual Product]
   748   C3539704:MS [Gene or Genome]
   714   C0439659:Start [Temporal Concept]
   714 E C1706701:Acquire [Activity]

Phrase: "at the indicated time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "after the laser shot."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:Shot [Therapeutic or Preventive Procedure]
   861   C1420042:SHOT [Gene or Genome]
   861   C2699298:Shot [Quantitative Concept]
   861   C2919062:Shot NOS [Injury or Poisoning]
Processing 00000000.tx.75: Bar, 10 m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.76: Time-lapse DIC images showing Ca2+-induced growth cone turning on L1 (B and C), N-cadherin (D and E), or laminin (F and G). 

Phrase: "Time-lapse DIC images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C1704254:Image [Intellectual Product]
   766   C1704922:Image [Entity]
   766   C3542466:Image [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "Ca2+-induced growth cone turning on L1 (B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0541749:turning [Finding]

Phrase: "and"

Phrase: "C"

Phrase: ")"

Phrase: ","

Phrase: "N-cadherin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.77: Rp-cAMPS (C and E) or Sp-cAMPS (G) was added to the culture media. 

Phrase: "Rp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525261:(RP)-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(C"

Phrase: "and"

Phrase: "E)"

Phrase: "or"

Phrase: "Sp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "added to the culture media."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0162867:Media [Tissue]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1254021:Media [Tissue]
   760   C1524062:Added [Functional Concept]
   760   C2242979:Culture [Laboratory Procedure]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C1883712:Add [Functional Concept]
   726 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.78: Loaded NP-EGTA in the growth cone was uncaged every 3 s by laser irradiation at the red spot. 

Phrase: "Loaded NP-EGTA in the growth cone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "uncaged"

Phrase: "every 3 s by laser irradiation"

Phrase: "at the red spot."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0329155:Spot [Fish]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]
Processing 00000000.tx.79: Digits represent minutes after the onset of repetitive FLIP. 

Phrase: "Digits"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0582802:Digits [Body Part, Organ, or Organ Component]
   966 E C1283912:Digit [Body Part, Organ, or Organ Component]
   966 E C3241971:Digit [Quantitative Concept]
   916 E C0442015:Digital [Intellectual Product]
   916 E C1883674:Digital [Qualitative Concept]
   900 E C0016129:Finger [Body Location or Region]
   900 E C0549188:fingers [Quantitative Concept]
   900 E C1281584:Finger [Body Part, Organ, or Organ Component]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "minutes after the onset of repetitive FLIP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0439232:minute [Temporal Concept]
   742   C0700321:minute [Quantitative Concept]
   742   C0702093:/minute [Temporal Concept]
   742   C1282918:Minute [Quantitative Concept]
   742   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.80: Growth cone images on laminin at different time points were superimposed (F and G). 

Phrase: "Growth cone images on laminin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "at different time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "were"

Phrase: "superimposed"

Phrase: "(F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.81: Bar, 10 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.82: View larger version (36K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.83: Involvement of cAMP and RyRs in Ca2+-induced growth cone turning. 

Phrase: "Involvement of cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involvement [Functional Concept]

Phrase: "and"

Phrase: "RyRs in Ca2+-induced growth cone turning."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   754 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   754 E C1753335:ryanodine receptor [Molecular Function]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.84: (A) The distribution of turning angles of chick DRG growth cones on the three different substrates. 

Phrase: "(A)"

Phrase: "The distribution of turning angles of chick DRG growth cones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0520511:distribution [Idea or Concept]
   736   C1704711:Distribution [Functional Concept]

Phrase: "on the three different substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.85: Focal Ca2+ signals were produced on one side of the growth cones by repetitive FLIP of NP-EGTA. 

Phrase: "Focal Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "produced on one side of the growth cones"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0205092:one side [Spatial Concept]
   770   C0596632:Growth Cones [Cell Component]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0205447:One [Quantitative Concept]
   744   C0206428:Cones [Cell]
   744   C0220844:growth [Physiologic Function]
   744   C0441987:Side [Spatial Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]
   711 E C0330095:Cone [Plant]
   711 E C2350017:Cone [Spatial Concept]

Phrase: "by repetitive FLIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031751:photolysis [Molecular Function]

Phrase: "of NP-EGTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.86: Each point represents the percentage of growth cones with turning angles equal to or smaller than that indicated on the abscissa. 

Phrase: "Each point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the percentage of growth cones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "with turning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0541749:turning [Finding]

Phrase: "angles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205143:Angle [Spatial Concept]

Phrase: "equal to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205163:Equal To [Qualitative Concept]
           Equal
   833   C1549782:Equal [Idea or Concept]

Phrase: "or"

Phrase: "smaller than that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0547044:Smaller [Qualitative Concept]
   790   C0700321:Smaller [Quantitative Concept]

Phrase: "indicated on the abscissa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.87: As a control, loading of BAPTA canceled FLIP-induced growth cone turning. 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "loading of BAPTA"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0043775:BAPTA [Organic Chemical,Pharmacologic Substance]
   790   C1708715:Loading [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "canceled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Canceled [Qualitative Concept]

Phrase: "FLIP-induced growth cone turning."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0541749:turning [Finding]
Processing 00000000.tx.88: (B) The average turning angles of growth cones on the three different substrates. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The average turning angles of growth cones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205143:angles [Spatial Concept]

Phrase: "on the three different substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.89: Treatment of growth cones with the indicated drugs (Sp-cAMPS, Rp-cAMPS, ryanodine, or KT5720) reversed the turning responses to Ca2+ signals. 

Phrase: "Treatment of growth cones"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with the indicated drugs"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C1277226:indicated drug [Finding]
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "(Sp-cAMPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "Rp-cAMPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525261:(RP)-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "ryanodine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "KT5720"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064433:KT5720 [Organic Chemical]

Phrase: ")"

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "the turning responses to Ca2+ signals."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]
Processing 00000000.tx.90: Growth cones without NP-EGTA loading (blank) did not show a directional response to repetitive laser irradiation. 

Phrase: "Growth cones without NP-EGTA loading"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0596632:Growth Cones [Cell Component]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0206428:Cones [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
   719 E C0330095:Cone [Plant]
   719 E C2350017:Cone [Spatial Concept]

Phrase: "(blank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750479:blank [Finding]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a directional response to repetitive laser irradiation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]
Processing 00000000.tx.91: Error bars represent 1121 growth cones.  

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "1121 growth cones."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0596632:Growth Cones [Cell Component]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0206428:Cones [Cell]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793 E C0330095:Cone [Plant]
   793 E C2350017:Cone [Spatial Concept]
Processing 00000000.tx.92: Substrate dependency of Ca2+-induced growth cone turning is accounted for by differential cAMP activities Hopker et al. 

Phrase: "Substrate dependency of Ca2+-induced growth cone turning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0011546:Dependency [Mental Process]
   744   C1546937:Dependency [Idea or Concept]

Phrase: "is"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by differential cAMP activities Hopker et al."
Processing 00000000.tx.93: (1999) previously reported that netrin-1mediated attraction of retinal growth cones was converted to repulsion by laminin. 

Phrase: "(1999"

Phrase: ")"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that netrin-1mediated attraction of retinal growth cones"

Phrase: "was"

Phrase: "converted to repulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0683283:repulsion [Mental Process]

Phrase: "by laminin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.94: These authors also explained that the amount of cAMP in growth cones, as assessed by immunocytochemistry, was decreased in the presence of laminin, suggesting that cAMP might mediate cross talk between growth cone guidance and adhesion. 

Phrase: "These authors also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0221193:Authors [Professional or Occupational Group]

Phrase: "explained"

Phrase: "that"

Phrase: "the amount of cAMP in growth cones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "as"

Phrase: "assessed by immunocytochemistry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242349:Immunocytochemistry [Laboratory Procedure]
   790   C1516048:Assessed [Activity]

Phrase: "was"

Phrase: "decreased in the presence of laminin,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "might"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cross talk between growth cone guidance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0010357:Crosstalk [Molecular Function]
   790   C2986468:Cross-talk [Cell Function]
   753   C0037817:Talk [Organism Function]
   753   C0234856:talk [Daily or Recreational Activity]
   753   C0600118:talk [Finding]
   753   C2828360:Cross [Conceptual Entity]

Phrase: "and"

Phrase: "adhesion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.95: Therefore, we first compared cAMP levels in DRG neurons cultured on three different substratesL1, N-cadherin, and laminin. 

Phrase: "Therefore,"

Phrase: "we first compared cAMP levels in DRG neurons"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   739   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "cultured on three different substratesL1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205449:Three [Quantitative Concept]
   760   C1705242:Different [Qualitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "N-cadherin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "laminin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.96: A competitive immunoassay showed that the neurons contained higher cAMP levels on L1 and N-cadherin than on laminin (Fig. 3 A). 

Phrase: "A competitive immunoassay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020980:Immunoassay [Laboratory Procedure]
   861   C0021060:immunoassay [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "higher cAMP levels on L1"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C0446432:L1 level [Body Location or Region]
   760   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "N-cadherin than"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1413277:N-CADHERIN [Gene or Genome]
   790   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441922:N+ [Intellectual Product]
   790   C1413274:cadherin [Gene or Genome]
   790   C1553036:[n] [Quantitative Concept]

Phrase: "on laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 3 A"

Phrase: ")."
Processing 00000000.tx.97: To quantify the activity of cAMP in the growth cone, we used FlCRhR, which changes the efficiency of fluorescence resonance energy transfer from fluorescein to rhodamine, in response to cAMP binding to the PKA regulatory subunits (Adams et al., 1991). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "the activity of cAMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "in the growth cone,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "FlCRhR,"

Phrase: "which"

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the efficiency of fluorescence resonance energy transfer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013682:Efficiency [Quantitative Concept]

Phrase: "from fluorescein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "to rhodamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to cAMP binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1148918:cAMP binding [Molecular Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "to the PKA regulatory subunits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   771   C1711351:Subunit [Quantitative Concept]
   717   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Adams et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.98: Consistent with our immunoassay data, the ratio images (F520/F580) showed that the cAMP activities in the growth cones were higher on L1 and N-cadherin than on laminin (Fig. 3, B and C). 

Phrase: "Consistent with our immunoassay data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the ratio images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "(F520/F580"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the cAMP activities in the growth cones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441655:Activities [Activity]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "higher on L1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "and"

Phrase: "N-cadherin than"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1413277:N-CADHERIN [Gene or Genome]
   790   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441922:N+ [Intellectual Product]
   790   C1413274:cadherin [Gene or Genome]
   790   C1553036:[n] [Quantitative Concept]

Phrase: "on laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C"

Phrase: ")."
Processing 00000000.tx.99: Next, the effect of cAMP modulation on Ca2+-induced growth cone turning was examined. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "the effect of cAMP modulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on Ca2+-induced growth cone turning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0541749:turning [Finding]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.100: Bath application of Rp-cAMPS, a membrane-permeable cAMP antagonist, converted Ca2+-induced attraction to repulsion on both L1 and N-cadherin substrates (Fig. 1, C and E; and Fig. 2 B). 

Phrase: "Bath application of Rp-cAMPS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185125:Application [Health Care Activity]
   760   C1947919:Application [Intellectual Product]
   760   C2347934:Application [Intellectual Product]
   760   C3539080:APPLICATION [Quantitative Concept]

Phrase: "a membrane-permeable cAMP antagonist,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0231491:Antagonist [Organ or Tissue Function]
   712 E C0680242:antagonism [Social Behavior]

Phrase: "converted Ca2+-induced attraction to repulsion"

Phrase: "on both L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "and"

Phrase: "N-cadherin substrates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1710236:Substrate [Manufactured Object]
   734   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1413277:N-CADHERIN [Gene or Genome]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "E"

Phrase: ";"

Phrase: "and"

Phrase: "Fig. 2 B"

Phrase: ")."
Processing 00000000.tx.101: An inhibition of PKA, a cAMP-dependent protein kinase, by KT5720 had a similar result (Fig. 2 B). 

Phrase: "An inhibition of PKA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "a cAMP-dependent protein kinase,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0010531:cAMP-Dependent Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "by KT5720"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064433:KT5720 [Organic Chemical]

Phrase: "had"

Phrase: "a similar result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "(Fig. 2 B"

Phrase: ")."
Processing 00000000.tx.102: Sp-cAMPS, a cAMP agonist that activates PKA, converted Ca2+-induced repulsion to attraction on laminin (Fig. 1 G and Fig. 2 B). 

Phrase: "Sp-cAMPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "a cAMP agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2987634:Agonist [Pharmacologic Substance]

Phrase: "that"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "PKA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "converted Ca2+-induced repulsion to attraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0683283:repulsion [Mental Process]

Phrase: "on laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1 G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Fig. 2 B"

Phrase: ")."
Processing 00000000.tx.103: These results indicate that differential cAMPPKA activities account for the substrate dependency of Ca2+-induced growth cone turning, with high cAMPPKA activities favoring attraction and low cAMPPKA activities causing repulsion. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that differential cAMPPKA activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "account for the substrate dependency of Ca2+-induced growth cone turning,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   756   C0596632:growth cone [Cell Component]
   738   C0011546:Dependency [Mental Process]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0205263:Induced [Functional Concept]
   738   C0206428:Cone [Cell]
   738   C0220844:growth [Physiologic Function]
   738   C0330095:Cone [Plant]
   738   C0541749:turning [Finding]
   738   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C1546937:Dependency [Idea or Concept]
   738   C1551359:account [Idea or Concept]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C1710236:Substrate [Manufactured Object]
   738   C2350017:Cone [Spatial Concept]
   738   C2741673:Account # [Clinical Attribute]
   738   C2911660:Growth [Activity]
   738   C2981730:Account [Classification]

Phrase: "with high cAMPPKA activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "favoring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:favoring [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "attraction"

Phrase: "and"

Phrase: "low cAMPPKA activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "repulsion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683283:repulsion [Mental Process]
Processing 00000000.tx.104: View larger version (38K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.105: CAMs regulate cAMP activities in growth cones. 

Phrase: "CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "regulate"

Phrase: "cAMP activities in growth cones."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C0596632:Growth Cones [Cell Component]
   804   C0206428:Cones [Cell]
   771 E C0330095:Cone [Plant]
   771 E C2350017:Cone [Spatial Concept]
Processing 00000000.tx.106: (A) Competitive immunoassays showing intracellular cAMP levels in chick DRG neurons on L1, N-cadherin, or laminin. 

Phrase: "(A) Competitive immunoassays"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0020980:Immunoassays [Laboratory Procedure]
   793 E C0021060:immunoassay [Laboratory Procedure]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "intracellular cAMP levels in chick DRG neurons"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "on L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "N-cadherin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "or"

Phrase: "laminin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.107: *, P < 0.05; 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.108: ***, P < 0.001; 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.109: compared with a laminin substrate (n = 7). 

Phrase: "compared with a laminin substrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0248561:laminin A [Amino Acid, Peptide, or Protein]
   797   C1416775:LAMININ A [Gene or Genome]
   760   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1707455:Compared [Activity]
   760   C1710236:Substrate [Manufactured Object]

Phrase: "(n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.110: (B) FlCRhR ratio images (F520/F580 in pseudocolor) showing cytosolic cAMP activities in chick DRG growth cones on L1, N-cadherin, or laminin. 

Phrase: "(B) FlCRhR ratio images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1704254:Image [Intellectual Product]
   779   C1704922:Image [Entity]
   779   C3542466:Image [Intellectual Product]

Phrase: "(F520/F580 in pseudocolor"

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "cytosolic cAMP activities in chick DRG growth cones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0441655:Activities [Activity]
   706 E C0205177:Activity [Functional Concept]
   706 E C0439167:% activity [Quantitative Concept]
   706 E C1561536:*Activity [Idea or Concept]

Phrase: "on L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "N-cadherin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "or"

Phrase: "laminin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.111: Bar, 10 m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.112: (C) Measurements of cAMP activities in growth cones on the three different substrates. 

Phrase: "(C"

Phrase: ")"

Phrase: "Measurements of cAMP activities in growth cones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0201979:cAMP measurement [Laboratory Procedure]
   748   C0242485:measurements [Functional Concept]

Phrase: "on the three different substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.113: The F520/F580 values of FlCRhR were averaged in growth cones. 

Phrase: "The F520/F580 values of FlCRhR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "in growth cones."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0596632:Growth Cones [Cell Component]
   827   C0206428:Cones [Cell]
   793 E C0330095:Cone [Plant]
   793 E C2350017:Cone [Spatial Concept]
Processing 00000000.tx.114: Error bars represent 2632 growth cones. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "2632 growth cones."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0596632:Growth Cones [Cell Component]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0206428:Cones [Cell]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793 E C0330095:Cone [Plant]
   793 E C2350017:Cone [Spatial Concept]
Processing 00000000.tx.115: **, P < 0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.116: ***, P < 0.001; 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.117: compared with a laminin substrate.  

Phrase: "compared with a laminin substrate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0248561:laminin A [Amino Acid, Peptide, or Protein]
   797   C1416775:LAMININ A [Gene or Genome]
   760   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1707455:Compared [Activity]
   760   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.118: Because PKA has been shown to phosphorylate RyRs and facilitate CICR in other biological systems (Yoshida et al., 1992; Valdivia et al., 1995; Wehrens and Marks, 2003), we assessed whether Ca2+-induced growth cone attraction depended also on RyR-mediated CICR in addition to cAMPPKA. 

Phrase: "Because"

Phrase: "PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "RyRs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   983 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   983 E C1753335:ryanodine receptor [Molecular Function]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "facilitate"

Phrase: "CICR in other biological systems"

Phrase: "(Yoshida et al.,"

Phrase: "1992"

Phrase: "; Valdivia et al.,"

Phrase: "1995"

Phrase: "; Wehrens"

Phrase: "and"

Phrase: "Marks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]

Phrase: "2003"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "whether"

Phrase: "Ca2+-induced growth cone attraction"

Phrase: "depended"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0725813:depend [Medical Device]

Phrase: "also on RyR-mediated CICR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1419778:RYR [Gene or Genome]

Phrase: "in addition to cAMPPKA."
Processing 00000000.tx.119: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.120: 2 B, Ca2+ signals caused growth cone repulsion even on L1 and N-cadherin substrates if neurons were pretreated with a high dose (100 M) of ryanodine to trap RyRs in the closed state (Zucchi and Ronca-Testoni, 1997), suggesting that RyRs cooperated with cAMPPKA in Ca2+-mediated growth cone attraction. 

Phrase: "2 B,"

Phrase: "Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "growth cone repulsion even on L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0683283:repulsion [Mental Process]

Phrase: "and"

Phrase: "N-cadherin substrates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1710236:Substrate [Manufactured Object]
   734   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1413277:N-CADHERIN [Gene or Genome]

Phrase: "if"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "pretreated with a high dose"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0444956:High dose [Quantitative Concept]
   760   C0178602:Dose [Quantitative Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "(100"

Phrase: "M) of ryanodine to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "trap"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184047:trap [Medical Device]

Phrase: "RyRs in the closed state"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   773 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   773 E C1753335:ryanodine receptor [Molecular Function]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Zucchi"

Phrase: "and"

Phrase: "Ronca-Testoni,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that RyRs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   983 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   983 E C1753335:ryanodine receptor [Molecular Function]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "cooperated with cAMPPKA"

Phrase: "in Ca2+-mediated growth cone attraction."
Processing 00000000.tx.121: cAMP facilitates RyR-mediated CICR in growth cones To test whether cAMPPKA facilitated CICR in growth cones, we analyzed the amplitude of Ca2+ signals by CG-1 imaging synchronized with FLIP. 

Phrase: "cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "facilitates"

Phrase: "RyR-mediated CICR in growth cones To"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   818   C0596632:Growth Cones [Cell Component]
   795   C0206428:Cones [Cell]
   762 E C0330095:Cone [Plant]
   762 E C2350017:Cone [Spatial Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "cAMPPKA"

Phrase: "facilitated"

Phrase: "CICR in growth cones,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0596632:Growth Cones [Cell Component]
   812   C0206428:Cones [Cell]
   779 E C0330095:Cone [Plant]
   779 E C2350017:Cone [Spatial Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the amplitude of Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "by CG-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0753494:calcium green 1 [Indicator, Reagent, or Diagnostic Aid]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0332583:Green [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "synchronized with FLIP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0031751:photolysis [Molecular Function]
   760   C0205234:Focal [Spatial Concept]
   760   C0439580:Synchronized [Temporal Concept]
Processing 00000000.tx.122: Focal [Ca2+]c was quantified by averaging CG-1 F/F0 within a 2-m-diameter zone centered by the FLIP site (Fig. 4). 

Phrase: "Focal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205234:Focal [Spatial Concept]
   928 E C1883677:Focality [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "quantified by averaging CG-1 F/F0"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0753494:calcium green 1 [Indicator, Reagent, or Diagnostic Aid]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   744   C0332583:Green [Qualitative Concept]
   744   C0439133:(f) [Intellectual Product]
   744   C1553038:[f] [Quantitative Concept]
   744   C2936886:Calcium [Pharmacologic Substance]
   711   C1510992:Average [Quantitative Concept]
   711   C1709793:Quantify [Quantitative Concept]
   711   C2825518:AVERAGE [Quantitative Concept]

Phrase: "within a 2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "m-"

Phrase: "diameter zone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1710706:Zone [Spatial Concept]
   789 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]

Phrase: "centered by the FLIP site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0031751:photolysis [Molecular Function]
   748   C0205099:centered [Spatial Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0205234:Focal [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.123: A transient elevation of [Ca2+]c was observed only in the first charge-coupled device (CCD) frame after FLIP (0.816.5 ms after a laser pulse; see Materials and methods). 

Phrase: "A transient elevation of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only in the first charge-coupled device"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   814   C1455741:Charge coupled device [Medical Device]
   748   C0007961:Charge [Quantitative Concept]
   748   C0025080:Device [Medical Device]
   748   C0205171:Only [Quantitative Concept]
   748   C0205435:First [Quantitative Concept]
   748   C0699733:Device [Manufactured Object]
   748   C1279901:First [Qualitative Concept]
   748   C1706211:Charge [Organism Attribute]
   748   C1720467:Only [Intellectual Product]
   748   C1948027:Coupled [Functional Concept]
   714 E C0010222:couple [Family Group]

Phrase: "(CCD) frame after FLIP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080089:Frame [Nucleotide Sequence]
   753   C0180979:Frame [Medical Device]
   753   C1705858:Frame [Manufactured Object]

Phrase: "(0.816.5 ms after a laser pulse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   744   C2349943:Ms. [Conceptual Entity]
   744   C3539704:MS [Gene or Genome]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: This elevation should be the sum of Ca2+ liberation from NP-EGTA and secondary Ca2+ influx to the cytosol, if applicable. 

Phrase: "This elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439775:Elevation [Therapeutic or Preventive Procedure]
  1000   C0702240:Elevation [Spatial Concept]

Phrase: "should"

Phrase: "be"

Phrase: "the sum of Ca2+ liberation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515051:Sum [Quantitative Concept]

Phrase: "from NP-EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "secondary Ca2+ influx to the cytosol,"

Phrase: "if"

Phrase: "applicable."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272460:applicable [Qualitative Concept]
  1000   C1706839:Applicable [Qualitative Concept]
Processing 00000000.tx.125: To dissect the two different Ca2+ sources, we compared the amplitude of [Ca2+]c elevations in the same growth cones before and after pharmacological treatments. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "dissect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissect [Functional Concept]

Phrase: "the two different Ca2+ sources,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0449416:sources [Finding]
   779 E C1705919:Source [Idea or Concept]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the amplitude of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations in the same growth cones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0702240:elevations [Spatial Concept]
   714 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "before"

Phrase: "and after pharmacological treatments."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0013216:Pharmacological Treatments [Therapeutic or Preventive Procedure]
   770   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   770   C0205464:pharmacological [Functional Concept]
   770   C1515981:And [Idea or Concept]
   737 E C0039798:treatment [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.126: In a growth cone on laminin, for example, a train of five laser pulses produced Ca2+ signals of similar amplitude that increased after treating the growth cone with Sp-cAMPS (Fig. 4, A and B). 

Phrase: "In a growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "on laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "a train of five laser"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0336809:Train [Manufactured Object]
   760   C1552514:Train [Manufactured Object]

Phrase: "pulses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034107:Pulses [Health Care Activity]
  1000   C0232117:PULSE [Clinical Attribute]
  1000   C0391850:PULSES [Physiologic Function]
  1000   C1947910:Pulse [Phenomenon or Process]

Phrase: "produced Ca2+ signals of similar amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "after"

Phrase: "treating"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treating [Therapeutic or Preventive Procedure]
  1000   C1522326:Treating [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "the growth cone with Sp-cAMPS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0596632:growth cone [Cell Component]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0206428:Cone [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C0330095:Cone [Plant]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2350017:Cone [Spatial Concept]
   753   C2911660:Growth [Activity]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.127: In contrast, Ca2+-signal amplitude decreased after a growth cone on N-cadherin was treated with 100 M ryanodine (Fig. 4, C and D). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Ca2+-signal amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "decreased after a growth cone"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   806   C0596632:growth cone [Cell Component]
   797   C0151686:Decreased growth [Pathologic Function]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0206428:Cone [Cell]
   760   C0220844:growth [Physiologic Function]
   760   C0330095:Cone [Plant]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2350017:Cone [Spatial Concept]
   760   C2911660:Growth [Activity]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "on N-cadherin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "was"

Phrase: "treated with 100 M ryanodine"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.128: The amplitude of five Ca2+ elevations (F/F0 spikes) after five laser pulses was averaged and compared in the same growth cone before and after a 5-min treatment with various pharmacological reagents (Fig. 5). 

Phrase: "The amplitude of five Ca2+ elevations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346753:Amplitude [Spatial Concept]

Phrase: "(F/F0 spikes"

Phrase: ")"

Phrase: "after"

Phrase: "five laser pulses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0034107:Pulses [Health Care Activity]
   827   C0391850:PULSES [Physiologic Function]
   793 E C0232117:PULSE [Clinical Attribute]
   793 E C1947910:Pulse [Phenomenon or Process]

Phrase: "was"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "and"

Phrase: "compared in the same growth cone"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0596632:growth cone [Cell Component]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0206428:Cone [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C0330095:Cone [Plant]
   753   C0445247:Same [Qualitative Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1707455:Compared [Activity]
   753   C2350017:Cone [Spatial Concept]
   753   C2911660:Growth [Activity]

Phrase: "before"

Phrase: "and after a 5-min treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0702093:/min [Temporal Concept]
   753   C1515981:And [Idea or Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with various pharmacological reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.129: The Sp-cAMPS treatment augmented Ca2+ signals in growth cones only on a laminin substrate, presumably because the downstream cascade of cAMP was fully active on L1 and N-cadherin, even in the absence of Sp-cAMPS. 

Phrase: "The Sp-cAMPS treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "augmented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:Augmented [Quantitative Concept]

Phrase: "Ca2+ signals in growth cones only on a laminin substrate,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0596632:Growth Cones [Cell Component]
   739   C0206428:Cones [Cell]
   706 E C0330095:Cone [Plant]
   706 E C2350017:Cone [Spatial Concept]

Phrase: "presumably"

Phrase: "because"

Phrase: "the downstream cascade of cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707310:Cascade [Manufactured Object]

Phrase: "was"

Phrase: "fully active on L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "N-cadherin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "even in the absence of Sp-cAMPS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.130: This augmentation by Sp-cAMPS on laminin was abolished by a simultaneous treatment with 100 M ryanodine, suggesting that Sp-cAMPS facilitated an additional increase of [Ca2+]c via ryanodine-sensitive channels, such as RyR-mediated CICR. 

Phrase: "This augmentation by Sp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1293122:Augmentation [Therapeutic or Preventive Procedure]

Phrase: "on laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "abolished by a simultaneous treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0521115:Simultaneous [Temporal Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1548968:Simultaneous [Idea or Concept]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with 100 M ryanodine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Sp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "facilitated"

Phrase: "an additional increase of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c via ryanodine-sensitive channels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1553033:[c] [Quantitative Concept]

Phrase: "such as RyR-mediated CICR."
Processing 00000000.tx.131: Consistent with this idea, the treatment with either Rp-cAMPS or ryanodine attenuated Ca2+ signals in growth cones on L1 and N-cadherin but not on laminin. 

Phrase: "Consistent with this idea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the treatment with either Rp-cAMPS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "ryanodine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "Ca2+ signals in growth cones on L1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   778   C0596632:Growth Cones [Cell Component]
   748   C0206428:Cones [Cell]
   714 E C0330095:Cone [Plant]
   714 E C2350017:Cone [Spatial Concept]

Phrase: "and"

Phrase: "N-cadherin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "but"

Phrase: "not on laminin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.132: View larger version (45K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.133: Pharmacological dissection of different components of Ca2+ signals induced by NP-EGTA photolysis. 

Phrase: "Pharmacological dissection of different components of Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "induced by NP-EGTA photolysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0031751:photolysis [Molecular Function]
   760   C0205263:Induced [Functional Concept]
Processing 00000000.tx.134: (A and B) Sp-cAMPS augments FLIP-induced Ca2+ signals in a chick DRG growth cone on laminin. 

Phrase: "(A"

Phrase: "and"

Phrase: "B) Sp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "FLIP-induced Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1710082:Signal [Phenomenon or Process]

Phrase: "in a chick DRG growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0596632:growth cone [Cell Component]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0206428:Cone [Cell]
   799   C0220844:growth [Physiologic Function]
   799   C0330095:Cone [Plant]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2350017:Cone [Spatial Concept]
   799   C2911660:Growth [Activity]

Phrase: "on laminin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.135: Before and after a 5-min treatment with Sp-cAMPS (A and B, respectively), the Ca2+ signals were analyzed in the same growth cone under the same FLIP conditions. 

Phrase: "Before"

Phrase: "and after a 5-min treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0702093:/min [Temporal Concept]
   753   C1515981:And [Idea or Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with Sp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "the Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "analyzed in the same growth cone"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0596632:growth cone [Cell Component]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0206428:Cone [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C0330095:Cone [Plant]
   753   C0445247:Same [Qualitative Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2350017:Cone [Spatial Concept]
   753   C2911660:Growth [Activity]

Phrase: "under the same FLIP conditions."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   771   C0012634:condition [Disease or Syndrome]
   771   C0348080:Condition [Qualitative Concept]
   771   C1705253:Condition [Conceptual Entity]
   721 E C0009647:Conditioned [Mental Process]
   721 E C1701901:Conditional [Qualitative Concept]
   721 E C1963686:Conditional [Functional Concept]
Processing 00000000.tx.136: CG-1 fluorescence was imaged at the exposure of 15.7 ms. 

Phrase: "CG-1 fluorescence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   756   C0753494:calcium green 1 [Indicator, Reagent, or Diagnostic Aid]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "imaged at the exposure of 15.7 ms."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0274281:Exposure, NOS [Injury or Poisoning]
   744   C0332157:Exposure [Clinical Attribute]
   744   C2349943:Ms. [Conceptual Entity]
   744   C3539704:MS [Gene or Genome]
   711   C1704254:Image [Intellectual Product]
   711   C1704922:Image [Entity]
   711   C3542466:Image [Intellectual Product]
Processing 00000000.tx.137: The pseudocolor images show F/F0 immediately before or 0.8 ms after single FLIP. 

Phrase: "The pseudocolor images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "F/F0 immediately before"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0205548:Immediately [Temporal Concept]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "or"

Phrase: "0.8 ms after single FLIP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   744   C2349943:Ms. [Conceptual Entity]
   744   C3539704:MS [Gene or Genome]
Processing 00000000.tx.138: The F/F0 values were averaged within a 2-m-diam zone centered by the FLIP site and plotted as a function of time. 

Phrase: "The F/F0 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "averaged within a 2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1510992:Average [Quantitative Concept]
   737   C2825518:AVERAGE [Quantitative Concept]

Phrase: "m-"

Phrase: "diam zone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1710706:Zone [Spatial Concept]
   789 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]

Phrase: "centered by the FLIP site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0031751:photolysis [Molecular Function]
   748   C0205099:centered [Spatial Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0205234:Focal [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "plotted as a function of time."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0031843:function [Physiologic Function]
   753   C0040223:Time [Temporal Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   753   C3541383:Time [Temporal Concept]
Processing 00000000.tx.139: The graphs show five Ca2+ elevations (F/F0 spikes) induced by five laser pulses at 300-ms intervals. 

Phrase: "The graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0681493:graphs [Intellectual Product]
   966 E C2698021:Graph [Conceptual Entity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "five Ca2+ elevations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0702240:elevations [Spatial Concept]
   793 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "(F/F0 spikes"

Phrase: ")"

Phrase: "induced by five laser"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0023089:Laser [Manufactured Object]
   770   C0205263:Induced [Functional Concept]
   770   C0205451:Five [Quantitative Concept]
   770   C0458142:Laser [Phenomenon or Process]
   770   C1023865:Laser [Plant]
   770   C1706315:Laser [Medical Device]

Phrase: "pulses at 300-ms intervals."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0034107:Pulses [Health Care Activity]
   760   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0232117:PULSE [Clinical Attribute]
   760   C0391850:PULSES [Physiologic Function]
   760   C1272706:intervals [Temporal Concept]
   760   C1947910:Pulse [Phenomenon or Process]
   760   C2349943:Ms. [Conceptual Entity]
   760   C3539704:MS [Gene or Genome]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
Processing 00000000.tx.140: Note that the amplitude of the Ca2+ signals is augmented by the Sp-cAMPS treatment (compare A and B). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the amplitude of the Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346753:Amplitude [Spatial Concept]

Phrase: "is"

Phrase: "augmented by the Sp-cAMPS treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0205217:Augmented [Quantitative Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.141: (C and D) A high dose of ryanodine attenuates FLIP-induced Ca2+ signals in a growth cone on N-cadherin. 

Phrase: "(C"

Phrase: "and"

Phrase: "D) A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "high dose of ryanodine"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0444956:High dose [Quantitative Concept]
   770   C0178602:Dose [Quantitative Concept]
   770   C0205250:High [Qualitative Concept]
   770   C0869039:Dose [Quantitative Concept]
   770   C1114758:Dose # [Clinical Attribute]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "FLIP-induced Ca2+ signals in a growth cone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1710082:Signal [Phenomenon or Process]

Phrase: "on N-cadherin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.142: The amplitude of Ca2+ signals was analyzed in the same growth cone before and after a 5-min treatment with 100 M ryanodine (C and D, respectively), using experimental methods described in A and B. 

Phrase: "The amplitude of Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "analyzed in the same growth cone"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0596632:growth cone [Cell Component]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0206428:Cone [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C0330095:Cone [Plant]
   753   C0445247:Same [Qualitative Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2350017:Cone [Spatial Concept]
   753   C2911660:Growth [Activity]

Phrase: "before"

Phrase: "and after a 5-min treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0702093:/min [Temporal Concept]
   753   C1515981:And [Idea or Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with 100 M ryanodine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]

Phrase: "(C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "experimental methods"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0871738:experimental methods [Research Activity]
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   861   C1517586:Experimental [Qualitative Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "described in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.143: Bar, 5 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "5 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.144: View larger version (38K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.145: CAMs influence RyR-mediated CICR via cAMP. 

Phrase: "CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "influence"

Phrase: "RyR-mediated CICR via cAMP."
Processing 00000000.tx.146: The effects of the indicated drugs on FLIP-induced Ca2+ signals were analyzed in chick DRG growth cones on laminin (A), L1 (B), or N-cadherin (C). 

Phrase: "The effects of the indicated drugs"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   809   C0728866:effect of drugs [Functional Concept]
           drug effects
   753   C1280500:effects [Qualitative Concept]
   750 E C0728867:Drug effect [Pathologic Function]
   750 E C1411996:drug effect [Biologic Function]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on FLIP-induced Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "analyzed in chick DRG growth cones"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   800   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   800   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   770   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   770   C0596632:Growth Cones [Cell Component]
   770   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   744   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0040452:Root [Body Part, Organ, or Organ Component]
   744   C0205095:Dorsal [Spatial Concept]
   744   C0206428:Cones [Cell]
   744   C0220844:growth [Physiologic Function]
   744   C0242726:Root [Plant]
   744   C0936012:Analyzed [Research Activity]
   744   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   744   C1318154:Root [Body Part, Organ, or Organ Component]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1705917:Root [Idea or Concept]
   744   C2911660:Growth [Activity]
   711 E C0330095:Cone [Plant]
   711 E C2350017:Cone [Spatial Concept]

Phrase: "on laminin (A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0248561:laminin A [Amino Acid, Peptide, or Protein]
  1000   C1416775:LAMININ A [Gene or Genome]
   861   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "L1 (B"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "N-cadherin (C)."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.147: As exemplified in Fig. 

Phrase: "As"

Phrase: "exemplified in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.148: 4, the amplitude of F/F0 spikes was defined as F/F0 values averaged within a 2-m-diam zone immediately after FLIP. 

Phrase: "4,"

Phrase: "the amplitude of F/F0 spikes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "defined as F/F0 values"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   760   C0042295:Values [Qualitative Concept]
   760   C0439133:(f) [Intellectual Product]
   760   C1553038:[f] [Quantitative Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "averaged within a 2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1510992:Average [Quantitative Concept]
   737   C2825518:AVERAGE [Quantitative Concept]

Phrase: "m-"

Phrase: "diam zone immediately after FLIP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710706:Zone [Spatial Concept]
Processing 00000000.tx.149: The amplitude of five F/F0 spikes induced by five laser pulses at 300-ms intervals was averaged and plotted as the ordinate. 

Phrase: "The amplitude of five F/F0 spikes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2346753:Amplitude [Spatial Concept]

Phrase: "induced by five laser"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0023089:Laser [Manufactured Object]
   770   C0205263:Induced [Functional Concept]
   770   C0205451:Five [Quantitative Concept]
   770   C0458142:Laser [Phenomenon or Process]
   770   C1023865:Laser [Plant]
   770   C1706315:Laser [Medical Device]

Phrase: "pulses at 300-ms intervals"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0034107:Pulses [Health Care Activity]
   760   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0232117:PULSE [Clinical Attribute]
   760   C0391850:PULSES [Physiologic Function]
   760   C1272706:intervals [Temporal Concept]
   760   C1947910:Pulse [Phenomenon or Process]
   760   C2349943:Ms. [Conceptual Entity]
   760   C3539704:MS [Gene or Genome]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]

Phrase: "was"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "and"

Phrase: "plotted as the ordinate."
Processing 00000000.tx.150: The abscissa indicates the minutes after an application of Sp-cAMPS, Rp-cAMPS, and/or ryanodine. 

Phrase: "The abscissa"

Phrase: "indicates"

Phrase: "the minutes after an application of Sp-cAMPS,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0439232:minute [Temporal Concept]
   744   C0700321:minute [Quantitative Concept]
   744   C0702093:/minute [Temporal Concept]
   744   C1282918:Minute [Quantitative Concept]
   744   C2347166:Minute [Quantitative Concept]

Phrase: "Rp-cAMPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525261:(RP)-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and/or"

Phrase: "ryanodine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.151: Each line represents a drug-induced change of the Ca2+-signal amplitude in a single growth cone. 

Phrase: "Each line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a drug-induced change of the Ca2+-signal amplitude"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "in a single growth cone."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0596632:growth cone [Cell Component]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0206428:Cone [Cell]
   827   C0220844:growth [Physiologic Function]
   827   C0330095:Cone [Plant]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2350017:Cone [Spatial Concept]
   827   C2911660:Growth [Activity]
Processing 00000000.tx.152: Datasets with statistically significant changes are marked by asterisks. 

Phrase: "Datasets with statistically significant changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0150098:Dataset [Intellectual Product]
   726   C1706233:Dataset [Intellectual Product]

Phrase: "are"

Phrase: "marked by asterisks."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0522501:Marked [Qualitative Concept]
   790   C1706089:Marked [Qualitative Concept]
   790   C2945706:asterisks [Conceptual Entity]
Processing 00000000.tx.153: **, P < 0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.154: ***, P < 0.001; 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.155: paired t test.  

Phrase: "paired t test."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.156: Among the three RyR isoforms (types 1, 2, and 3), only the type 3 isoform (RyR3) has been detected in DRGs by Western blotting (Lokuta et al., 2002). 

Phrase: "Among the three RyR isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(types 1,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0441729:Type 1 [Classification]
   861   C0332307:Types [Qualitative Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the type 3 isoform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   734   C0441731:Type 3 [Classification]

Phrase: "(RyR3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   923   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   861   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0441731:Type 3 [Classification]
   861   C1753335:ryanodine receptor [Molecular Function]
   812   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "detected in DRGs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0011928:DRGs [Intellectual Product]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756 E C1414151:DRG [Gene or Genome]

Phrase: "by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(Lokuta et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.157: Therefore, we analyzed DRG neurons derived from RyR3 knockout mice (Futatsugi et al., 1999) to further confirm that the RyR is involved in the augmentation of Ca2+ signals induced by cAMP. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "DRG neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0027882:Neurons [Cell]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "derived from RyR3 knockout mice"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   793   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   793   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   770   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0206745:Knock-out Mice [Mammal]
   770   C0441731:Type 3 [Classification]
   770   C1753335:ryanodine receptor [Molecular Function]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   744   C0332307:Type [Qualitative Concept]
   744   C0560617:knock out [Injury or Poisoning]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1441547:Derived [Qualitative Concept]
   744   C1522225:Knock-out [Experimental Model of Disease]
   744   C1547052:*Type [Quantitative Concept]
   744   C3245521:derived [Idea or Concept]

Phrase: "(Futatsugi et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the RyR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419778:RYR [Gene or Genome]

Phrase: "is"

Phrase: "involved in the augmentation of Ca2+ signals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1293122:Augmentation [Therapeutic or Preventive Procedure]
   748   C1314939:Involved [Functional Concept]
   714   C1710082:Signal [Phenomenon or Process]

Phrase: "induced by cAMP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.158: As reviewed by Bouchard et al. 

Phrase: "As"

Phrase: "reviewed by Bouchard et al."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0282443:reviewed [Intellectual Product]
   760   C1709940:Reviewed [Qualitative Concept]
   726 E C1552617:Review [Idea or Concept]
Processing 00000000.tx.159: (2003), there has been accumulating evidence for the presence of functional RyRs in the axons and presynaptic terminals. 

Phrase: "(2003"

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "has"

Phrase: "been"

Phrase: "accumulating evidence for the presence of functional RyRs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axons [Cell Component]

Phrase: "and"

Phrase: "presynaptic terminals."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206181:Presynaptic Terminals [Cell Component]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.160: Our immunocytochemical analysis showed the punctate distribution of RyRs in growth cones with strong expression in the central domain and weak expression in the lamellipodia (Fig. 6, A, B, D, and E). 

Phrase: "Our immunocytochemical analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the punctate distribution of RyRs in growth cones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0520511:distribution [Idea or Concept]
   742   C1704711:Distribution [Functional Concept]

Phrase: "with strong expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the central domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "weak expression in the lamellipodia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.161: RyR expression and distribution were not influenced by culture substrates (unpublished data). 

Phrase: "RyR expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influenced by culture substrates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C2242979:Culture [Laboratory Procedure]
   737   C1710236:Substrate [Manufactured Object]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.162: Although the primary antibody recognized all three RyR isoforms (Kuwajima et al., 1992; Futatsugi et al., 1999), the immunoreactivity to this antibody was reduced or sometimes absent in RyR3-deficient growth cones (Fig. 6, C and F), further confirming that RyR3 is a predominant isoform in DRG neurons. 

Phrase: "Although"

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognized"

Phrase: "all three RyR isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(Kuwajima et al.,"

Phrase: "1992"

Phrase: "; Futatsugi et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "the immunoreactivity to this antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "or"

Phrase: "sometimes absent in RyR3-deficient growth cones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332197:Absent [Quantitative Concept]
   739   C2699517:ABSENT [Finding]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that RyR3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   923   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   861   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0441731:Type 3 [Classification]
   861   C1753335:ryanodine receptor [Molecular Function]
   812   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "a predominant isoform in DRG neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.163: On a laminin substrate, the Sp-cAMPS treatment augmented the amplitude of FLIP-induced Ca2+ signals in wild-type growth cones, whereas the same Sp-cAMPS treatment did not have that effect in RyR3-deficient growth cones (Fig. 6 G). 

Phrase: "On a laminin substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "the Sp-cAMPS treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "augmented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:Augmented [Quantitative Concept]

Phrase: "the amplitude of FLIP-induced Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2346753:Amplitude [Spatial Concept]

Phrase: "in wild-type growth cones,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0596632:Growth Cones [Cell Component]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0206428:Cones [Cell]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0330095:Cone [Plant]
   779 E C2350017:Cone [Spatial Concept]

Phrase: "whereas"

Phrase: "the same Sp-cAMPS treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "that effect in RyR3-deficient growth cones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 6 G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.164: On L1, the Rp-cAMPS treatment attenuated the amplitude of Ca2+ signals in wild-type growth cones but not in RyR3-deficient growth cones (Fig. 6 H). 

Phrase: "On L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "the Rp-cAMPS treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0525261:(RP)-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the amplitude of Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "in wild-type growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0596632:Growth Cones [Cell Component]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0206428:Cones [Cell]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0330095:Cone [Plant]
   779 E C2350017:Cone [Spatial Concept]

Phrase: "but"

Phrase: "not in RyR3-deficient growth cones"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   784   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   784   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   764   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0441731:Type 3 [Classification]
   764   C0596632:Growth Cones [Cell Component]
   764   C1753335:ryanodine receptor [Molecular Function]
   742   C0011155:Deficient [Functional Concept]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   742   C0206428:Cones [Cell]
   742   C0220844:growth [Physiologic Function]
   742   C0332307:Type [Qualitative Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1518422:Not [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1636779:% deficient [Quantitative Concept]
   742   C2911660:Growth [Activity]
   708 E C0330095:Cone [Plant]
   708 E C2350017:Cone [Spatial Concept]

Phrase: "(Fig. 6 H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.165: Collectively, our results indicate that the growth cone regulates the efficiency of RyR3-mediated CICR through cAMPPKA upon contact with different substrates. 

Phrase: "Collectively,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "regulates"

Phrase: "the efficiency of RyR3-mediated CICR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0013682:Efficiency [Quantitative Concept]

Phrase: "through cAMPPKA"

Phrase: "upon contact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332158:contact [Functional Concept]
  1000   C0337611:Contact [Population Group]
  1000   C1705415:Contact [Idea or Concept]

Phrase: "with different substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.166: View larger version (23K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.167: Ca2+ signals and turning directions of RyR3-deficient growth cones. 

Phrase: "Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "turning directions of RyR3-deficient growth cones."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0439755:Directions [Spatial Concept]
   706 E C0449738:Direction [Spatial Concept]
Processing 00000000.tx.168: (AF) Immunocytochemistry of RyRs in mouse DRG neurons. 

Phrase: "(AF) Immunocytochemistry of RyRs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "in mouse DRG neurons."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]
   717   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   717   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
Processing 00000000.tx.169: RyRs in wild-type (A and D) or RyR3-deficient (C and F) growth cones were labeled with an antibody that recognized all three isoforms. 

Phrase: "RyRs in wild-type"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   790 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790 E C1753335:ryanodine receptor [Molecular Function]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(A"

Phrase: "and"

Phrase: "D)"

Phrase: "or"

Phrase: "RyR3-deficient"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0011155:Deficient [Functional Concept]
   804   C1636779:% deficient [Quantitative Concept]
   722   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   722   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]

Phrase: "(C"

Phrase: "and"

Phrase: "F) growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0596632:Growth Cones [Cell Component]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0206428:Cones [Cell]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793 E C0330095:Cone [Plant]
   793 E C2350017:Cone [Spatial Concept]

Phrase: "were"

Phrase: "labeled with an antibody"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "that"

Phrase: "recognized"

Phrase: "all three isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.170: As a control, the primary antibody was omitted from the labeling procedure on wild-type growth cones (B and E). 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "omitted from the labeling procedure"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0750563:omitted [Idea or Concept]
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C1948041:Procedure [Therapeutic or Preventive Procedure]
   760   C2700391:Procedure [Activity]
   760   C2827499:Labeling [Governmental or Regulatory Activity]
   760   C3274430:PROCEDURE [Health Care Activity]
   760   C3538935:Procedure [Idea or Concept]
   760   C3539779:Procedure [Intellectual Product]
   726 E C0181496:Label [Manufactured Object]

Phrase: "on wild-type growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0596632:Growth Cones [Cell Component]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0206428:Cones [Cell]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0330095:Cone [Plant]
   779 E C2350017:Cone [Spatial Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.171: Shown are RyR immunofluorescence (AC) and DIC images (DF). 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "RyR immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(AC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "and"

Phrase: "DIC images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1704254:Image [Intellectual Product]
   779   C1704922:Image [Entity]
   779   C3542466:Image [Intellectual Product]

Phrase: "(DF"

Phrase: ")."
Processing 00000000.tx.172: Bar, 10 m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.173: (G and H) FLIP-induced Ca2+ signals in wild-type and RyR3-deficient growth cones. 

Phrase: "(G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "H) FLIP-induced Ca2+ signals in wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "RyR3-deficient growth cones."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   818   C0596632:Growth Cones [Cell Component]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0206428:Cones [Cell]
   795   C0220844:growth [Physiologic Function]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2911660:Growth [Activity]
   762 E C0330095:Cone [Plant]
   762 E C2350017:Cone [Spatial Concept]
Processing 00000000.tx.174: As described in Fig. 

Phrase: "As"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.175: 5, the effects of drugs (Sp-cAMPS or Rp-cAMPS) on the F/F0 spike amplitude were analyzed in growth cones on laminin (G) or L1 (H). 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "the effects of drugs"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   898   C0728866:effect of drugs [Functional Concept]
           drug effects
   786 E C0728867:Drug effect [Pathologic Function]
   786 E C1411996:drug effect [Biologic Function]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "(Sp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "or"

Phrase: "Rp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525261:(RP)-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "on the F/F0 spike amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2346753:Amplitude [Spatial Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "in growth cones on laminin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0596632:Growth Cones [Cell Component]
   760   C0206428:Cones [Cell]
   726 E C0330095:Cone [Plant]
   726 E C2350017:Cone [Spatial Concept]

Phrase: "(G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "L1 (H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.176: Each line represents a drug-induced change of the amplitude in a single growth cone. 

Phrase: "Each line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a drug-induced change of the amplitude"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "in a single growth cone."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0596632:growth cone [Cell Component]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0206428:Cone [Cell]
   827   C0220844:growth [Physiologic Function]
   827   C0330095:Cone [Plant]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2350017:Cone [Spatial Concept]
   827   C2911660:Growth [Activity]
Processing 00000000.tx.177: Datasets with statistically significant changes are marked by asterisks. 

Phrase: "Datasets with statistically significant changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0150098:Dataset [Intellectual Product]
   726   C1706233:Dataset [Intellectual Product]

Phrase: "are"

Phrase: "marked by asterisks."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0522501:Marked [Qualitative Concept]
   790   C1706089:Marked [Qualitative Concept]
   790   C2945706:asterisks [Conceptual Entity]
Processing 00000000.tx.178: **, P < 0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.179: ***, P < 0.001; 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.180: paired t test. 

Phrase: "paired t test."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.181: (I) The average turning angles of wild-type (WT) or RyR3-knockout (KO) growth cones on the three different substrates. 

Phrase: "(I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "The average turning angles of wild-type (WT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205143:angles [Spatial Concept]

Phrase: "or"

Phrase: "RyR3-knockout (KO) growth cones on the three different substrates."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0596632:Growth Cones [Cell Component]
   736   C0018270:'growth' NOS [Organism Function]
   736   C0206428:Cones [Cell]
   736   C0220844:growth [Physiologic Function]
   736   C1621966:Growth [Organ or Tissue Function]
   736   C2911660:Growth [Activity]
   703 E C0330095:Cone [Plant]
   703 E C2350017:Cone [Spatial Concept]
   701   C2752783:differential growth [Organism Function]
Processing 00000000.tx.182: As indicated, some growth cones were analyzed in the presence of Sp-cAMPS. 

Phrase: "As"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "some growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0596632:Growth Cones [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cones [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0330095:Cone [Plant]
   827 E C2350017:Cone [Spatial Concept]

Phrase: "were"

Phrase: "analyzed in the presence of Sp-cAMPS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.183: Error bars represent 915 growth cones. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "915 growth cones."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0596632:Growth Cones [Cell Component]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0206428:Cones [Cell]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793 E C0330095:Cone [Plant]
   793 E C2350017:Cone [Spatial Concept]
Processing 00000000.tx.184: *, P < 0.05; 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.185: **, P < 0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.186: compared with wild-type growth cones under the same culture conditions.  

Phrase: "compared with wild-type growth cones"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0596632:Growth Cones [Cell Component]
   790   C1883559:Wild Type [Organism Attribute]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0206428:Cones [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1707455:Compared [Activity]
   753   C2911660:Growth [Activity]
   719 E C0330095:Cone [Plant]
   719 E C2350017:Cone [Spatial Concept]

Phrase: "under the same culture conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.187: RyR3 controls Ca2+-mediated turning of growth cones Our results up to this point suggested that cAMPPKA controlled Ca2+-induced turning of growth cones by modulating the efficiency of RyR3-mediated CICR. 

Phrase: "RyR3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   923   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   861   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0441731:Type 3 [Classification]
   861   C1753335:ryanodine receptor [Molecular Function]
   812   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Ca2+-mediated turning of growth cones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0541749:turning [Finding]

Phrase: "Our results up to this point"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that cAMPPKA"

Phrase: "controlled"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "Ca2+-induced turning of growth cones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0541749:turning [Finding]

Phrase: "by modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "the efficiency of RyR3-mediated CICR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0013682:Efficiency [Quantitative Concept]
Processing 00000000.tx.188: Therefore, we next performed the axon turning assay using RyR3-deficient neurons. 

Phrase: "Therefore,"

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the axon turning assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RyR3-deficient neurons."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]
   700   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   700   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
Processing 00000000.tx.189: On L1 and N-cadherin substrates that activated the cAMP pathway, RyR3-deficient growth cones showed Ca2+-mediated repulsion, whereas wild-type growth cones exhibited attraction (Fig. 6 I). 

Phrase: "On L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "and"

Phrase: "N-cadherin substrates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1710236:Substrate [Manufactured Object]
   734   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1413277:N-CADHERIN [Gene or Genome]

Phrase: "that"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the cAMP pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "RyR3-deficient growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   818   C0596632:Growth Cones [Cell Component]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0206428:Cones [Cell]
   795   C0220844:growth [Physiologic Function]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2911660:Growth [Activity]
   762 E C0330095:Cone [Plant]
   762 E C2350017:Cone [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "Ca2+-mediated repulsion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683283:repulsion [Mental Process]

Phrase: "whereas"

Phrase: "wild-type growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0596632:Growth Cones [Cell Component]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0206428:Cones [Cell]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0330095:Cone [Plant]
   779 E C2350017:Cone [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "attraction"

Phrase: "(Fig. 6 I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.190: The most important evidence for the involvement of RyR3 downstream of the cAMP pathway came from the assay on a laminin substrate, in which Ca2+-mediated repulsion of wild-type growth cones, but not of RyR3-deficient growth cones, was converted to attraction by Sp-cAMPS (Fig. 6 I). 

Phrase: "The most important evidence for the involvement of RyR3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "downstream of the cAMP pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "came from the assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "on a laminin substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "in which Ca2+-mediated repulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683283:repulsion [Mental Process]

Phrase: "of wild-type growth cones,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0596632:Growth Cones [Cell Component]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0206428:Cones [Cell]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0330095:Cone [Plant]
   779 E C2350017:Cone [Spatial Concept]

Phrase: "but"

Phrase: "not of RyR3-deficient growth cones,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   784   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   784   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   764   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0441731:Type 3 [Classification]
   764   C0596632:Growth Cones [Cell Component]
   764   C1753335:ryanodine receptor [Molecular Function]
   742   C0011155:Deficient [Functional Concept]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   742   C0206428:Cones [Cell]
   742   C0220844:growth [Physiologic Function]
   742   C0332307:Type [Qualitative Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1518422:Not [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1636779:% deficient [Quantitative Concept]
   742   C2911660:Growth [Activity]
   708 E C0330095:Cone [Plant]
   708 E C2350017:Cone [Spatial Concept]

Phrase: "was"

Phrase: "converted to attraction"

Phrase: "by Sp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(Fig. 6 I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.191: Collectively, growth conesubstrate interactions regulate cAMP-activated RyR3-mediated CICR that determines the turning response to Ca2+ signals. 

Phrase: "Collectively,"

Phrase: "growth conesubstrate interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "regulate"

Phrase: "cAMP-activated RyR3-mediated CICR"

Phrase: "that"

Phrase: "determines"

Phrase: "the turning response to Ca2+ signals."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.192: Because RyR-mediated CICR augmented the amplitude of FLIP-induced Ca2+ signals (Fig. 5), it remained to be determined whether the turning behavior of growth cones depended on the amplitude or the source of Ca2+ signals. 

Phrase: "Because"

Phrase: "RyR-mediated CICR"

Phrase: "augmented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:Augmented [Quantitative Concept]

Phrase: "the amplitude of FLIP-induced Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2346753:Amplitude [Spatial Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "remained"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "whether"

Phrase: "the turning behavior of growth cones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1523628:turning behavior [Individual Behavior]
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "depended on the amplitude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2346753:Amplitude [Spatial Concept]
   737   C0725813:depend [Medical Device]

Phrase: "or"

Phrase: "the source of Ca2+ signals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]
Processing 00000000.tx.193: Therefore, we tested whether attractive turning of growth cones could be switched to repulsion when the Ca2+-signal amplitude was lowered by coloading neurons with NP-EGTA and increasing concentrations of BAPTA followed by laser irradiation (Fig. 7). 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "attractive turning of growth cones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0541749:turning [Finding]

Phrase: "could"

Phrase: "be"

Phrase: "switched to repulsion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0683283:repulsion [Mental Process]
   756   C1707719:Switch [Manufactured Object]

Phrase: "when"

Phrase: "the Ca2+-signal amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "lowered by coloading neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0027882:Neurons [Cell]
   770   C0441994:lowered [Spatial Concept]
   770   C1272755:Lowered [Quantitative Concept]
   770   C2003888:Lowered [Activity]
   737 E C1548802:Lower [Body Location or Region]

Phrase: "with NP-EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "increasing concentrations of BAPTA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "followed by laser irradiation"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C0871799:laser irradiation [Therapeutic or Preventive Procedure]
   770   C0023089:Laser [Manufactured Object]
   770   C0458142:Laser [Phenomenon or Process]
   770   C1023865:Laser [Plant]
   770   C1282930:Irradiation [Natural Phenomenon or Process]
   770   C1522449:irradiation [Therapeutic or Preventive Procedure]
   770   C1706315:Laser [Medical Device]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.194: Elevating BAPTA acetoxymethyl ester (AM) concentrations caused attenuated or undetectable Ca2+ signals (CG-1 F/F0) in growth cones on N-cadherin and decreased the attractive turning angle to zero without causing a significant repulsive turn. 

Phrase: "Elevating BAPTA acetoxymethyl ester (AM) concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0086045:Concentrations [Mental Process]
   771 E C1446561:Concentration [Quantitative Concept]
   721 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "or"

Phrase: "undetectable Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "(CG-1 F/F0) in growth cones"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0596632:Growth Cones [Cell Component]
   793   C0206428:Cones [Cell]
   760 E C0330095:Cone [Plant]
   760 E C2350017:Cone [Spatial Concept]

Phrase: "on N-cadherin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the attractive turning angle to zero"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205143:Angle [Spatial Concept]

Phrase: "without causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "a significant repulsive turn."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0541749:turn [Finding]
   827   C1709743:Turn [Spatial Concept]
Processing 00000000.tx.195: This result indicated that lowering the amplitude of Ca2+ signals was not sufficient to induce growth cone repulsion if the cAMPPKA pathway was active. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that lowering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441994:lowering [Spatial Concept]
  1000   C2003888:Lowering [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "the amplitude of Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "growth cone repulsion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0683283:repulsion [Mental Process]
   734   C0596632:growth cone [Cell Component]

Phrase: "if"

Phrase: "the cAMPPKA pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "was"

Phrase: "active."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205177:Active [Functional Concept]
Processing 00000000.tx.196: We also tested whether growth cone repulsion on laminin could be converted to attraction by increasing the Ca2+-signal amplitude. 

Phrase: "We also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "growth cone repulsion on laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0683283:repulsion [Mental Process]

Phrase: "could"

Phrase: "be"

Phrase: "converted to attraction"

Phrase: "by increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the Ca2+-signal amplitude."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]
Processing 00000000.tx.197: Previous work demonstrated that FLIP-induced Ca2+ signals in the growth cones of Xenopus laevis spinal neurons on laminin caused attractive or repulsive turning when the growth cones had been loaded with 6 or 2 M NP-EGTA, respectively (Wen et al., 2004). 

Phrase: "Previous work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "demonstrated"

Phrase: "that FLIP-induced Ca2+ signals in the growth cones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C1710082:Signal [Phenomenon or Process]

Phrase: "of Xenopus laevis spinal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "on laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "attractive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346874:Attractive [Qualitative Concept]

Phrase: "or"

Phrase: "repulsive turning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0541749:turning [Finding]

Phrase: "when"

Phrase: "the growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0596632:Growth Cones [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cones [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0330095:Cone [Plant]
   827 E C2350017:Cone [Spatial Concept]

Phrase: "had"

Phrase: "been"

Phrase: "loaded with 6"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "or"

Phrase: "2 M NP-EGTA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0250426:2-nitrophenyl-EGTA [Organic Chemical]
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "respectively"

Phrase: "(Wen et al.,"

Phrase: "2004"

Phrase: ")."
Processing 00000000.tx.198: However, under our experimental conditions, wild-type mouse DRG growth cones on laminin still showed repulsive turning (13.3  7.4, n = 11) even if loaded with the high concentration (6 M) of NP-EGTA followed by FLIP. 

Phrase: "However,"

Phrase: "under our experimental conditions,"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "wild-type mouse DRG growth cones on laminin still"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   756   C0596632:Growth Cones [Cell Component]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0206428:Cones [Cell]
   738   C0220844:growth [Physiologic Function]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C2911660:Growth [Activity]
   704 E C0330095:Cone [Plant]
   704 E C2350017:Cone [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "repulsive turning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0541749:turning [Finding]

Phrase: "(13.3  7.4,"

Phrase: "n = 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "even"

Phrase: "if"

Phrase: "loaded with the high concentration"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0086045:Concentration [Mental Process]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1446561:Concentration [Quantitative Concept]
   760   C1708715:Loaded [Activity]
   760   C2700149:HIGH [Intellectual Product]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]

Phrase: "(6"

Phrase: "M) of NP-EGTA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "followed by FLIP."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0031751:photolysis [Molecular Function]
   760   C0205234:Focal [Spatial Concept]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.199: This result was further confirmed with RyR3-deficient growth cones on N-cadherin. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed with RyR3-deficient growth cones"
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   784   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   784   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   764   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0441731:Type 3 [Classification]
   764   C0596632:Growth Cones [Cell Component]
   764   C1753335:ryanodine receptor [Molecular Function]
   742   C0011155:Deficient [Functional Concept]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   742   C0206428:Cones [Cell]
   742   C0220844:growth [Physiologic Function]
   742   C0332307:Type [Qualitative Concept]
   742   C0521093:confirmed [Qualitative Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0750484:Confirmed [Idea or Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1636779:% deficient [Quantitative Concept]
   742   C2911660:Growth [Activity]
   708 E C0330095:Cone [Plant]
   708 E C1456348:Confirm [Qualitative Concept]
   708 E C2350017:Cone [Spatial Concept]

Phrase: "on N-cadherin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.200: In this set of experiments, wild-type and RyR3-deficient growth cones were loaded with 2 and 6 M NP-EGTA, respectively. 

Phrase: "In this set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "of experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "RyR3-deficient growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   818   C0596632:Growth Cones [Cell Component]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0206428:Cones [Cell]
   795   C0220844:growth [Physiologic Function]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2911660:Growth [Activity]
   762 E C0330095:Cone [Plant]
   762 E C2350017:Cone [Spatial Concept]

Phrase: "were"

Phrase: "loaded with 2"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "6 M NP-EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "respectively."
Processing 00000000.tx.201: The baseline [Ca2+]c in the growth cones was measured by Fura-2 ratio imaging, and the amplitude of [Ca2+]c elevations immediately after FLIP was determined by CG-1 single-wavelength measurements as described previously (Lev-Ram et al., 1992). 

Phrase: "The baseline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "the growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0596632:Growth Cones [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cones [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0330095:Cone [Plant]
   827 E C2350017:Cone [Spatial Concept]

Phrase: "was"

Phrase: "measured by Fura-2 ratio"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0444706:Measured [Qualitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "imaging,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "the amplitude of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations immediately after FLIP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0702240:elevations [Spatial Concept]
   714 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "determined by CG-1 single-wavelength measurements"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0753494:calcium green 1 [Indicator, Reagent, or Diagnostic Aid]
   767   C0201925:calcium measurements [Laboratory Procedure]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C0242485:measurements [Functional Concept]
   744   C0332583:Green [Qualitative Concept]
   744   C0449819:Wavelength [Quantitative Concept]
   744   C2936886:Calcium [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Lev-Ram et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.202: The baseline [Ca2+]c in wild-type growth cones was 202  17 nM (n = 50), which rose to 643  48 nM (n = 8) after FLIP. 

Phrase: "The baseline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in wild-type growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0596632:Growth Cones [Cell Component]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0206428:Cones [Cell]
   799   C0220844:growth [Physiologic Function]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2911660:Growth [Activity]
   766 E C0330095:Cone [Plant]
   766 E C2350017:Cone [Spatial Concept]

Phrase: "was"

Phrase: "202  17 nM (n = 50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "rose to 643  48 nM (n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0035853:Rose [Plant]
   748   C0312860:NM [Cell Function]
   748   C0995005:ROSE [Pharmacologic Substance]

Phrase: ")"

Phrase: "after FLIP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031751:photolysis [Molecular Function]
Processing 00000000.tx.203: Similarly, [Ca2+]c in RyR3-deficient growth cones rose from 207  12 nM (n = 51) to 861  106 nM (n = 11) in response to FLIP. 

Phrase: "Similarly,"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in RyR3-deficient growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   807   C0596632:Growth Cones [Cell Component]
   791   C0018270:'growth' NOS [Organism Function]
   791   C0206428:Cones [Cell]
   791   C0220844:growth [Physiologic Function]
   791   C1621966:Growth [Organ or Tissue Function]
   791   C2911660:Growth [Activity]
   758 E C0330095:Cone [Plant]
   758 E C2350017:Cone [Spatial Concept]

Phrase: "rose from 207  12 nM (n = 51"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0035853:Rose [Plant]
   748   C0312860:NM [Cell Function]
   748   C0995005:ROSE [Pharmacologic Substance]

Phrase: ")"

Phrase: "to 861  106 nM (n = 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to FLIP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031751:photolysis [Molecular Function]
Processing 00000000.tx.204: Statistical analysis showed no significant difference between the two groups of growth cones, indicating that the Ca2+-signal amplitude in RyR3-deficient growth cones with 6 M NP-EGTA loading was equivalent to or slightly higher than that in wild-type growth cones with 2 M NP-EGTA loading. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no significant difference between the two groups of growth cones,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]
   722   C2752783:differential growth [Organism Function]

Phrase: "indicating"

Phrase: "that"

Phrase: "the Ca2+-signal amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "in RyR3-deficient growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   818   C0596632:Growth Cones [Cell Component]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0206428:Cones [Cell]
   795   C0220844:growth [Physiologic Function]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2911660:Growth [Activity]
   762 E C0330095:Cone [Plant]
   762 E C2350017:Cone [Spatial Concept]

Phrase: "with 6 M NP-EGTA loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "equivalent to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205163:Equivalent [Qualitative Concept]
   833   C0439185:equivalent [Quantitative Concept]

Phrase: "or"

Phrase: "slightly higher than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in wild-type growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0596632:Growth Cones [Cell Component]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0206428:Cones [Cell]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0330095:Cone [Plant]
   779 E C2350017:Cone [Spatial Concept]

Phrase: "with 2 M NP-EGTA loading."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1708715:Loading [Activity]
   722   C0250426:2-nitrophenyl-EGTA [Organic Chemical]
Processing 00000000.tx.205: Then, the two groups were tested for their turning response to FLIP-induced Ca2+-signals. 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "tested for their turning response"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0392366:tested [Intellectual Product]
   760   C0541749:turning [Finding]
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   726 E C1709743:Turn [Spatial Concept]

Phrase: "to FLIP-induced Ca2+-signals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.206: RyR3-deficient growth cones with 6 M NP-EGTA exhibited repulsive turning (14.6  8.1, n = 10), whereas wild-type growth cones with 2 M NP-EGTA showed attraction (26.5  8.6, n = 7) in parallel experiments. 

Phrase: "RyR3-deficient growth cones with 6 M NP-EGTA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0596632:Growth Cones [Cell Component]
   736   C0018270:'growth' NOS [Organism Function]
   736   C0206428:Cones [Cell]
   736   C0220844:growth [Physiologic Function]
   736   C1621966:Growth [Organ or Tissue Function]
   736   C2911660:Growth [Activity]
   703 E C0330095:Cone [Plant]
   703 E C2350017:Cone [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "repulsive turning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0541749:turning [Finding]

Phrase: "(14.6  8.1,"

Phrase: "n = 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "wild-type growth cones with 2 M NP-EGTA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C0596632:Growth Cones [Cell Component]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0206428:Cones [Cell]
   742   C0220844:growth [Physiologic Function]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2911660:Growth [Activity]
   708 E C0330095:Cone [Plant]
   708 E C2350017:Cone [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "attraction"

Phrase: "(26.5  8.6,"

Phrase: "n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in parallel experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.207: The difference was statistically significant (P < 0.05). 

Phrase: "The difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "statistically significant"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.208: This result indicated that, depending on the occurrence of RyR3-mediated CICR, growth cones were either attracted or repelled by [Ca2+]c elevations of the equivalent amplitude on top of the same baseline level. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that,"

Phrase: "depending on the occurrence of RyR3-mediated CICR,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   772   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   772   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   756   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0441731:Type 3 [Classification]
   756   C1753335:ryanodine receptor [Molecular Function]
   738   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   738   C0086597:mediated [Social Behavior]
   738   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   738   C0243132:occurrence [Functional Concept]
   738   C0332307:Type [Qualitative Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C1547052:*Type [Quantitative Concept]
   738   C1554210:occurrence [Idea or Concept]
   738   C2745955:Occurrence [Temporal Concept]
   704   C0725813:depend [Medical Device]

Phrase: "growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0596632:Growth Cones [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cones [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0330095:Cone [Plant]
   827 E C2350017:Cone [Spatial Concept]

Phrase: "were"

Phrase: "either"

Phrase: "attracted"

Phrase: "or"

Phrase: "repelled by"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations of the equivalent amplitude"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0702240:elevations [Spatial Concept]
   719 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "on top of the same baseline level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0168634:baseline [Biomedical or Dental Material]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1442488:Baseline [Quantitative Concept]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.209: We conclude that the source of Ca2+ influx, rather than its amplitude or the baseline Ca2+ level, is a decisive factor that regulates the direction of growth cone steering: RyR3-mediated CICR triggers attraction, whereas Ca2+ signals without CICR induce repulsion. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the source of Ca2+ influx,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "rather than"

Phrase: "its amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]

Phrase: "or"

Phrase: "the baseline Ca2+ level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "a decisive factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "regulates"

Phrase: "the direction of growth cone steering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449738:Direction [Spatial Concept]

Phrase: ":"

Phrase: "RyR3-mediated CICR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   700   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   700   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "attraction,"

Phrase: "whereas"

Phrase: "Ca2+ signals without CICR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "repulsion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683283:repulsion [Mental Process]
Processing 00000000.tx.210: View larger version (26K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.211: The relationship between the Ca2+-signal amplitude and growth cone turning. 

Phrase: "The relationship between the Ca2+-signal amplitude"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "growth cone turning."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0541749:turning [Finding]
   734   C0596632:growth cone [Cell Component]
Processing 00000000.tx.212: The amplitude of FLIP-induced Ca2+ signals was controlled by preloading chick neurons with increasing concentrations of BAPTA. 

Phrase: "The amplitude of FLIP-induced Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "controlled by preloading chick neurons"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0332298:Controlled by [Functional Concept]
   760   C0027882:Neurons [Cell]
   760   C2587213:Controlled [Functional Concept]
   726 E C0243148:control [Qualitative Concept]
   726 E C1550141:Control [Substance]
   726 E C1882979:Control [Conceptual Entity]
   726 E C3274648:Control [Qualitative Concept]

Phrase: "with increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of BAPTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043775:BAPTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.213: Blue dots indicate the mean amplitude of F/F0 spikes that was calculated as described in Fig. 

Phrase: "Blue dots"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1720485:Dots [Finding]
   827 E C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "indicate"

Phrase: "the mean amplitude of F/F0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0444504:Mean [Quantitative Concept]
   753   C2346753:Amplitude [Spatial Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]

Phrase: "spikes"

Phrase: "that"

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.214: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.215: Each dot involves 610 growth cones. 

Phrase: "Each dot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "involves"

Phrase: "610 growth cones."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0596632:Growth Cones [Cell Component]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0206428:Cones [Cell]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793 E C0330095:Cone [Plant]
   793 E C2350017:Cone [Spatial Concept]
Processing 00000000.tx.216: Red diamonds indicate the mean turning angles, each involving 813 growth cones. 

Phrase: "Red diamonds"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0057717:Diamonds [Element, Ion, or Isotope]
   827 E C1706341:Diamond [Qualitative Concept]

Phrase: "indicate"

Phrase: "the mean turning angles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205143:angles [Spatial Concept]

Phrase: "each"

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "813 growth cones."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0596632:Growth Cones [Cell Component]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0206428:Cones [Cell]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793 E C0330095:Cone [Plant]
   793 E C2350017:Cone [Spatial Concept]
Processing 00000000.tx.217: *, P < 0.05; 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.218: **, P < 0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.219: ***, P < 0.001; 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.220: compared with the turning angles of growth cones that were not loaded with NP-EGTA.  

Phrase: "compared with the turning angles of growth cones"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0596632:Growth Cones [Cell Component]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0205143:angles [Spatial Concept]
   744   C0206428:Cones [Cell]
   744   C0220844:growth [Physiologic Function]
   744   C0541749:turning [Finding]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1707455:Compared [Activity]
   744   C2911660:Growth [Activity]
   711 E C0330095:Cone [Plant]
   711 E C1709743:Turn [Spatial Concept]
   711 E C2350017:Cone [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "loaded with NP-EGTA."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.221: RyR3 is implicated in DRG axon guidance in vivo To test for the involvement of RyRs in growth cone steering in vivo, we analyzed DRG axon trajectories in the spinal cord of RyR3 knockout mice. 

Phrase: "RyR3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   923   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   861   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0441731:Type 3 [Classification]
   861   C1753335:ryanodine receptor [Molecular Function]
   812   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "implicated in DRG axon guidance in vivo To"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   782   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   782   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   760   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   760   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   760   C2984268:Axon guidance [Cell Function]
   757   C1515655:In Vivo [Spatial Concept]
           vivo
   739   C0004461:Axon [Cell Component]
   739   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   739   C0040452:Root [Body Part, Organ, or Organ Component]
   739   C0150600:Guidance [Health Care Activity]
   739   C0205095:Dorsal [Spatial Concept]
   739   C0242726:Root [Plant]
   739   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   739   C1318154:Root [Body Part, Organ, or Organ Component]
   739   C1705917:Root [Idea or Concept]
   739   C1959633:Guidance [Clinical Attribute]
   724 E C0598948:axonal guidance [Cell Function]

Phrase: "test for the involvement of RyRs in growth cone steering"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   756   C0596632:growth cone [Cell Component]
   756   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   739 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   739 E C1753335:ryanodine receptor [Molecular Function]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0022885:Test [Laboratory Procedure]
   738   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   738   C0039593:Test [Functional Concept]
   738   C0206428:Cone [Cell]
   738   C0220844:growth [Physiologic Function]
   738   C0330095:Cone [Plant]
   738   C0392366:test [Intellectual Product]
   738   C0553654:steering [Finding]
   738   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   738   C1314939:Involvement [Functional Concept]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C2350017:Cone [Spatial Concept]
   738   C2911660:Growth [Activity]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "DRG axon trajectories in the spinal cord"

Phrase: "of RyR3 knockout mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0206745:Knock-out Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   700   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   700   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
Processing 00000000.tx.222: Because our in vitro experiments were performed using DRG neuronal cultures supplemented with NGF, the corresponding subpopulation of DRG axons in vivo was labeled by an antibody against calcitonin gene-related peptide (CGRP), a marker for the NGF-dependent TrkA-positive nociceptive neurons (Snider, 1994; Averill et al., 1995). 

Phrase: "Because"

Phrase: "our in vitro experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DRG neuronal cultures"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]
   717   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   717   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]

Phrase: "supplemented with NGF,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1417719:NGF [Gene or Genome]
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "the corresponding subpopulation of DRG axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1257890:Subpopulation [Population Group]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "was"

Phrase: "labeled by an antibody"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "against calcitonin gene-related peptide (CGRP),"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]
   812   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0017337:Gene [Gene or Genome]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C0770558:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C2825090:Calcitonin [Pharmacologic Substance]
   812   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   779 E C0163712:Relate [Organic Chemical]
   756 E C0115656:Thyrocalcitonin [Organic Chemical,Pharmacologic Substance]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "a marker for the NGF-dependent TrkA-positive nociceptive neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0005516:Marker [Clinical Attribute]

Phrase: "(Snider,"

Phrase: "1994"

Phrase: "; Averill et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.223: As reported previously (Gibson et al., 1984), there are two major types of CGRP-positive axon projections in the spinal cord: those that terminate in the superficial dorsal horn (laminae I and II) and those that project deeply in the dorsal gray commissure (dorsal to the central canal; Fig. 8). 

Phrase: "As"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(Gibson et al.,"

Phrase: "1984"

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "are"

Phrase: "two major types of CGRP-positive axon projections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   754   C0314611:GENE TYPES [Genetic Function]
   738   C0332307:Types [Qualitative Concept]
   704 E C1547052:*Type [Quantitative Concept]
   701   C2335335:Type relation [Conceptual Entity]

Phrase: "in the spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: ":"

Phrase: "those that"

Phrase: "terminate in the superficial dorsal horn"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0228575:dorsal horn [Body Part, Organ, or Organ Component]
   753   C0019939:Horn [Body Part, Organ, or Organ Component]
   753   C0205095:Dorsal [Spatial Concept]
   753   C0205124:Superficial [Spatial Concept]

Phrase: "(laminae I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1709063:Lamina I [Tissue]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II"

Phrase: ")"

Phrase: "and"

Phrase: "those"

Phrase: "that"

Phrase: "project"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709701:Project [Conceptual Entity]

Phrase: "deeply in the dorsal gray commissure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0228563:Grey commissure [Body Part, Organ, or Organ Component]
   790   C2338155:Gray Commissure [Body Part, Organ, or Organ Component]
   753   C0205095:Dorsal [Spatial Concept]
   753   C0556636:gray [Quantitative Concept]
   753   C1185742:Commissure [Body Space or Junction]
   753   C1269776:Gray [Qualitative Concept]

Phrase: "(dorsal to the central canal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205095:Dorsal [Spatial Concept]

Phrase: "; Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.224: Although the CGRP-positive superficial projections were not affected by RyR3 deficiency, we found a significant difference in the deep projections between wild-type and RyR3 knockout mice. 

Phrase: "Although"

Phrase: "the CGRP-positive superficial projections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0016538:projections [Intellectual Product]
   795   C0033363:projections [Mental Process]
   795   C0348018:projections [Spatial Concept]
   710   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by RyR3 deficiency,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   804   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   804   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   778   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0441731:Type 3 [Classification]
   778   C1753335:ryanodine receptor [Molecular Function]
   748   C0011155:Deficiency [Functional Concept]
   748   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C0332307:Type [Qualitative Concept]
   748   C0392760:Affected [Functional Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1314939:Affected [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1623416:deficiency [Qualitative Concept]
   714 E C0001721:Affect [Mental Process]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a significant difference in the deep projections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "between wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "RyR3 knockout mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0206745:Knock-out Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   700   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   700   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
Processing 00000000.tx.225: In the wild-type spinal cord, CGRP-positive axons projecting toward the dorsal gray commissure extended horizontally or in a slightly dorsal trajectory away from the central canal (Fig. 8, A and B). 

Phrase: "In the wild-type spinal cord,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   861   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   812   C0521329:Spinal [Spatial Concept]
   812   C1550235:Cord [Body Part, Organ, or Organ Component]
   812   C1552938:cord [Quantitative Concept]
   812   C1706500:Cord [Manufactured Object]

Phrase: "CGRP-positive axons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0004461:Axons [Cell Component]
   734   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "projecting toward the dorsal gray commissure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0228563:Grey commissure [Body Part, Organ, or Organ Component]
   790   C2338155:Gray Commissure [Body Part, Organ, or Organ Component]
   753   C0205095:Dorsal [Spatial Concept]
   753   C0556636:gray [Quantitative Concept]
   753   C1185742:Commissure [Body Space or Junction]
   753   C1269776:Gray [Qualitative Concept]
   719   C1709701:Project [Conceptual Entity]

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "horizontally"

Phrase: "or in a slightly dorsal trajectory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205095:Dorsal [Spatial Concept]
   753   C0750482:Slightly [Idea or Concept]

Phrase: "away from the central canal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0459414:Central canal [Body Part, Organ, or Organ Component]
   861   C0086881:Canal [Body Space or Junction]
   861   C0205099:Central [Spatial Concept]
   861   C0442636:Canal [Geographic Area]
   861   C1550227:Canal [Body Part, Organ, or Organ Component]
   861   C1879652:Central - [Laboratory Procedure]

Phrase: "(Fig. 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.226: In the RyR3-deficient spinal cord, however, the axons projected ventrally toward the central canal (Fig. 8, C and D). 

Phrase: "In the RyR3-deficient spinal cord,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   818   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   795   C0521329:Spinal [Spatial Concept]
   795   C1550235:Cord [Body Part, Organ, or Organ Component]
   795   C1552938:cord [Quantitative Concept]
   795   C1706500:Cord [Manufactured Object]

Phrase: "however,"

Phrase: "the axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axons [Cell Component]

Phrase: "projected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016538:Projected [Intellectual Product]
   966 E C1709701:Project [Conceptual Entity]

Phrase: "ventrally toward the central canal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0459414:Central canal [Body Part, Organ, or Organ Component]
   760   C0086881:Canal [Body Space or Junction]
   760   C0205099:Central [Spatial Concept]
   760   C0442636:Canal [Geographic Area]
   760   C1550227:Canal [Body Part, Organ, or Organ Component]
   760   C1879652:Central - [Laboratory Procedure]

Phrase: "(Fig. 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.227: This phenotype was consistently observed in six knockout animals in comparison with six wild-type littermates. 

Phrase: "This phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "was"

Phrase: "consistently"

Phrase: "observed in six knockout animals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1171353:knockout animal [Animal]
   760   C0003062:Animals [Animal]
   760   C0205452:Six [Quantitative Concept]
   760   C0560617:knock out [Injury or Poisoning]
   760   C1441672:Observed [Functional Concept]
   760   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with six wild-type littermates."
Processing 00000000.tx.228: The similar pathfinding error of nociceptive axons was observed when the spinal cord was treated with a function-blocking antibody against NgCAM (a chick homologue of L1) or its binding partner, axonin-1 (Perrin et al., 2001), suggesting that homophilic or heterophilic L1 interactions are required for these axons to be guided correctly by extracellular cues. 

Phrase: "The similar pathfinding error of nociceptive axons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0743559:error [Qualitative Concept]
   748   C1608199:Error [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "the spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "was"

Phrase: "treated with a function-blocking antibody"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   790   C0282682:Blocking antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0031843:function [Physiologic Function]
   753   C0233660:Blocking [Mental or Behavioral Dysfunction]
   753   C0332206:Blocking [Functional Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1522326:Treated [Functional Concept]
   753   C1705273:Function [Intellectual Product]
   719 E C0028778:Block [Pathologic Function]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "against NgCAM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027876:Ng-CAM [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "("

Phrase: "a chick homologue of L1)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homologue [Gene or Genome]

Phrase: "or"

Phrase: "its binding partner,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0243122:binding [Functional Concept]
   861   C0682323:Partner [Family Group]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "axonin-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0084710:Axonin-1 [Amino Acid, Peptide, or Protein]
  1000   C1413560:AXONIN 1 [Gene or Genome]

Phrase: "(Perrin et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that homophilic"

Phrase: "or"

Phrase: "heterophilic L1 interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "required for these axons to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0004461:Axons [Cell Component]
   760   C1514873:Required [Functional Concept]

Phrase: "be"

Phrase: "guided"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0181090:Guide [Professional or Occupational Group]
   966   C0302614:Guide [Medical Device]
   966   C1706050:Guide [Manufactured Object]

Phrase: "correctly by extracellular cues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010439:Cues [Idea or Concept]
   770   C0521119:Extracellular [Cell Component]
Processing 00000000.tx.229: View larger version (54K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.230: CGRP-positive axon trajectories in the spinal cords. 

Phrase: "CGRP-positive axon trajectories in the spinal cords."
Processing 00000000.tx.231: Nociceptive DRG axons were labeled by CGRP immunofluorescence. 

Phrase: "Nociceptive DRG axons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0004461:Axons [Cell Component]
   717   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   717   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "labeled by CGRP immunofluorescence."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   853   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]
   748   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0016318:Immunofluorescence [Laboratory Procedure]
   748   C0017337:Gene [Gene or Genome]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0079603:Immunofluorescence [Laboratory Procedure]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C0770558:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1708632:Labeled [Qualitative Concept]
   748   C2825090:Calcitonin [Pharmacologic Substance]
   748   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   714 E C0163712:Relate [Organic Chemical]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.232: Shown are transverse sections of the spinal cord at the fifth lumbar segment from wild-type (A and B) or RyR3-knockout (C and D) mice. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "transverse sections of the spinal cord"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   756   C0446380:Transverse section [Spatial Concept]
           Transverse
   753   C0205106:Transverse [Spatial Concept]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "at the fifth lumbar segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441635:Segment [Spatial Concept]
   755 E C0205122:Segmental [Spatial Concept]

Phrase: "from wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "RyR3-knockout"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0560617:knock out [Injury or Poisoning]
   804   C1522225:Knock-out [Experimental Model of Disease]
   722   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   722   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]

Phrase: "(C"

Phrase: "and"

Phrase: "D)"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.233: Dorsal is uppermost, and the arrows indicate the central canal. 

Phrase: "Dorsal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205095:Dorsal [Spatial Concept]

Phrase: "is"

Phrase: "uppermost,"

Phrase: "and"

Phrase: "the arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the central canal."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0459414:Central canal [Body Part, Organ, or Organ Component]
   861   C0086881:Canal [Body Space or Junction]
   861   C0205099:Central [Spatial Concept]
   861   C0442636:Canal [Geographic Area]
   861   C1550227:Canal [Body Part, Organ, or Organ Component]
   861   C1879652:Central - [Laboratory Procedure]
Processing 00000000.tx.234: Bar, 200 m.   

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "200 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.235: Discussion Top Abstract Introduction Results Discussion Materials and methods References  During development, the precise pattern of neuronal networks depends on the guided advance of growth cones along correct paths toward their targets. 

Phrase: "Discussion Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References  During development,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1514811:Reference [Idea or Concept]
   790   C1527148:Development [Functional Concept]
   790   C1706462:Reference [Conceptual Entity]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "the precise pattern of neuronal networks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "depends on the guided advance of growth cones"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0596632:Growth Cones [Cell Component]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0206428:Cones [Cell]
   744   C0220844:growth [Physiologic Function]
   744   C0725066:Advance [Medical Device]
   744   C0725813:depend [Medical Device]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]
   711   C0181090:Guide [Professional or Occupational Group]
   711   C0302614:Guide [Medical Device]
   711 E C0330095:Cone [Plant]
   711   C1706050:Guide [Manufactured Object]
   711 E C2350017:Cone [Spatial Concept]

Phrase: "along correct paths"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0919386:PATH [Laboratory Procedure]
   827   C1705483:Path [Intellectual Product]

Phrase: "toward their targets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521840:Target [Functional Concept]
   966   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.236: The growth cone serves as the sensory and motile apparatus for translating extracellular cues into directional elongation of the axon. 

Phrase: "The growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "serves as the sensory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0445254:Sensory [Qualitative Concept]

Phrase: "and"

Phrase: "motile apparatus for translating extracellular cues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243111:apparatus [Manufactured Object]
   753   C1947951:Apparatus [Anatomical Structure]

Phrase: "into directional elongation"

Phrase: "of the axon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axon [Cell Component]
Processing 00000000.tx.237: A cytosolic Ca2+ signal is one of the most important messengers that relay extracellular information to the motile behavior of growth cones (Davenport et al., 1993; Kuhn et al., 1998; Takei et al., 1998; Gomez and Spitzer, 1999; Doherty et al., 2000; Gomez et al., 2001; Tang et al., 2003). 

Phrase: "A cytosolic Ca2+ signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "one of the most important messengers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "relay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709893:Relay [Medical Device]

Phrase: "extracellular information to the motile behavior of growth cones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1533716:Information [Idea or Concept]

Phrase: "(Davenport et al.,"

Phrase: "1993"

Phrase: "; Kuhn et al.,"

Phrase: "1998"

Phrase: "; Takei et al.,"

Phrase: "1998"

Phrase: "; Gomez"

Phrase: "and"

Phrase: "Spitzer,"

Phrase: "1999"

Phrase: "; Doherty et al.,"

Phrase: "2000"

Phrase: "; Gomez et al.,"

Phrase: "2001"

Phrase: "; Tang et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.238: Elongating axons could respond to the cytosolic Ca2+ signal in multiple ways, depending on the source of Ca2+ influx to the cytosol and its amplitude and frequency. 

Phrase: "Elongating axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004461:Axons [Cell Component]

Phrase: "could"

Phrase: "respond to the cytosolic Ca2+ signal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1383501:Cytosolic [Cell Component]
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "in multiple ways,"

Phrase: "depending on the source of Ca2+ influx"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0449416:Source [Finding]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1705919:Source [Idea or Concept]
   714   C0725813:depend [Medical Device]

Phrase: "to the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "its amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]

Phrase: "and"

Phrase: "frequency."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]
Processing 00000000.tx.239: The work we present here demonstrates the importance of the source of Ca2+ signals in determining the turning direction of growth cones, in which RyR-mediated CICR triggers attraction, whereas Ca2+ signals without CICR induce repulsion. 

Phrase: "The work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "we"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "here"

Phrase: "demonstrates"

Phrase: "the importance of the source of Ca2+ signals"

Phrase: "in determining"

Phrase: "the turning direction of growth cones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449738:Direction [Spatial Concept]

Phrase: "in which RyR-mediated CICR"

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "attraction,"

Phrase: "whereas"

Phrase: "Ca2+ signals without CICR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "repulsion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683283:repulsion [Mental Process]
Processing 00000000.tx.240: We also show that CAMs regulate RyR activity through cAMP and PKA and that the growth cone is able to change its turning behavior on different substrates. 

Phrase: "We also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "regulate"

Phrase: "RyR activity through cAMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that"

Phrase: "the growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "its turning behavior on different substrates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1523628:turning behavior [Individual Behavior]
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.241: The most significant point of our work is the direct demonstration, using gene-manipulated mice, that RyR3 is a downstream component of the cAMPPKA pathway and that RyR3 controls the bidirectional turning responses induced by Ca2+ signals of the same polarity in growth cones. 

Phrase: "The most significant point of our work"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]

Phrase: "is"

Phrase: "the direct demonstration,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "gene-manipulated mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "that RyR3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   923   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   861   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0441731:Type 3 [Classification]
   861   C1753335:ryanodine receptor [Molecular Function]
   812   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "a downstream component of the cAMPPKA pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "that RyR3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   923   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   861   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0441731:Type 3 [Classification]
   861   C1753335:ryanodine receptor [Molecular Function]
   812   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the bidirectional turning responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "induced by Ca2+ signals of the same polarity in growth cones."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   756   C0596632:Growth Cones [Cell Component]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0205263:Induced [Functional Concept]
   738   C0206428:Cones [Cell]
   738   C0220844:growth [Physiologic Function]
   738   C0445247:Same [Qualitative Concept]
   738   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C0596963:Polarity [Quantitative Concept]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C2911660:Growth [Activity]
   704 E C0330095:Cone [Plant]
   704   C1710082:Signal [Phenomenon or Process]
   704 E C2350017:Cone [Spatial Concept]
Processing 00000000.tx.242: In this way, axon-guiding and CAM-derived signals are integrated at the level of RyR3, which may provide growth cones with the flexibility of generating distinct responses to the same guidance cue in different environmental situations in vivo. 

Phrase: "In this way,"

Phrase: "axon-guiding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0181090:Guide [Professional or Occupational Group]
   827   C0302614:Guide [Medical Device]
   827   C1706050:Guide [Manufactured Object]

Phrase: "and"

Phrase: "CAM-derived signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "integrated at the level of RyR3,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   784   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   784   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   764   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0441731:Type 3 [Classification]
   764   C1753335:ryanodine receptor [Molecular Function]
   762   C0456949:Level 3 [Intellectual Product]
   742   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   742   C0332307:Type [Qualitative Concept]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1547052:*Type [Quantitative Concept]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "growth cones with the flexibility of generating distinct responses"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C0596632:Growth Cones [Cell Component]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0206428:Cones [Cell]
   742   C0220844:growth [Physiologic Function]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2911660:Growth [Activity]
   708 E C0330095:Cone [Plant]
   708 E C2350017:Cone [Spatial Concept]

Phrase: "to the same guidance cue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0010439:cue [Idea or Concept]

Phrase: "in different environmental situations"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.243: This concept has been supported by our experiment that showed the altered projection of DRG axons in the RyR3-deficient spinal cord, although axon-guiding molecules involved in this phenotype remain to be identified. 

Phrase: "This concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "supported by our experiment"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1706386:Experiment [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the altered projection of DRG axons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0016538:Projection [Intellectual Product]
   744   C0033363:Projection [Mental Process]
   744   C0348018:Projection [Spatial Concept]

Phrase: "in the RyR3-deficient spinal cord,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   818   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   795   C0521329:Spinal [Spatial Concept]
   795   C1550235:Cord [Body Part, Organ, or Organ Component]
   795   C1552938:cord [Quantitative Concept]
   795   C1706500:Cord [Manufactured Object]

Phrase: "although"

Phrase: "axon-guiding molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "involved in this phenotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031437:Phenotype [Organism Attribute]
   770   C1285572:Phenotype [Laboratory Procedure]
   770   C1314939:Involved [Functional Concept]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.244: Antibody perturbation experiments by Perrin et al. 

Phrase: "Antibody perturbation experiments by Perrin et al."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.245: (2001) suggested that impaired L1 interactions with its binding partners caused a similar guidance error of DRG axons, which is consistent with our concept that L1 controls growth cone turning responses to guidance cues by modifying cytosolic Ca2+ signals. 

Phrase: "(2001"

Phrase: ")"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that impaired L1 interactions with its binding partners"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1704675:Interaction [Functional Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a similar guidance error of DRG axons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0743559:error [Qualitative Concept]
   742   C1608199:Error [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "consistent with our concept"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "growth cone turning responses to guidance"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "cues by modifying cytosolic Ca2+ signals."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0010439:Cues [Idea or Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1383501:Cytosolic [Cell Component]
   719   C0392747:MODIFY [Functional Concept]
   719   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.246: Because the occurrence of CICR and the amplitude of Ca2+ signals are tightly associated, it has been challenging to dissect these two factors experimentally. 

Phrase: "Because"

Phrase: "the occurrence of CICR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243132:occurrence [Functional Concept]
   770   C1554210:occurrence [Idea or Concept]
   770   C2745955:Occurrence [Temporal Concept]

Phrase: "and"

Phrase: "the amplitude of Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "are"

Phrase: "tightly"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: ","

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "challenging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0798503:Challenge [Clinical Attribute]
   966   C0805586:Challenge [Health Care Activity]
   966   C3274764:Challenge [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "dissect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissect [Functional Concept]

Phrase: "these two factors experimentally."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.247: Although our data support the idea that the source of Ca2+ signals is the primary determinant of the turning direction of growth cones, several previous studies have suggested that the Ca2+-signal amplitude is the important factor. 

Phrase: "Although"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that"

Phrase: "the source of Ca2+ signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "is"

Phrase: "the primary determinant of the turning direction of growth cones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1521761:Determinant [Functional Concept]

Phrase: "several previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the Ca2+-signal amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "is"

Phrase: "the important factor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.248: For example, Henley et al. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "Henley et al."
Processing 00000000.tx.249: (2004) conducted clever experiments in which different levels of [Ca2+]c gradients were created across a growth cone by unilateral application of a Ca2+-selective ionophore through a micropipette in the presence of distinct preset Ca2+ concentrations in bathing media. 

Phrase: "(2004"

Phrase: ")"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "clever experiments in which different levels of [Ca2+"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0681814:Experiments [Research Activity]
   711 E C1706386:Experiment [Conceptual Entity]

Phrase: "]c gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0812409:gradients [Quantitative Concept]
   827 E C0439182:% gradient [Quantitative Concept]

Phrase: "were"

Phrase: "created across a growth cone"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0596632:growth cone [Cell Component]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0206428:Cone [Cell]
   760   C0220844:growth [Physiologic Function]
   760   C0330095:Cone [Plant]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1706214:Created [Activity]
   760   C2350017:Cone [Spatial Concept]
   760   C2911660:Growth [Activity]
   726 E C3244320:create [Functional Concept]

Phrase: "by unilateral application"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0185125:Application [Health Care Activity]
   861   C1947919:Application [Intellectual Product]
   861   C2347934:Application [Intellectual Product]
   861   C3539080:APPLICATION [Quantitative Concept]

Phrase: "of a Ca2+-selective ionophore"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022022:Ionophore [Pharmacologic Substance]
   827   C1517596:ionophore [Molecular Function]

Phrase: "through a micropipette"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0182301:MICRO PIPETTE [Medical Device]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of distinct preset Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in bathing media."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.250: Their study showed that high- or low-amplitude Ca2+ signals were sufficient to trigger attraction or repulsion of the growth cone, respectively. 

Phrase: "Their study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that high-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "or"

Phrase: "low-amplitude Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "attraction"

Phrase: "or"

Phrase: "repulsion of the growth cone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0683283:repulsion [Mental Process]

Phrase: "respectively."
Processing 00000000.tx.251: In their experiments, however, low-amplitude Ca2+ signals were produced after treating the cells with thapsigargin that depleted Ca2+ from the internal stores, raising the possibility that impaired CICR might have been responsible for the repulsion. 

Phrase: "In their experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "however,"

Phrase: "low-amplitude Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "produced after treating"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332293:treating [Therapeutic or Preventive Procedure]
   790   C1522326:Treating [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "the cells with thapsigargin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   816   C0007634:THE CELL [Cell]
           Cells
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "that depleted Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "from the internal stores,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1698986:Store [Functional Concept]

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that impaired CICR"

Phrase: "might"

Phrase: "have"

Phrase: "been"

Phrase: "responsible for the repulsion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.252: Another example comes from studies by Zheng and colleagues (Zheng, 2000; Wen et al., 2004), in which they lowered the absolute level of cytosolic Ca2+ signals by removing Ca2+ from external bathing media. 

Phrase: "Another example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "comes from studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "by Zheng"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "2000"

Phrase: "; Wen et al.,"

Phrase: "2004"

Phrase: ")"

Phrase: ","

Phrase: "in which"

Phrase: "they"

Phrase: "lowered"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0441994:lowered [Spatial Concept]
  1000   C1272755:Lowered [Quantitative Concept]
  1000   C2003888:Lowered [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "the absolute level of cytosolic Ca2+ signals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "by removing Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "from external bathing media."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.253: The growth cone repulsion observed under this experimental condition might have been attributable to the indirect depletion of internal Ca2+ stores. 

Phrase: "The growth cone repulsion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0683283:repulsion [Mental Process]
   734   C0596632:growth cone [Cell Component]

Phrase: "observed under this experimental condition"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0012634:condition [Disease or Syndrome]
   760   C0348080:Condition [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1517586:Experimental [Qualitative Concept]
   760   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "might"

Phrase: "have"

Phrase: "been"

Phrase: "attributable to the indirect depletion of internal Ca2+ stores."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0596130:Attributable [Mental Process]
Processing 00000000.tx.254: Therefore, the results in these two papers do not contradict our proposal that RyR-mediated CICR triggers attraction, whereas Ca2+ signals without CICR induce repulsion. 

Phrase: "Therefore,"

Phrase: "the results in these two papers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contradict"

Phrase: "our proposal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1555306:proposal [Idea or Concept]
  1000   C1948033:Proposal [Intellectual Product]

Phrase: "that RyR-mediated CICR"

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "attraction,"

Phrase: "whereas"

Phrase: "Ca2+ signals without CICR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "repulsion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683283:repulsion [Mental Process]
Processing 00000000.tx.255: A study by Henley et al. 

Phrase: "A study by Henley et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.256: (2004) showed that MAG-induced growth cone repulsion was blocked by inhibiting Ca2+ influx from ryanodine-sensitive channels but not from plasmalemmal channels. 

Phrase: "(2004"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that MAG-induced growth cone repulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0683283:repulsion [Mental Process]

Phrase: "was"

Phrase: "blocked by inhibiting Ca2+ influx"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C2983591:BLOCKED [Research Activity]
   760   C3463820:Inhibiting [Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "from ryanodine-sensitive channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "but"

Phrase: "not from plasmalemmal channels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1518422:Not [Functional Concept]
   737   C0439799:Channel [Spatial Concept]
   737   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.257: Furthermore, Nishiyama et al. 

Phrase: "Furthermore,"

Phrase: "Nishiyama et al."
Processing 00000000.tx.258: (2003) reported that netrin-1induced attraction was associated with high-amplitude Ca2+ influx through plasmalemmal L-type channels. 

Phrase: "(2003"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that netrin-1induced attraction"

Phrase: "was"

Phrase: "associated with high-amplitude Ca2+ influx"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0205250:High [Qualitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1299351:High [Qualitative Concept]
   753   C2346753:Amplitude [Spatial Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "through plasmalemmal L-type channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.259: These results initially appear to be in conflict with our conclusions; 

Phrase: "These results initially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be in conflict"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0009671:Conflict [Individual Behavior]
   790   C1705242:Conflict [Qualitative Concept]
   790   C2987476:Be [Conceptual Entity]

Phrase: "with our conclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.260: however, we used a direct [Ca2+]c elevation approach that bypassed activation of the MAG or netrin-1 receptors on the plasma membrane and could avoid cross talk among different intracellular signals. 

Phrase: "however,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "that bypassed activation of the MAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "or"

Phrase: "netrin-1 receptors on the plasma membrane"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0538359:netrin-1 receptors [Amino Acid, Peptide, or Protein,Receptor]
           netrin receptors
   774   C0230664:membrane receptors [Receptor]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "could"

Phrase: "avoid"

Phrase: "cross talk among different intracellular signals."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0010357:Crosstalk [Molecular Function]
   790   C2986468:Cross-talk [Cell Function]
   753   C0037817:Talk [Organism Function]
   753   C0234856:talk [Daily or Recreational Activity]
   753   C0600118:talk [Finding]
   753   C2828360:Cross [Conceptual Entity]
Processing 00000000.tx.261: Therefore, growth cone turning assayed by extracellular application of guidance molecules cannot be compared simply with our study that focuses on [Ca2+]c elevations and their downstream events. 

Phrase: "Therefore,"

Phrase: "growth cone turning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0541749:turning [Finding]
   734   C0596632:growth cone [Cell Component]

Phrase: "assayed by extracellular application of guidance molecules"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0150600:Guidance [Health Care Activity]
   748   C0185125:Application [Health Care Activity]
   748   C0521119:Extracellular [Cell Component]
   748   C0567416:molecules [Substance]
   748   C1947919:Application [Intellectual Product]
   748   C1959633:Guidance [Clinical Attribute]
   748   C2347934:Application [Intellectual Product]
   748   C3539080:APPLICATION [Quantitative Concept]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "cannot"

Phrase: "be"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "simply with our"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "focuses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205234:Focus [Spatial Concept]
  1000   C1285542:focus [Functional Concept]

Phrase: "on [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0702240:elevations [Spatial Concept]
   827 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "their downstream events."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]
Processing 00000000.tx.262: We propose that Ca2+-signal localization at the molecular level is a decisive factor for switching the steering direction of growth cones. 

Phrase: "We"

Phrase: "propose"

Phrase: "that Ca2+-signal localization at the molecular level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "a decisive factor for"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   819   C0960756:factor A [Organic Chemical]
   770   C1521761:Factor [Functional Concept]
   770   C2827422:Factor [Conceptual Entity]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "the steering direction of growth cones."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449738:Direction [Spatial Concept]
Processing 00000000.tx.263: Perhaps Ca2+ signals confined to nanodomains/microdomains activate distinct sets of molecular targets (Augustine et al., 2003), depending on the location of open Ca2+ channels as well as on the distance between these channels and Ca2+-binding proteins. 

Phrase: "Perhaps Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "confined to nanodomains/microdomains"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "distinct sets of molecular targets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "(Augustine et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: ","

Phrase: "depending on the location of open Ca2+ channels"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0175566:Open [Spatial Concept]
   744   C0450429:Location [Spatial Concept]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1515974:Location [Body Location or Region]
   711   C0439799:Channel [Spatial Concept]
   711   C0725813:depend [Medical Device]
   711   C1706095:Channel [Conceptual Entity]

Phrase: "as well as on the distance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0012751:Distance [Quantitative Concept]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "between these channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439799:Channel [Spatial Concept]
   966   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "Ca2+-binding proteins."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C0251337:Ca2+-binding protein- [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.264: Although recent papers have identified some of the downstream effectors of Ca2+ (Robles et al., 2003; Wen et al., 2004), much more work will need to be done to understand the whole picture of switch-like mechanisms that navigate the growth cone bidirectionally in response to Ca2+ signals of different localization and amplitude. 

Phrase: "Although"

Phrase: "recent papers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0030351:Papers [Manufactured Object]
   827 E C1547566:Paper [Idea or Concept]

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "some of the downstream effectors of Ca2+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205392:Some [Quantitative Concept]
   748   C0522506:Downstream [Spatial Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C3540770:Some [Intellectual Product]

Phrase: "(Robles et al.,"

Phrase: "2003"

Phrase: "; Wen et al.,"

Phrase: "2004"

Phrase: ")"

Phrase: ","

Phrase: "much more"

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "will"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "done"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the whole picture of switch-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441468:picture [Manufactured Object]
   760   C0441469:Picture [Manufactured Object]

Phrase: "like mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "navigate"

Phrase: "the growth cone bidirectionally in response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0596632:growth cone [Cell Component]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0206428:Cone [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C0330095:Cone [Plant]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2350017:Cone [Spatial Concept]
   753   C2911660:Growth [Activity]

Phrase: "to Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "of different localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "amplitude."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]
Processing 00000000.tx.265: Another important question concerns the causal relationship between cAMPPKA and Ca2+ signals. 

Phrase: "Another important question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522634:Question [Intellectual Product]

Phrase: "concerns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699424:Concern [Idea or Concept]

Phrase: "the causal relationship between cAMPPKA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "Ca2+ signals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.266: Wen et al. 

Phrase: "Wen et al."
Processing 00000000.tx.267: (2004) demonstrated that the cAMP pathway acts downstream of [Ca2+]c elevations, negatively regulating the repulsive signaling cascade that involves calcineurin and phosphatase-1. 

Phrase: "(2004"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the cAMP pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "acts downstream of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]
   790   C0522506:Downstream [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0702240:elevations [Spatial Concept]
   827 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "negatively"

Phrase: "regulating"

Phrase: "the repulsive signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]

Phrase: "that"

Phrase: "involves"

Phrase: "calcineurin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054450:Calcineurin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1149946:calcineurin [Molecular Function]

Phrase: "and"

Phrase: "phosphatase-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.268: This inhibition by cAMP allows [Ca2+]c elevations to activate only the attractive signaling components, thereby switching growth cone repulsion to attraction. 

Phrase: "This inhibition by cAMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0702240:elevations [Spatial Concept]
   793 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the attractive signaling components,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]

Phrase: "thereby"

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "growth cone repulsion to attraction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0683283:repulsion [Mental Process]
Processing 00000000.tx.269: In contrast, the cAMP pathway acts upstream of Ca2+ signals in growth cones guided by netrin-1 or MAG. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the cAMP pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "acts upstream of Ca2+ signals in growth cones"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0596632:Growth Cones [Cell Component]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0079613:ACT [Therapeutic or Preventive Procedure]
   744   C0206428:Cones [Cell]
   744   C0220844:growth [Physiologic Function]
   744   C0522505:Upstream [Spatial Concept]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]
   711 E C0330095:Cone [Plant]
   711   C1710082:Signal [Phenomenon or Process]
   711 E C2350017:Cone [Spatial Concept]

Phrase: "guided by netrin-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0258174:netrin-1 [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   833   C1334908:netrin 1 [Gene or Genome]
   833   C1442814:Netrin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0181090:Guide [Professional or Occupational Group]
   737   C0302614:Guide [Medical Device]
   737   C1706050:Guide [Manufactured Object]

Phrase: "or"

Phrase: "MAG."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0129439:Myelin Associated Glycoprotein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           myelin glycoprotein
  1000   C1416969:MYELIN-ASSOCIATED GLYCOPROTEIN [Gene or Genome]
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.270: Activation of the cAMP pathway increases the basal [Ca2+]c in growth cones, which converts MAG-induced repulsion to attraction because MAG-induced [Ca2+]c elevations can be superimposed on top of the higher basal [Ca2+]c (Henley et al., 2004). 

Phrase: "Activation of the cAMP pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in growth cones,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0596632:Growth Cones [Cell Component]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0206428:Cones [Cell]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0330095:Cone [Plant]
   779 E C2350017:Cone [Spatial Concept]

Phrase: "which"

Phrase: "converts"

Phrase: "MAG-induced repulsion to attraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0683283:repulsion [Mental Process]

Phrase: "because"

Phrase: "MAG-induced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205263:Induced [Functional Concept]
   756   C0129439:Myelin Associated Glycoprotein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           myelin glycoprotein
   756   C1416969:MYELIN-ASSOCIATED GLYCOPROTEIN [Gene or Genome]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0702240:elevations [Spatial Concept]
   827 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "superimposed on top of the higher basal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205112:Basal [Spatial Concept]
   748   C1704458:Top [Spatial Concept]
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c (Henley et al.,"

Phrase: "2004"

Phrase: ")."
Processing 00000000.tx.271: Also, growth cone attraction by netrin-1 depends on L-type Ca2+ channel activation by cAMPPKA (Nishiyama et al., 2003). 

Phrase: "Also,"

Phrase: "growth cone attraction by netrin-1"

Phrase: "depends on L-type Ca2+ channel activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0332307:Type [Qualitative Concept]
   748   C0439799:Channel [Spatial Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0725813:depend [Medical Device]
   748   C1547052:*Type [Quantitative Concept]
   748   C1706095:Channel [Conceptual Entity]
   748   C1879547:Activation [Activity]

Phrase: "by cAMPPKA"

Phrase: "(Nishiyama et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.272: The present study has demonstrated that the cAMP pathway activates RyRs and allows primary [Ca2+]c elevations to induce the secondary Ca2+ influx from the internal stores, thereby acting at the level of Ca2+ signaling. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the cAMP pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "RyRs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   983 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   983 E C1753335:ryanodine receptor [Molecular Function]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "primary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205225:Primary [Qualitative Concept]
  1000   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0702240:elevations [Spatial Concept]
   793 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the secondary Ca2+ influx from the internal stores,"

Phrase: "thereby"

Phrase: "acting at the level of Ca2+ signaling."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0037083:Signaling [Cell Function]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
   748   C3537152:signaling [Biologic Function]
   714   C0079613:ACT [Therapeutic or Preventive Procedure]
Processing 00000000.tx.273: Although the cAMP pathway may exert multiple roles at multiple steps in signal transduction cascades, we believe that the major mode of cAMP action, at least in DRG growth cones, is on the RyR-mediated CICR because RyR3-deficient axons did not respond to cAMP activation in either the Ca2+ imaging (Fig. 6 G) or the turning assay (Fig. 6 I). 

Phrase: "Although"

Phrase: "the cAMP pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "may"

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "multiple roles at multiple steps"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "in signal transduction cascades,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1707310:Cascade [Manufactured Object]
   734   C0037083:Signal Transduction [Cell Function]

Phrase: "we"

Phrase: "believe"

Phrase: "that"

Phrase: "the major mode of cAMP action,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1524059:mode of action [Functional Concept]
   753   C1513371:Mode [Functional Concept]
   753   C1705738:Mode [Quantitative Concept]
   753   C2347637:Mode [Quantitative Concept]
   753   C2348146:Mode [Quantitative Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in DRG growth cones,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   840   C0596632:Growth Cones [Cell Component]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0206428:Cones [Cell]
   804   C0220844:growth [Physiologic Function]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]
   771 E C0330095:Cone [Plant]
   771 E C2350017:Cone [Spatial Concept]
   717   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   717   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]

Phrase: "is on the RyR-mediated CICR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C1419778:RYR [Gene or Genome]

Phrase: "because"

Phrase: "RyR3-deficient axons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0004461:Axons [Cell Component]
   700   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   700   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "respond to cAMP activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C1879547:Activation [Activity]

Phrase: "in either"

Phrase: "the Ca2+ imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: "(Fig. 6 G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "the turning assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 6 I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.274: In summary, this study shows that CAMs control Ca2+-mediated steering of growth cones via cAMP and RyRs. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Ca2+-mediated steering of growth cones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0553654:steering [Finding]

Phrase: "via cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "RyRs."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   983 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   983 E C1753335:ryanodine receptor [Molecular Function]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.275: Upon contact with differing extracellular environments, growth cones could change their turning responses to axon guidance cues by modulating the efficiency of RyR-mediated CICR. 

Phrase: "Upon contact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332158:contact [Functional Concept]
  1000   C0337611:Contact [Population Group]
  1000   C1705415:Contact [Idea or Concept]

Phrase: "with differing extracellular environments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014406:Environments [Spatial Concept]

Phrase: "growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0596632:Growth Cones [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cones [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0330095:Cone [Plant]
   827 E C2350017:Cone [Spatial Concept]

Phrase: "could"

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "their turning responses to axon guidance"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "cues by modulating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0010439:Cues [Idea or Concept]
   790   C0443264:Modulating [Spatial Concept]

Phrase: "the efficiency of RyR-mediated CICR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013682:Efficiency [Quantitative Concept]
Processing 00000000.tx.276: In this way, CAMs and axon-guiding molecules cooperate to navigate axons along their correct paths. 

Phrase: "In this way,"

Phrase: "CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "axon-guiding molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "cooperate"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "navigate"

Phrase: "axons along their correct paths."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004461:Axons [Cell Component]
Processing 00000000.tx.277: Because activating cAMP pathways has been shown to overcome myelin-associated inhibitors of axon regeneration (e.g., MAG) in the damaged central nervous system (Cai et al., 1999; Neumann et al., 2002; Qiu et al., 2002), our findings further suggest that CAMs may play a role in regenerating axons, presumably through a mechanism similar to that used by cAMP-dependent switching of growth cone repulsion to attraction.  

Phrase: "Because"

Phrase: "activating cAMP pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "myelin-associated inhibitors of axon regeneration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "MAG"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0129439:Myelin Associated Glycoprotein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           myelin glycoprotein
  1000   C1416969:MYELIN-ASSOCIATED GLYCOPROTEIN [Gene or Genome]
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: "in the damaged central nervous system"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   923   C0927232:Central Nervous System [Body System]
   923   C1269563:Central nervous system [Body System]
   861   C0027763:Nervous System [Body System]
   861   C0422837:NERVOUS SYSTEM [Finding]
   861   C1269560:Nervous system [Body System]
   812   C0027769:Nervous [Sign or Symptom]
   812   C0205099:Central [Spatial Concept]
   812   C0449913:System [Functional Concept]
   812   C0599851:Nervous [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   812   C1879652:Central - [Laboratory Procedure]
   805 E C0205494:Neurologic [Qualitative Concept]
   768 E C0027855:Neurology [Biomedical Occupation or Discipline]
   750 E C2707261:Neurological [Clinical Attribute]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Cai et al.,"

Phrase: "1999"

Phrase: "; Neumann et al.,"

Phrase: "2002"

Phrase: "; Qiu et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: ","

Phrase: "our findings further"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in regenerating axons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "presumably through a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "used by cAMP-dependent"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C1273517:Used by [Finding]
           used
   770   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "switching of growth cone repulsion"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0596632:growth cone [Cell Component]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0206428:Cone [Cell]
   760   C0220844:growth [Physiologic Function]
   760   C0330095:Cone [Plant]
   760   C0683283:repulsion [Mental Process]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2350017:Cone [Spatial Concept]
   760   C2911660:Growth [Activity]
   726   C1707719:Switch [Manufactured Object]

Phrase: "to attraction."
Processing 00000000.tx.278: Materials and methods Top Abstract Introduction Results Discussion Materials and methods References  Cell culture DRGs dissected from embryonic day 9 chicks or postnatal day 0 mice were dissociated as previously described (Nakai and Kamiguchi, 2002) and plated on a glass-based dish coated with 9 g/cm2 laminin (Life Technologies) or CAM-Fc chimeric proteins that consisted of the whole extracellular domain of a CAM (L1 or N-cadherin) and the Fc region of human IgG. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell culture DRGs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0011928:DRGs [Intellectual Product]
   793 E C1414151:DRG [Gene or Genome]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "dissected from embryonic day 9 chicks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0013935:Embryonic [Embryonic Structure]
   753   C0205239:dissected [Functional Concept]
   753   C0332173:/day [Temporal Concept]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]

Phrase: "or"

Phrase: "postnatal day 0 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "dissociated as previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Nakai"

Phrase: "and"

Phrase: "Kamiguchi,"

Phrase: "2002"

Phrase: ")"

Phrase: "and"

Phrase: "plated on a glass-based dish"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0017596:Glass [Manufactured Object]
   753   C0020498:DISH [Disease or Syndrome]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1947936:Glass [Medical Device]
   719 E C0002055:base [Inorganic Chemical]
   719   C0005971:Plate [Medical Device]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719   C1139930:plate [Medical Device]
   719 E C1880279:Base [Biomedical or Dental Material]
   719   C3537155:Plate [Manufactured Object]

Phrase: "coated with 9 g/cm2 laminin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C2348886:g/cm2 [Quantitative Concept]
   783   C0912065:laminin-9 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439267:g% [Quantitative Concept]
   753   C0439479:cm2 [Quantitative Concept]
   753   C0555206:CM2 [Congenital Abnormality]
   753   C1522408:Coated [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: "or"

Phrase: "CAM-Fc chimeric proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0162768:chimeric proteins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "consisted of the whole extracellular domain of a CAM (L1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C1517050:Extracellular Domain [Spatial Concept]
   739   C0441918:L1 [Finding]
   739   C0444667:Whole [Quantitative Concept]
   739   C0521119:Extracellular [Cell Component]
   739   C1179698:L1 [Body Location or Region]
   739   C1416177:L1 [Gene or Genome]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]
   706   C0332529:CONSIST [Qualitative Concept]

Phrase: "or"

Phrase: "N-cadherin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the Fc region of human IgG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
Processing 00000000.tx.279: The L1-Fc cDNA construct was provided by Dr. 

Phrase: "The L1-Fc cDNA construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.280: Vance Lemmon (University of Miami, Miami, FL), and the N-cadherin-Fc construct by Dr. 

Phrase: "Vance Lemmon"

Phrase: "(University of Miami,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1551421:Miami [Population Group]

Phrase: "Miami,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551421:Miami [Population Group]

Phrase: "FL),"

Phrase: "and"

Phrase: "the N-cadherin-Fc construct by Dr."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2827421:Construct [Classification]
Processing 00000000.tx.281: Patrick Doherty (King's College London, London, UK). 

Phrase: "Patrick Doherty"

Phrase: "(King's College London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023973:London [Geographic Area]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.282: Production of CAM-Fc and preparation of CAM-Fccoated dishes were performed as described previously (Kamiguchi and Yoshihara, 2001). 

Phrase: "Production of CAM-Fc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "preparation of CAM-Fccoated dishes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Kamiguchi"

Phrase: "and"

Phrase: "Yoshihara,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.283: The neuronal cultures were maintained in Leibovitz's L-15 medium (Life Technologies) supplemented with N-2 (Life Technologies), 50 ng/ml NGF (Promega), and 750 g/ml BSA (Life Technologies) in a humidified atmosphere of 100% air at 37C. 

Phrase: "The neuronal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "maintained in Leibovitz's L-15 medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719 E C0024501:Maintain [Activity]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: "supplemented with N-2 (Life Technologies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0039421:technologies [Occupation or Discipline]
   753   C0376558:Life [Idea or Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "50 ng/ml NGF (Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "750 g/ml BSA (Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: "in a humidified atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004178:Atmosphere [Natural Phenomenon or Process]
   861   C0678214:atmosphere [Quantitative Concept]

Phrase: "of 100% air"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0001861:Air [Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "at 37C."
Processing 00000000.tx.284: FLIP setup The 355-nm Nd:YAG laser beam (a pulse width of 5 ns; New Wave Research) was introduced into an inverted microscope (TE300; Nikon) through the random-scanning photolysis system (Hamamatsu Photonics) and was focused on a growth cone using a 100x Plan Fluor (NA 1.3, oil objective). 

Phrase: "FLIP setup"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1550029:Setup [Idea or Concept]

Phrase: "The 355-nm Nd:YAG laser beam"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0458142:Laser beam [Phenomenon or Process]
   799   C0338248:BEAM [Therapeutic or Preventive Procedure]
   799   C2347880:Beam [Phenomenon or Process]

Phrase: "("

Phrase: "a pulse width of 5 ns"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C0487742:Width [Quantitative Concept]
   753   C1947910:Pulse [Phenomenon or Process]

Phrase: "; New Wave Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]

Phrase: ")"

Phrase: "was"

Phrase: "introduced into an inverted microscope"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0181839:Microscope [Medical Device]
   760   C0443241:Inverted [Qualitative Concept]
   760   C1706379:Microscope [Medical Device]
   726   C1292748:introduce [Functional Concept]

Phrase: "(TE300"

Phrase: "; Nikon"

Phrase: ")"

Phrase: "through the random-scanning photolysis system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Hamamatsu Photonics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328817:Photonics [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "focused on a growth cone"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0596632:growth cone [Cell Component]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0205234:Focused [Spatial Concept]
   760   C0206428:Cone [Cell]
   760   C0220844:growth [Physiologic Function]
   760   C0330095:Cone [Plant]
   760   C1285542:focused [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2350017:Cone [Spatial Concept]
   760   C2911660:Growth [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 100x Plan Fluor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0235665:FLUOR [Pathologic Function]

Phrase: "(NA 1.3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1272460:{NA} [Qualitative Concept]

Phrase: "oil objective"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018017:Objective [Intellectual Product]
   861   C1571702:Objective [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.285: Spatial restriction of FLIP (1 m in diam in the xy plane and 2 m in thickness in the z direction) was demonstrated by irradiating caged fluorescein maleimide (Dojindo) immobilized in acrylic polymer. 

Phrase: "Spatial restriction of FLIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443288:Restriction [Functional Concept]

Phrase: "(1 m in diam"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "in the xy plane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444660:Plane [Spatial Concept]

Phrase: "and"

Phrase: "2 m in thickness"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "in the z direction"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0449738:Direction [Spatial Concept]
   761 E C1707761:Directionality [Functional Concept]
   761 E C3274524:Directionality [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "demonstrated by irradiating caged fluorescein maleimide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0060522:fluorescein maleimide [Organic Chemical,Pharmacologic Substance]
   753   C0024579:maleimide [Organic Chemical]
   753   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0065573:Maleimide [Organic Chemical]
   719   C0337189:Cage [Manufactured Object]
   719   C0441239:Cage [Medical Device]
   719   C1522449:Irradiate [Therapeutic or Preventive Procedure]

Phrase: "(Dojindo"

Phrase: ")"

Phrase: "immobilized in acrylic polymer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0444831:Acrylic polymer [Biomedical or Dental Material,Organic Chemical]
   770   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   770   C0440181:Acrylic [Biomedical or Dental Material,Organic Chemical]
Processing 00000000.tx.286: Growth cone turning assay DRG neurons were incubated, unless otherwise noted, with 2 M NP-EGTA AM (Invitrogen) and 0.025% Cremophor EL (Sigma-Aldrich) for 30 min and then washed. 

Phrase: "Growth cone turning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0541749:turning [Finding]
   734   C0596632:growth cone [Cell Component]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "DRG neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0027882:Neurons [Cell]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: ","

Phrase: "unless"

Phrase: "otherwise"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "with 2 M NP-EGTA AM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0377848:EGTA acetoxymethyl ester [Organic Chemical]
   799   C0014898:Ester [Organic Chemical]
   700   C0250426:2-nitrophenyl-EGTA [Organic Chemical]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "0.025% Cremophor EL (Sigma-Aldrich"

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]
Processing 00000000.tx.287: After an additional 1.5-h incubation, an area within a lamellipodium in one side of the growth cone was irradiated with a laser (35 nJ/pulse) every 3 s while time-lapse differential interference contrast (DIC) images of the growth cone were acquired with a CCD camera. 

Phrase: "After an additional 1.5-h incubation,"

Phrase: "an area within a lamellipodium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "in one side"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205092:one side [Spatial Concept]
   861   C0441987:Side [Spatial Concept]

Phrase: "of the growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596632:growth cone [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cone [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C0330095:Cone [Plant]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2350017:Cone [Spatial Concept]
   861   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "irradiated with a laser"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023089:Laser [Manufactured Object]
   770   C0458142:Laser [Phenomenon or Process]
   770   C1023865:Laser [Plant]
   770   C1517600:Irradiated [Functional Concept]
   770   C1522449:Irradiated [Therapeutic or Preventive Procedure]
   770   C1548980:Irradiated [Idea or Concept]
   770   C1706315:Laser [Medical Device]

Phrase: "(35 nJ/pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0232117:PULSE [Clinical Attribute]
   827   C0391850:Pulse [Physiologic Function]
   827   C1947910:Pulse [Phenomenon or Process]
   743 E C0034107:Pulses [Health Care Activity]

Phrase: ")"

Phrase: "every 3 s"

Phrase: "while"

Phrase: "time-lapse differential interference contrast (DIC) images of the growth cone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C1704254:Image [Intellectual Product]
   706   C1704922:Image [Entity]
   706   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired with a CCD camera."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0598124:CCD camera [Manufactured Object]
   760   C0179533:Camera [Medical Device]
   760   C0439661:Acquired [Temporal Concept]
   760   C1654607:Camera [Eukaryote]
   760   C1706254:CAMERA [Medical Device]
   760   C3245488:acquired [Intellectual Product]
   726 E C1706701:Acquire [Activity]
Processing 00000000.tx.288: Growth cone turning was assessed by tracing the middle point of the distal edge of the growth cone central domain. 

Phrase: "Growth cone turning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0541749:turning [Finding]
   734   C0596632:growth cone [Cell Component]

Phrase: "was"

Phrase: "assessed by tracing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516048:Assessed [Activity]

Phrase: "the middle point of the distal edge of the growth cone central domain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C1552961:Point [Quantitative Concept]
   735   C2347617:point [Quantitative Concept]
Processing 00000000.tx.289: On L1 and N-cadherin substrates, the original (preFLIP) direction of axon extension was defined as a straight line connecting the positions of the growth cone at the onset and 15 min before the onset of FLIP. 

Phrase: "On L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "and"

Phrase: "N-cadherin substrates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1710236:Substrate [Manufactured Object]
   734   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1413277:N-CADHERIN [Gene or Genome]

Phrase: "the original"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205313:Original [Idea or Concept]
  1000   C2347409:Original [Occupational Activity]

Phrase: "(preFLIP"

Phrase: ")"

Phrase: "direction of axon extension"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449738:Direction [Spatial Concept]

Phrase: "was"

Phrase: "defined as a straight line"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205132:Line [Spatial Concept]
   760   C0445291:Straight [Spatial Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "connecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986575:Connect [Activity]

Phrase: "the positions of the growth cone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:positions [Spatial Concept]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "15 min before the onset of FLIP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0702093:/min [Temporal Concept]
Processing 00000000.tx.290: The direction during FLIP was defined as a straight line connecting the positions of the growth cone at the onset and at the end of repetitive FLIP for 60 min. 

Phrase: "The direction during FLIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449738:Direction [Spatial Concept]

Phrase: "was"

Phrase: "defined as a straight line"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205132:Line [Spatial Concept]
   760   C0445291:Straight [Spatial Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "connecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986575:Connect [Activity]

Phrase: "the positions of the growth cone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:positions [Spatial Concept]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "and at the end of repetitive FLIP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0031751:photolysis [Molecular Function]
   742   C0205234:Focal [Spatial Concept]
   742   C0444930:End [Spatial Concept]
   742   C1515981:And [Idea or Concept]
   742   C2746065:End [Temporal Concept]

Phrase: "for 60 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.291: The growth cone turning angle was defined by the angle between the original direction and the direction during FLIP. 

Phrase: "The growth cone turning angle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205143:Angle [Spatial Concept]

Phrase: "was"

Phrase: "defined by the angle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205143:Angle [Spatial Concept]
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]

Phrase: "between the original direction"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0449738:Direction [Spatial Concept]
   761 E C1707761:Directionality [Functional Concept]
   761 E C3274524:Directionality [Functional Concept]

Phrase: "and"

Phrase: "the direction during FLIP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449738:Direction [Spatial Concept]
Processing 00000000.tx.292: Because axons extended faster on a laminin substrate, the turning angle on laminin was determined using the positions of the growth cone at 10 min before, at the onset of, and at 30 min after repetitive FLIP. 

Phrase: "Because"

Phrase: "axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axons [Cell Component]

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "faster on a laminin substrate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0248561:laminin A [Amino Acid, Peptide, or Protein]
   797   C1416775:LAMININ A [Gene or Genome]
   760   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1710236:Substrate [Manufactured Object]
   726   C0015663:Fast [Finding]
   726   C0456962:Fast [Qualitative Concept]

Phrase: "the turning angle on laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205143:Angle [Spatial Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the positions of the growth cone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:positions [Spatial Concept]

Phrase: "at 10 min before,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of,"

Phrase: "and at 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "after repetitive FLIP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031751:photolysis [Molecular Function]
Processing 00000000.tx.293: Included in this assay were only those growth cones with net extension >5 m during the preFLIP periods and without collapse during the time-lapse imaging. 

Phrase: "Included in this assay"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0332257:included [Functional Concept]
   770   C1510438:Assay [Laboratory Procedure]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "were"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "those growth cones with net extension"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0596632:Growth Cones [Cell Component]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0206428:Cones [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
   719 E C0330095:Cone [Plant]
   719 E C2350017:Cone [Spatial Concept]

Phrase: ">5 m during the preFLIP periods"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1440942:M-5 [Immunologic Factor]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "and without collapse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0036974:collapse [Pathologic Function]
   790   C0332521:Collapse [Phenomenon or Process]
   790   C0344329:Collapse [Finding]
   790   C1515981:And [Idea or Concept]
   790   C1880118:COLLAPSE [Phenomenon or Process]

Phrase: "during the time-lapse"

Phrase: "imaging."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.294: In some experiments, various concentrations of BAPTA AM (Invitrogen) were loaded into neurons before the turning assay (a 20-min incubation with BAPTA AM and Cremophor EL followed by a 30-min incubation). 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "various concentrations of BAPTA AM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "were"

Phrase: "loaded into neurons"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "before the turning assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "("

Phrase: "a 20-min incubation with BAPTA AM"

Phrase: "and"

Phrase: "Cremophor EL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0056476:cremophor EL [Carbohydrate,Pharmacologic Substance]
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: "followed by a 30-min incubation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332283:Followed by [Temporal Concept]
           followed
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.295: The following reagents were applied to some cultures 30 min before the turning assay: 20 M Sp-cAMPS (Calbiochem), 20 M Rp-cAMPS (Calbiochem), 100 M ryanodine (Calbiochem), and 100 nM KT5720 (Calbiochem). 

Phrase: "The following reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "applied to some"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0185125:Applied [Health Care Activity]
   756 E C1632850:Apply [Functional Concept]
   756 E C1879355:Apply [Functional Concept]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "30 min before the turning assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]

Phrase: ":"

Phrase: "20 M Sp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "20 M Rp-cAMPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0525261:(RP)-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "100 M ryanodine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "100 nM KT5720"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064433:KT5720 [Organic Chemical]

Phrase: "(Calbiochem"

Phrase: ")."
Processing 00000000.tx.296: Imaging FLIP-induced Ca2+ signals Dextran (10,000 D) conjugated with CG-1 (3 mg/ml; Invitrogen) was introduced into DRG neurons by trituration loading as described previously (Sydor et al., 1996). 

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "FLIP-induced Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "Dextran"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]

Phrase: "(10,000"

Phrase: "D)"

Phrase: "conjugated with CG-1"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0753494:calcium green 1 [Indicator, Reagent, or Diagnostic Aid]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0332583:Green [Qualitative Concept]
   760   C0522529:Conjugated [Spatial Concept]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(3 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; Invitrogen"

Phrase: ")"

Phrase: "was"

Phrase: "introduced into DRG neurons"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   833   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   790   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   790   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   753   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   753   C0027882:Neurons [Cell]
   753   C0040452:Root [Body Part, Organ, or Organ Component]
   753   C0205095:Dorsal [Spatial Concept]
   753   C0242726:Root [Plant]
   753   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   753   C1318154:Root [Body Part, Organ, or Organ Component]
   753   C1705917:Root [Idea or Concept]
   719   C1292748:introduce [Functional Concept]

Phrase: "by trituration loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Sydor et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.297: After NP-EGTA loading, FLIP-induced Ca2+ signals were imaged with a high-speed CCD camera (HiSCA; Hamamatsu Photonics) coupled with a Gen IV image intensifier (Hamamatsu Photonics). 

Phrase: "After NP-EGTA loading,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708715:Loading [Activity]

Phrase: "FLIP-induced Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "imaged with a high-speed CCD camera"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0598124:CCD camera [Manufactured Object]
   748   C0179533:Camera [Medical Device]
   748   C0205250:High [Qualitative Concept]
   748   C0678536:Speed [Quantitative Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1654607:Camera [Eukaryote]
   748   C1706254:CAMERA [Medical Device]
   748   C2700149:HIGH [Intellectual Product]
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "(HiSCA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428729:HISCA [Gene or Genome]

Phrase: "; Hamamatsu Photonics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328817:Photonics [Classification]

Phrase: ")"

Phrase: "coupled with a Gen IV image intensifier"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0181273:Image intensifier [Medical Device]
   748   C1704254:Image [Intellectual Product]
   748   C1704351:GEN [Quantitative Concept]
   748   C1704922:Image [Entity]
   748   C1948027:Coupled [Functional Concept]
   748   C2239486:Gen [Gene or Genome]
   748   C3542466:Image [Intellectual Product]
   714 E C0010222:couple [Family Group]

Phrase: "(Hamamatsu Photonics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328817:Photonics [Classification]

Phrase: ")."
Processing 00000000.tx.298: The images were background subtracted and expressed as the change in CG-1 fluorescence relative to the baseline before FLIP (F/F0) using the AquaCosmos software version 2.0 (Hamamatsu Photonics). 

Phrase: "The images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "subtracted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1719767:Subtract [Intellectual Product]
   966   C2348589:Subtract [Phenomenon or Process]

Phrase: "and"

Phrase: "expressed as the change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "in CG-1 fluorescence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   756   C0753494:calcium green 1 [Indicator, Reagent, or Diagnostic Aid]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "relative to the baseline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "before FLIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031751:photolysis [Molecular Function]

Phrase: "(F/F0)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the AquaCosmos software version 2.0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0037585:Software [Intellectual Product,Manufactured Object]
   804   C0333052:Version [Functional Concept]
   804   C2607870:Version [Spatial Concept]

Phrase: "(Hamamatsu Photonics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328817:Photonics [Classification]

Phrase: ")."
Processing 00000000.tx.299: Each image was acquired by a 15.7-ms exposure with CCD binning set at 2 x 2. 

Phrase: "Each image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "acquired by a 15.7-ms exposure"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]
   748   C0439661:Acquired [Temporal Concept]
   748   C2349943:Ms. [Conceptual Entity]
   748   C3245488:acquired [Intellectual Product]
   748   C3539704:MS [Gene or Genome]
   714 E C1706701:Acquire [Activity]

Phrase: "with CCD binning"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "at 2 x 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1516077:At [Spatial Concept]
Processing 00000000.tx.300: The sampling rate was 63.7 Hz. 

Phrase: "The sampling rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "63.7 Hz."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439482:Hz [Quantitative Concept]
Processing 00000000.tx.301: To synchronize FLIP with CG-1 imaging, a laser shot was triggered by a transistortransistor logic signal that was generated by AquaCosmos and controlled in timing by a pulse generator (Nihon Kohden). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "synchronize"

Phrase: "FLIP with CG-1 imaging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0031751:photolysis [Molecular Function]

Phrase: "a laser shot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:Shot [Therapeutic or Preventive Procedure]
   861   C1420042:SHOT [Gene or Genome]
   861   C2699298:Shot [Quantitative Concept]
   861   C2919062:Shot NOS [Injury or Poisoning]

Phrase: "was"

Phrase: "triggered by a transistortransistor logic signal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1444748:Triggered by [Qualitative Concept]
           Trigger
   753   C0023963:Logic [Idea or Concept]
   753   C1710082:Signal [Phenomenon or Process]
   719   C0032930:Trigger [Clinical Attribute]

Phrase: "that"

Phrase: "was"

Phrase: "generated by AquaCosmos"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "controlled in timing"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0449243:Timing [Temporal Concept]
   790   C1704250:Timing [Conceptual Entity]
   790   C2587213:Controlled [Functional Concept]
   756 E C0243148:control [Qualitative Concept]
   756 E C1550141:Control [Substance]
   756 E C1882979:Control [Conceptual Entity]
   756 E C3274648:Control [Qualitative Concept]

Phrase: "by a pulse generator"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1140627:pulse generator [Medical Device]
   861   C0232117:PULSE [Clinical Attribute]
   861   C0237638:Generator [Manufactured Object]
   861   C0391850:Pulse [Physiologic Function]
   861   C1947910:Pulse [Phenomenon or Process]
   777 E C0034107:Pulses [Health Care Activity]

Phrase: "(Nihon Kohden"

Phrase: ")."
Processing 00000000.tx.302: Typically, a CCD exposure was initiated 0.8 ms after the laser shot (90 nJ/pulse). 

Phrase: "Typically,"

Phrase: "a CCD exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "was"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "0.8 ms after the laser shot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C2349943:Ms. [Conceptual Entity]
   748   C3539704:MS [Gene or Genome]

Phrase: "(90 nJ/pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0232117:PULSE [Clinical Attribute]
   827   C0391850:Pulse [Physiologic Function]
   827   C1947910:Pulse [Phenomenon or Process]
   743 E C0034107:Pulses [Health Care Activity]

Phrase: ")."
Processing 00000000.tx.303: This interval was sufficiently long to prevent laser-induced autofluorescence from affecting the CG-1 image. 

Phrase: "This interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1272706:Interval [Temporal Concept]
  1000   C1552654:Interval [Idea or Concept]
  1000   C1552713:Interval [Intellectual Product]

Phrase: "was"

Phrase: "sufficiently long to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205166:Long [Qualitative Concept]
   827   C1706317:Long [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "laser-induced autofluorescence from affecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0544711:Autofluorescence [Finding]

Phrase: "the CG-1 image."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1704254:Image [Intellectual Product]
   812   C1704922:Image [Entity]
   812   C3542466:Image [Intellectual Product]
   756   C0753494:calcium green 1 [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.304: Focal Ca2+ signals were evaluated by averaging F/F0 values within a 2-m-diam zone centered by the FLIP site. 

Phrase: "Focal Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "evaluated by averaging F/F0 values"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0042295:Values [Qualitative Concept]
   753   C0220825:Evaluated [Functional Concept]
   753   C0439133:(f) [Intellectual Product]
   753   C1553038:[f] [Quantitative Concept]
   719   C1510992:Average [Quantitative Concept]
   719 E C1522609:Value [Quantitative Concept]
   719   C2825518:AVERAGE [Quantitative Concept]

Phrase: "within a 2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "m-"

Phrase: "diam zone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1710706:Zone [Spatial Concept]
   789 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]

Phrase: "centered by the FLIP site."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0031751:photolysis [Molecular Function]
   748   C0205099:centered [Spatial Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0205234:Focal [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
Processing 00000000.tx.305: After a 5-min incubation with 20 M Sp-cAMPS, 20 M Rp-cAMPS, and/or 100 M ryanodine, FLIP-induced Ca2+ signals were again analyzed in the same growth cone under the same experimental conditions. 

Phrase: "After a 5-min incubation"

Phrase: "with 20 M Sp-cAMPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0525262:Sp-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "20 M Rp-cAMPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0525261:(RP)-cAMPS [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and/or"

Phrase: "100 M ryanodine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]

Phrase: "FLIP-induced Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "again"

Phrase: "analyzed in the same growth cone"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0596632:growth cone [Cell Component]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0206428:Cone [Cell]
   753   C0220844:growth [Physiologic Function]
   753   C0330095:Cone [Plant]
   753   C0445247:Same [Qualitative Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2350017:Cone [Spatial Concept]
   753   C2911660:Growth [Activity]

Phrase: "under the same experimental conditions."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.306: In some experiments, FLIP-induced Ca2+ signals were quantified by converting the CG-1 F/F0 value to [Ca2+] using the following formula (Lev-Ram et al., 1992): [Ca2+] = ([Ca2+]rest + Kd x f/fmax)/(1  f/fmax), where f = F/F0 and fmax = Fmax/F0. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "FLIP-induced Ca2+ signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "quantified by converting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "the CG-1 F/F0 value to [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following formula"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0489829:Formula [Intellectual Product]
   861   C1705501:Formula [Intellectual Product]

Phrase: "(Lev-Ram et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ":"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "="

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]rest + Kd x f/fmax)/(1  f/fmax"

Phrase: ")"

Phrase: ","

Phrase: "where f = F/F0"

Phrase: "and"

Phrase: "fmax = Fmax/F0."
Processing 00000000.tx.307: The dissociation constant (Kd) of dextran-conjugated CG-1 was determined as 413 nM (37C, pH 7.2) by using the calcium calibration buffer kit with magnesium #2 (Invitrogen). 

Phrase: "The dissociation constant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   861   C1547014:*Constant [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]

Phrase: "(Kd) of dextran-conjugated CG-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0026691:KD [Disease or Syndrome]
   748   C1705240:KD [Gene or Genome]
   748   C1839259:KD [Disease or Syndrome]

Phrase: "was"

Phrase: "determined as 413 nM (37C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "pH 7.2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the calcium calibration buffer kit with magnesium #2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0812225:KIT [Medical Device]
   744   C1150635:KIT [Molecular Function]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C3273202:Kit [Manufactured Object]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.308: The resting Ca2+ concentration ([Ca2+]rest) was measured by Fura-2 ratio imaging as described in the next section. 

Phrase: "The resting Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: ")"

Phrase: "was"

Phrase: "measured by Fura-2 ratio"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0444706:Measured [Qualitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "as"

Phrase: "described in the next section."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0205117:next [Spatial Concept]
   760   C0205155:Section [Spatial Concept]
   760   C0332282:Next [Temporal Concept]
   760   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   760   C1522472:Section [Substance]
   760   C1552738:described [Idea or Concept]
   760   C1552923:Section [Quantitative Concept]
   760   C1705191:Section [Physical Object]
   760   C1883708:Next [Temporal Concept]
Processing 00000000.tx.309: The Fmax was the maximal change of CG-1 fluorescence, which was determined in every growth cone by applying 10 M of calcium ionophore A23187 (Sigma-Aldrich) in media with a saturating amount of Ca2+ (1.26 mM). 

Phrase: "The Fmax"

Phrase: "was"

Phrase: "the maximal change of CG-1 fluorescence,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0025320:The change [Physiologic Function]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "determined in every growth cone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0596632:growth cone [Cell Component]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0206428:Cone [Cell]
   760   C0220844:growth [Physiologic Function]
   760   C0330095:Cone [Plant]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2350017:Cone [Spatial Concept]
   760   C2911660:Growth [Activity]

Phrase: "by applying 10 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "of calcium ionophore A23187"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0878412:A23187 [Antibiotic,Organic Chemical]
   734   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Sigma-Aldrich"

Phrase: ")"

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "with a saturating amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "of Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(1.26 mM"

Phrase: ")."
Processing 00000000.tx.310: Fura-2 ratio imaging DRG neurons were incubated with 2 M Fura-2 AM (Invitrogen) and 0.025% Cremophor EL for 30 min. 

Phrase: "Fura-2 ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]
   734   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "DRG neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0027882:Neurons [Cell]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "incubated with 2 M Fura-2 AM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0014898:Ester [Organic Chemical]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "0.025% Cremophor EL for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0056476:cremophor EL [Carbohydrate,Pharmacologic Substance]
   748   C1416870:EL [Gene or Genome]
   748   C1823249:EL [Gene or Genome]
Processing 00000000.tx.311: After an additional 1-h incubation, Fura-2 was excited at two wavelengths (340 and 380 nm), and emission images were acquired at 510 nm. 

Phrase: "After an additional 1-h incubation,"

Phrase: "Fura-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "excited at two wavelengths"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205448:Two [Quantitative Concept]
   770   C0449819:wavelengths [Quantitative Concept]
   770   C0549255:Excited [Activity]

Phrase: "(340"

Phrase: "and"

Phrase: "380 nm),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "emission images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired at 510 nm."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0439661:Acquired [Temporal Concept]
   770   C3245488:acquired [Intellectual Product]
   737 E C1706701:Acquire [Activity]
Processing 00000000.tx.312: After background subtraction, the ratio of fluorescence intensity (R = F340/F380) was measured in a growth cone and converted to [Ca2+] using the following standard formula (Grynkiewicz et al., 1985): [Ca2+] = Kd x (Ffree/Fbound) x (R  Rmin)/(Rmax  R). 

Phrase: "After background subtraction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348589:Subtraction [Phenomenon or Process]

Phrase: "the ratio of fluorescence intensity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "(R = F340/F380"

Phrase: ")"

Phrase: "was"

Phrase: "measured in a growth cone"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0596632:growth cone [Cell Component]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0206428:Cone [Cell]
   760   C0220844:growth [Physiologic Function]
   760   C0330095:Cone [Plant]
   760   C0444706:Measured [Qualitative Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2350017:Cone [Spatial Concept]
   760   C2911660:Growth [Activity]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "converted"

Phrase: "to [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following standard formula"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0489829:Formula [Intellectual Product]
   827   C1442989:Standard [Qualitative Concept]
   827   C1705501:Formula [Intellectual Product]
   827   C2828392:Standard [Intellectual Product]

Phrase: "(Grynkiewicz et al.,"

Phrase: "1985"

Phrase: ")"

Phrase: ":"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]"

Phrase: "= Kd x (Ffree/Fbound"

Phrase: ")"

Phrase: "x (R  Rmin"

Phrase: ")"

Phrase: "/"

Phrase: "(Rmax  R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.313: The dissociation constant (Kd) of Fura-2 was determined as 207 nM (37C, pH 7.2) by using the calcium calibration buffer kit with magnesium #2 (Invitrogen). 

Phrase: "The dissociation constant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   861   C1547014:*Constant [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]

Phrase: "(Kd) of Fura-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026691:KD [Disease or Syndrome]
   770   C1705240:KD [Gene or Genome]
   770   C1839259:KD [Disease or Syndrome]

Phrase: "was"

Phrase: "determined as 207 nM (37C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "pH 7.2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the calcium calibration buffer kit with magnesium #2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0812225:KIT [Medical Device]
   744   C1150635:KIT [Molecular Function]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C3273202:Kit [Manufactured Object]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.314: The constant Ffree/Fbound was the fluorescence ratio of the Ca2+-free and -saturated forms of Fura-2 upon 380-nm excitation. 

Phrase: "The constant Ffree/Fbound"

Phrase: "was"

Phrase: "the fluorescence ratio of the Ca2+-free"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "and -"

Phrase: "saturated forms of Fura-2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "upon 380-nm excitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0549255:Excitation [Activity]
Processing 00000000.tx.315: Rmin designated the minimum R measured in the absence of Ca2+, and Rmax the maximum R at a saturating Ca2+ concentration. 

Phrase: "Rmin"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "the minimum R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "measured in the absence of Ca2+,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0332197:absence [Quantitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "Rmax"

Phrase: "the maximum R at a saturating Ca2+ concentration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205090:R- [Spatial Concept]
   744   C0684010:R. [Professional or Occupational Group]
   744   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.316: These parameters were determined in growth cones by applying 10 M A23187 in media with a saturating amount of Ca2+ (1.26 mM) followed by perfusion with Ca2+-free buffer containing 2 mM EGTA. 

Phrase: "These parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "in growth cones by applying 10 M A23187"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0596632:Growth Cones [Cell Component]
   744   C0206428:Cones [Cell]
   711 E C0330095:Cone [Plant]
   711 E C2350017:Cone [Spatial Concept]

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "with a saturating amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "of Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(1.26 mM)"

Phrase: "followed by perfusion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0031001:Perfusion [Therapeutic or Preventive Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with Ca2+-free buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2 mM EGTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.317: Values for Ffree/Fbound, Rmin, and Rmax were 2.15, 0.32, and 4.12, respectively. 

Phrase: "Values for Ffree/Fbound,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "Rmin,"

Phrase: "and"

Phrase: "Rmax"

Phrase: "were"

Phrase: "2.15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "0.32,"

Phrase: "and"

Phrase: "4.12,"

Phrase: "respectively."
Processing 00000000.tx.318: cAMP measurements Intracellular cAMP levels in neurons were measured using a competitive nonacetylation immunoassay kit (GE Healthcare), according to the manufacturer's instructions. 

Phrase: "cAMP measurements Intracellular cAMP levels in neurons"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a competitive nonacetylation immunoassay kit (GE Healthcare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086388:Health Care [Health Care Activity]

Phrase: ")"

Phrase: ","

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.319: We used fluorescence ratio imaging of FlCRhR to measure the activity of cAMP in the growth cone cytosol. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescence ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "imaging of FlCRhR to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the activity of cAMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "in the growth cone cytosol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1383501:Cytosol [Cell Component]
   734   C0596632:growth cone [Cell Component]
Processing 00000000.tx.320: FlCRhR (20  5 M; Invitrogen) was pressure-injected into a DRG neuron with a micropipette. 

Phrase: "FlCRhR"

Phrase: "(20  5 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "; Invitrogen"

Phrase: ")"

Phrase: "was"

Phrase: "pressure-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033095:Pressure [Phenomenon or Process]
  1000   C0460139:Pressure [Finding]
  1000   C1306345:Pressure [Functional Concept]

Phrase: "injected into a DRG neuron"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   814   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   778   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   778   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   748   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   748   C0027882:Neuron [Cell]
   748   C0040452:Root [Body Part, Organ, or Organ Component]
   748   C0205095:Dorsal [Spatial Concept]
   748   C0242726:Root [Plant]
   748   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   748   C1318154:Root [Body Part, Organ, or Organ Component]
   748   C1705917:Root [Idea or Concept]
   714   C1720154:Inject [Functional Concept]

Phrase: "with a micropipette."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0182301:MICRO PIPETTE [Medical Device]
Processing 00000000.tx.321: After 3 h of incubation, FlCRhR was excited using a band-pass filter (484/15 nm), and two single-wavelength emission images (F520 and F580) were simultaneously acquired using a band-pass (520/30 nm) and a log-pass filter (570 nm), respectively. 

Phrase: "After 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of incubation,"

Phrase: "FlCRhR"

Phrase: "was"

Phrase: "excited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excited [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a band-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0230715:A band [Cell Component]
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "pass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828386:Pass [Finding]

Phrase: "filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0180860:Filter [Manufactured Object]
  1000   C0581406:Filter [Medical Device]
  1000   C1522664:Filter [Intellectual Product]
  1000   C1704449:Filter [Conceptual Entity]
  1000   C1704684:Filter [Medical Device]
  1000   C1875155:FILTER [Medical Device]

Phrase: "(484/15 nm),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "two single-wavelength emission images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C1704254:Image [Intellectual Product]
   771   C1704922:Image [Entity]
   771   C3542466:Image [Intellectual Product]

Phrase: "(F520"

Phrase: "and"

Phrase: "F580"

Phrase: ")"

Phrase: "were"

Phrase: "simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a band-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0230715:A band [Cell Component]
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "pass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828386:Pass [Finding]

Phrase: "(520/30 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "a log-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708728:Log [Intellectual Product]
  1000   C2986775:log [Occupational Activity]

Phrase: "pass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828386:Pass [Finding]

Phrase: "filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0180860:Filter [Manufactured Object]
  1000   C0581406:Filter [Medical Device]
  1000   C1522664:Filter [Intellectual Product]
  1000   C1704449:Filter [Conceptual Entity]
  1000   C1704684:Filter [Medical Device]
  1000   C1875155:FILTER [Medical Device]

Phrase: "(570 nm),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "respectively."
Processing 00000000.tx.322: After background subtraction, the ratio of F520/F580 was calculated and averaged within the growth cone using AquaCosmos. 

Phrase: "After background subtraction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348589:Subtraction [Phenomenon or Process]

Phrase: "the ratio of F520/F580"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "and"

Phrase: "averaged within the growth cone"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0596632:growth cone [Cell Component]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0206428:Cone [Cell]
   760   C0220844:growth [Physiologic Function]
   760   C0330095:Cone [Plant]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2350017:Cone [Spatial Concept]
   760   C2911660:Growth [Activity]
   726   C1510992:Average [Quantitative Concept]
   726   C2825518:AVERAGE [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "AquaCosmos."
Processing 00000000.tx.323: RyR immunocytochemistry DRG neurons were fixed with 4% formaldehyde in PBS for 40 min, permeabilized and blocked with 0.1% Triton X-100 and 10% horse serum in PBS for 1 h, and then incubated with rabbit polyclonal anti-RyR antibody (anti-C2; 2 g/ml; Kuwajima et al., 1992) overnight at 4C. 

Phrase: "RyR immunocytochemistry DRG neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "fixed with 4% formaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "for 40 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "permeabilized"

Phrase: "and"

Phrase: "blocked with 0.1% Triton X-100"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0028778:Blocked [Pathologic Function]
   748   C0242759:Triton [Geographic Area]
   748   C0332206:Blocked [Functional Concept]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "10% horse serum in PBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1518416:Serum, Horse [Immunologic Factor]
   760   C0019944:Horse [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C0242616:Horse [Mammal]
   760   C1265527:Horse [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]

Phrase: "for 1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with rabbit polyclonal anti-RyR antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034493:Rabbit [Mammal]
   748   C1419778:RYR [Gene or Genome]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "(anti-C2"

Phrase: "; 2 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; Kuwajima et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: "overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]
Processing 00000000.tx.324: Primary antibody binding was detected using Alexa 488conjugated goat antirabbit IgG secondary antibody (10 g/ml; Invitrogen). 

Phrase: "Primary antibody binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Alexa 488conjugated goat antirabbit IgG secondary antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C2754943:IgG antibody [Cell Component]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(10 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; Invitrogen"

Phrase: ")."
Processing 00000000.tx.325: CGRP immunohistochemistry Postnatal day 0 mice were deeply anesthetized and perfused with 4% formaldehyde in 0.1% Na-phosphate buffer. 

Phrase: "CGRP immunohistochemistry Postnatal day 0 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "deeply"

Phrase: "anesthetized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720436:Anesthetized [Finding]

Phrase: "and"

Phrase: "perfused with 4% formaldehyde"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   737   C1549542:Perfuse [Functional Concept]

Phrase: "in 0.1% Na-phosphate buffer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.326: The lumbar spinal cord was dissected, postfixed overnight in the same fixative at 4C, and infiltrated overnight with 25% sucrose in PBS at 4C. 

Phrase: "The lumbar spinal cord"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0457848:Lumbar spinal cord [Body Location or Region]
  1000   C0581621:Lumbar spinal cord [Body Part, Organ, or Organ Component]
  1000   C1278838:Lumbar spinal cord [Body Part, Organ, or Organ Component]
   901   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   901   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   827   C0024090:Lumbar [Body Location or Region]
   827   C0521329:Spinal [Spatial Concept]
   827   C1550235:Cord [Body Part, Organ, or Organ Component]
   827   C1552938:cord [Quantitative Concept]
   827   C1706500:Cord [Manufactured Object]

Phrase: "was"

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: ","

Phrase: "postfixed"

Phrase: "overnight in the same fixative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016184:Fixative [Indicator, Reagent, or Diagnostic Aid]
   760   C0439583:Overnight [Temporal Concept]
   760   C0445247:Same [Qualitative Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "infiltrated overnight with 25% sucrose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439583:Overnight [Temporal Concept]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.327: 16-m-thick cryostat sections were collected and stored at 20C. 

Phrase: "16-"

Phrase: "m-"

Phrase: "thick cryostat sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "stored at 20C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.328: After blocking and permeabilization with 10% horse serum and 0.1% Triton X-100 in PBS, the sections were incubated sequentially with rabbit polyclonal anti-CGRP antiserum (1:5,000 dilution; 

Phrase: "After"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "permeabilization with 10% horse serum"

Phrase: "and"

Phrase: "0.1% Triton X-100 in PBS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0242759:Triton [Geographic Area]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "sequentially with rabbit polyclonal anti-CGRP antiserum"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   806   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]
   739   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0017337:Gene [Gene or Genome]
   739   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0034493:Rabbit [Mammal]
   739   C0439849:Related [Qualitative Concept]
   739   C0445223:Related [Finding]
   739   C0770558:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C2825090:Calcitonin [Pharmacologic Substance]
   739   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C0163712:Relate [Organic Chemical]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5,000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.329: overnight at 4C; 

Phrase: "overnight at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.330: Sigma-Aldrich) and Alexa 488conjugated goat antirabbit IgG (10 g/ml). 

Phrase: "Sigma-Aldrich"

Phrase: ")"

Phrase: "and"

Phrase: "Alexa 488conjugated goat antirabbit IgG"

Phrase: "(10 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.331: Statistics Data were expressed as the mean  SEM. 

Phrase: "Statistics Data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C2828391:Statistic (data) [Quantitative Concept]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "expressed as the mean  SEM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444504:Mean [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.332: Statistical analyses were performed using Prism version 3.0a (GraphPad Software). 

Phrase: "Statistical analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Prism version 3.0a"

Phrase: "(GraphPad Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: ")."
Processing 00000000.tx.333: Unless otherwise noted, a comparison between two groups was performed by an unpaired t test and a comparison among three or more groups by a one-way analysis of variance followed by Tukey's posttest. 

Phrase: "Unless"

Phrase: "otherwise"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "a comparison between two groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "was"

Phrase: "performed by an unpaired t test"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1710574:Unpaired t-Test [Intellectual Product]
   790   C1550369:Performed By [Qualitative Concept]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0884358:Performed [Functional Concept]
   753   C2700112:Unpaired [Qualitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "a comparison among three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "or"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "groups by a one-way analysis of variance"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   869   C1709320:One-way Analysis of Variance [Quantitative Concept]
   800   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   767   C0441835:Group A [Classification]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0205447:One [Quantitative Concept]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C0936012:Analysis [Research Activity]
   744   C1257890:Group [Population Group]
   744   C1524024:analysis [Functional Concept]
   744   C1552516:Group [Health Care Related Organization]
   744   C1552839:groups [Idea or Concept]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C1711260:Variance [Qualitative Concept]
   744   C2348152:Variance [Quantitative Concept]

Phrase: "followed by Tukey's posttest."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.334: P values <0.05 were judged statistically different.  

Phrase: "P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "<0.05"

Phrase: "were"

Phrase: "judged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0221191:Judge [Professional or Occupational Group]

Phrase: "statistically different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.335: Acknowledgments  We would like to thank Dr. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "would like to"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.336: Vance Lemmon for providing us with the L1-Fc construct and Dr. 

Phrase: "Vance Lemmon for providing"

Phrase: "us with the L1-Fc construct"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441918:L1 [Finding]
   753   C1179698:L1 [Body Location or Region]
   753   C1416177:L1 [Gene or Genome]
   753   C2827421:Construct [Classification]
   753   C2983605:FC [Activity]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.337: Patrick Doherty for the N-cadherin-Fc construct. 

Phrase: "Patrick Doherty for the N-cadherin-Fc construct."
Processing 00000000.tx.338: This study was partially supported by a Grant-in-Aid for Scientific Research (C) of the Japan Society for the Promotion of Science (16500210) to H. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "partially"

Phrase: "supported by a Grant-in-Aid"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0018173:Grant [Quantitative Concept]
   753   C0018896:Aid [Social Behavior]
   753   C0449435:Aid [Manufactured Object]
   753   C1521721:Supported [Conceptual Entity]
   753   C1548284:Grant [Idea or Concept]
   753   C3540469:AID [Gene or Genome]
   719 E C0183683:Support [Medical Device]

Phrase: "for Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "(C"

Phrase: ")"

Phrase: "of the Japan Society"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037455:society [Organization]

Phrase: "for the Promotion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promotion [Activity]

Phrase: "of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "(16500210"

Phrase: ")"

Phrase: "to H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.339: Kamiguchi. 

Phrase: "Kamiguchi."
Processing 00000000.tx.340: Submitted: 29 March 2005 Accepted: 19 August 2005  References Top Abstract Introduction Results Discussion Materials and methods References  Adams, S.R., A.T. 

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ":"

Phrase: "29 March 2005"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: ":"

Phrase: "19 August 2005"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "S.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "A.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]
Processing 00000000.tx.341: Harootunian, Y.J. 

Phrase: "Harootunian,"

Phrase: "Y.J."
Processing 00000000.tx.342: Buechler, S.S. 

Phrase: "Buechler,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.343: Taylor, and R.Y. 

Phrase: "Taylor,"

Phrase: "and"

Phrase: "R.Y."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.344: Tsien. 

Phrase: "Tsien."
Processing 00000000.tx.345: 1991. 

Phrase: "1991."
Processing 00000000.tx.346: Fluorescence ratio imaging of cyclic AMP in single cells. 

Phrase: "Fluorescence ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "imaging of cyclic AMP"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0439596:Cyclic [Temporal Concept]
   770   C1511572:Cyclic [Temporal Concept]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "in single cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.347: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.348: 349:694697.[CrossRef][Medline] Augustine, G.J., F. 

Phrase: "349"

Phrase: ":"

Phrase: "694697."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Augustine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555063:Augustine [Population Group]

Phrase: "G.J.,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.349: Santamaria, and K. 

Phrase: "Santamaria,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.350: Tanaka. 

Phrase: "Tanaka."
Processing 00000000.tx.351: 2003. 

Phrase: "2003."
Processing 00000000.tx.352: Local calcium signaling in neurons. 

Phrase: "Local calcium signaling in neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0600431:Calcium Signaling [Cell Function]
   760   C0037083:Signaling [Cell Function]
   760   C3537152:signaling [Biologic Function]
Processing 00000000.tx.353: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.354: 40:331346.[CrossRef][Medline] Averill, S., S.B. 

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "331346."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Averill,"

Phrase: "S."

Phrase: ","

Phrase: "S."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.355: McMahon, D.O. 

Phrase: "McMahon,"

Phrase: "D.O."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512020:D.O. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.356: Clary, L.F. 

Phrase: "Clary,"

Phrase: "L.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.357: Reichardt, and J.V. 

Phrase: "Reichardt,"

Phrase: "and"

Phrase: "J.V."
Processing 00000000.tx.358: Priestley. 

Phrase: "Priestley."
Processing 00000000.tx.359: 1995. 

Phrase: "1995."
Processing 00000000.tx.360: Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. 

Phrase: "Immunocytochemical localization of trkA receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "in chemically identified subgroups"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1079230:subgroups [Virus]
   793 E C1515021:Subgroup [Classification]

Phrase: "of adult rat sensory neurons."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0027883:sensory neurons [Cell]
   861   C0034837:Neurons, Sensory [Cell Component]
   812   C0027882:Neurons [Cell]
   812   C0445254:Sensory [Qualitative Concept]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.361: Eur. 

Phrase: "Eur."
Processing 00000000.tx.362: J. 

Phrase: "J."
Processing 00000000.tx.363: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.364: 7:14841494.[Medline] Bouchard, R., R. 

Phrase: "7"

Phrase: ":"

Phrase: "14841494."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bouchard,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.365: Pattarini, and J.D. 

Phrase: "Pattarini,"

Phrase: "and"

Phrase: "J.D."
Processing 00000000.tx.366: Geiger. 

Phrase: "Geiger."
Processing 00000000.tx.367: 2003. 

Phrase: "2003."
Processing 00000000.tx.368: Presence and functional significance of presynaptic ryanodine receptors. 

Phrase: "Presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "functional significance of presynaptic ryanodine receptors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]
Processing 00000000.tx.369: Prog. 

Phrase: "Prog."
Processing 00000000.tx.370: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.371: 69:391418.[CrossRef][Medline] Brummendorf, T., and F.G. 

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "391418."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brummendorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.372: Rathjen. 

Phrase: "Rathjen."
Processing 00000000.tx.373: 1994. 

Phrase: "1994."
Processing 00000000.tx.374: Cell adhesion molecules. 

Phrase: "Cell adhesion molecules."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.375: 1: immunoglobulin superfamily. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "immunoglobulin superfamily."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]
   861   C1883220:Superfamily [Conceptual Entity]
Processing 00000000.tx.376: Protein Profile. 

Phrase: "Protein Profile."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]
Processing 00000000.tx.377: 1:9511058.[Medline] Cai, D., Y. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "9511058."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "D."

Phrase: ","

Phrase: "Y."
Processing 00000000.tx.378: Shen, M. 

Phrase: "Shen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.379: De Bellard, S. 

Phrase: "De Bellard,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.380: Tang, and M.T. 

Phrase: "Tang,"

Phrase: "and"

Phrase: "M.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.381: Filbin. 

Phrase: "Filbin."
Processing 00000000.tx.382: 1999. 

Phrase: "1999."
Processing 00000000.tx.383: Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. 

Phrase: "Prior exposure to neurotrophins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "inhibition of axonal regeneration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   982   C2253949:inhibition of axon regeneration [Organ or Tissue Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by MAG"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0129439:Myelin Associated Glycoprotein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           myelin glycoprotein
  1000   C1416969:MYELIN-ASSOCIATED GLYCOPROTEIN [Gene or Genome]
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "myelin via a cAMP-dependent mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026969:Myelin [Tissue]
   753   C0026973:Myelin [Cell Component]
Processing 00000000.tx.384: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.385: 22:89101.[CrossRef][Medline] Castellani, V., A. 

Phrase: "22"

Phrase: ":"

Phrase: "89101."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Castellani,"

Phrase: "V.,"

Phrase: "A."
Processing 00000000.tx.386: Chedotal, M. 

Phrase: "Chedotal,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.387: Schachner, C. 

Phrase: "Schachner,"

Phrase: "C."
Processing 00000000.tx.388: Faivre-Sarrailh, and G. 

Phrase: "Faivre-Sarrailh,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.389: Rougon. 

Phrase: "Rougon."
Processing 00000000.tx.390: 2000. 

Phrase: "2000."
Processing 00000000.tx.391: Analysis of the L1-deficient mouse phenotype reveals cross-talk between Sema3A and L1 signaling pathways in axonal guidance. 

Phrase: "Analysis of the L1-deficient mouse phenotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "cross-talk between Sema3A"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0010357:Crosstalk [Molecular Function]
   833   C2986468:Cross-talk [Cell Function]
   770   C0037817:Talk [Organism Function]
   770   C0234856:talk [Daily or Recreational Activity]
   770   C0600118:talk [Finding]
   770   C2828360:Cross [Conceptual Entity]

Phrase: "and"

Phrase: "L1 signaling pathways in axonal guidance."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   786   C2984268:Axon Guidance Pathway [Cell Function]
   783   C0037080:pathways signaling [Molecular Function]
   773 E C0037083:signaling pathway [Cell Function]
   773 E C0086982:Signaling Pathway [Molecular Function]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.392: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.393: 27:237249.[CrossRef][Medline] Castellani, V., E. 

Phrase: "27"

Phrase: ":"

Phrase: "237249."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Castellani,"

Phrase: "V.,"

Phrase: "E."
Processing 00000000.tx.394: De Angelis, S. 

Phrase: "De Angelis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.395: Kenwrick, and G. 

Phrase: "Kenwrick,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.396: Rougon. 

Phrase: "Rougon."
Processing 00000000.tx.397: 2002. 

Phrase: "2002."
Processing 00000000.tx.398: Cis and trans interactions of L1 with neuropilin-1 control axonal responses to semaphorin 3A. 

Phrase: "Cis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504308:Cis [Eukaryote]

Phrase: "and"

Phrase: "trans interactions of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "with neuropilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0100804:Neuropilin-1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1334905:NEUROPILIN 1 [Gene or Genome]
   861   C0287275:Neuropilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "axonal responses to semaphorin 3A."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]
Processing 00000000.tx.399: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.400: 21:63486357.[Abstract/Free FullText] Cheng, S., M.S. 

Phrase: "21"

Phrase: ":"

Phrase: "63486357."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cheng,"

Phrase: "S."

Phrase: ","

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.401: Geddis, and V. 

Phrase: "Geddis,"

Phrase: "and"

Phrase: "V."
Processing 00000000.tx.402: Rehder. 

Phrase: "Rehder."
Processing 00000000.tx.403: 2002. 

Phrase: "2002."
Processing 00000000.tx.404: Local calcium changes regulate the length of growth cone filopodia. 

Phrase: "Local calcium changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "regulate"

Phrase: "the length of growth cone filopodia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0424639:length growth [Finding]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.405: J. 

Phrase: "J."
Processing 00000000.tx.406: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.407: 50:263275.[CrossRef][Medline] Davenport, R.W., P. 

Phrase: "50"

Phrase: ":"

Phrase: "263275."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Davenport,"

Phrase: "R.W., P."
Processing 00000000.tx.408: Dou, V. 

Phrase: "Dou,"

Phrase: "V."
Processing 00000000.tx.409: Rehder, and S.B. 

Phrase: "Rehder,"

Phrase: "and S.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.410: Kater. 

Phrase: "Kater."
Processing 00000000.tx.411: 1993. 

Phrase: "1993."
Processing 00000000.tx.412: A sensory role for neuronal growth cone filopodia. 

Phrase: "A sensory role for neuronal growth cone filopodia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.413: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.414: 361:721724.[CrossRef][Medline] Doherty, P., G. 

Phrase: "361"

Phrase: ":"

Phrase: "721724."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Doherty,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.415: Williams, and E.J. 

Phrase: "Williams,"

Phrase: "and"

Phrase: "E.J."
Processing 00000000.tx.416: Williams. 

Phrase: "Williams."
Processing 00000000.tx.417: 2000. 

Phrase: "2000."
Processing 00000000.tx.418: CAMs and axonal growth: a critical evaluation of the role of calcium and the MAPK cascade. 

Phrase: "CAMs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "axonal growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   964   C1749784:axon growth [Organ or Tissue Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: ":"

Phrase: "a critical evaluation of the role of calcium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0220825:Evaluation [Functional Concept]
   744   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "the MAPK cascade."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752319:MAPK cascade [Molecular Function]
   861   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.419: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.420: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.421: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.422: 16:283295.[CrossRef][Medline] Futatsugi, A., K. 

Phrase: "16"

Phrase: ":"

Phrase: "283295."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Futatsugi,"

Phrase: "A.,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.423: Kato, H. 

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.424: Ogura, S.T. 

Phrase: "Ogura,"

Phrase: "S."

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.425: Li, E. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "E."
Processing 00000000.tx.426: Nagata, G. 

Phrase: "Nagata,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.427: Kuwajima, K. 

Phrase: "Kuwajima,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.428: Tanaka, S. 

Phrase: "Tanaka,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.429: Itohara, and K. 

Phrase: "Itohara,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.430: Mikoshiba. 

Phrase: "Mikoshiba."
Processing 00000000.tx.431: 1999. 

Phrase: "1999."
Processing 00000000.tx.432: Facilitation of NMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3. 

Phrase: "Facilitation of NMDAR-independent LTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "and"

Phrase: "spatial learning in mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0582587:spatial learning [Mental Process]
   760   C0013621:learning [Educational Activity]
   760   C0023185:Learning [Mental Process]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "ryanodine receptor type 3."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0524964:Ryanodine Receptor 3 [Amino Acid, Peptide, or Protein,Receptor]
   923   C1419780:RYANODINE RECEPTOR 3 [Gene or Genome]
   861   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0441731:Type 3 [Classification]
   861   C1753335:ryanodine receptor [Molecular Function]
   812   C0035983:Ryanodine [Organic Chemical,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.433: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.434: 24:701713.[CrossRef][Medline] Gibson, S.J., J.M. 

Phrase: "24"

Phrase: ":"

Phrase: "701713."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gibson,"

Phrase: "S."

Phrase: "J.,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.435: Polak, S.R. 

Phrase: "Polak,"

Phrase: "S.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.436: Bloom, I.M. 

Phrase: "Bloom,"

Phrase: "I.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.437: Sabate, P.M. 

Phrase: "Sabate,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.438: Mulderry, M.A. 

Phrase: "Mulderry,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.439: Ghatei, G.P. 

Phrase: "Ghatei,"

Phrase: "G.P."
Processing 00000000.tx.440: McGregor, J.F. 

Phrase: "McGregor,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.441: Morrison, J.S. 

Phrase: "Morrison,"

Phrase: "J.S."
Processing 00000000.tx.442: Kelly, and R.M. 

Phrase: "Kelly,"

Phrase: "and"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.443: Evans. 

Phrase: "Evans."
Processing 00000000.tx.444: 1984. 

Phrase: "1984."
Processing 00000000.tx.445: Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. 

Phrase: "Calcitonin gene-related peptide immunoreactivity in the spinal cord of man"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0597879:immunoreactivity [Molecular Function]

Phrase: "and of eight"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205454:Eight [Quantitative Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "other species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.446: J. 

Phrase: "J."
Processing 00000000.tx.447: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.448: 4:31013111.[Abstract] Gomez, T.M., and N.C. 

Phrase: "4"

Phrase: ":"

Phrase: "31013111."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gomez,"

Phrase: "T.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "N.C."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.449: Spitzer. 

Phrase: "Spitzer."
Processing 00000000.tx.450: 1999. 

Phrase: "1999."
Processing 00000000.tx.451: In vivo regulation of axon extension and pathfinding by growth-cone calcium transients. 

Phrase: "In vivo regulation of axon extension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C1154406:regulation of axon extension [Cell Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "pathfinding by growth-cone calcium transients."
Processing 00000000.tx.452: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.453: 397:350355.[CrossRef][Medline] Gomez, T.M., E. 

Phrase: "397"

Phrase: ":"

Phrase: "350355."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gomez,"

Phrase: "T.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "E."
Processing 00000000.tx.454: Robles, M. 

Phrase: "Robles,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.455: Poo, and N.C. 

Phrase: "Poo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015733:poo [Body Substance]

Phrase: "and"

Phrase: "N.C."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.456: Spitzer. 

Phrase: "Spitzer."
Processing 00000000.tx.457: 2001. 

Phrase: "2001."
Processing 00000000.tx.458: Filopodial calcium transients promote substrate-dependent growth cone turning. 

Phrase: "Filopodial calcium transients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0040704:Transients [Population Group]
   827   C0687129:Transients [Finding]
   793 E C0205374:Transient [Temporal Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "substrate-dependent growth cone turning."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0541749:turning [Finding]
Processing 00000000.tx.459: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.460: 291:19831987.[Abstract/Free FullText] Grynkiewicz, G., M. 

Phrase: "291"

Phrase: ":"

Phrase: "19831987."

Phrase: "[Abstract/Free FullText"

Phrase: "] Grynkiewicz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.461: Poenie, and R.Y. 

Phrase: "Poenie,"

Phrase: "and"

Phrase: "R.Y."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.462: Tsien. 

Phrase: "Tsien."
Processing 00000000.tx.463: 1985. 

Phrase: "1985."
Processing 00000000.tx.464: A new generation of Ca2+ indicators with greatly improved fluorescence properties. 

Phrase: "A new generation of Ca2+ indicators"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "with greatly improved fluorescence properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0871161:properties [Qualitative Concept]
   812   C1292721:properties [Functional Concept]
   779 E C1882134:Property [Conceptual Entity]
   779 E C2347695:Property [Entity]
Processing 00000000.tx.465: J. 

Phrase: "J."
Processing 00000000.tx.466: Biol. 

Phrase: "Biol."
Processing 00000000.tx.467: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.468: 260:34403450.[Abstract] Henley, J.R., K.H. 

Phrase: "260"

Phrase: ":"

Phrase: "34403450."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Henley,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.469: Huang, D. 

Phrase: "Huang,"

Phrase: "D."
Processing 00000000.tx.470: Wang, and M.M. 

Phrase: "Wang,"

Phrase: "and"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: Poo. 

Phrase: "Poo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015733:poo [Body Substance]
Processing 00000000.tx.472: 2004. 

Phrase: "2004."
Processing 00000000.tx.473: Calcium mediates bidirectional growth cone turning induced by myelin-associated glycoprotein. 

Phrase: "Calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "bidirectional growth cone turning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0541749:turning [Finding]

Phrase: "induced by myelin-associated glycoprotein."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   862   C0129439:Myelin Associated Glycoprotein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           myelin glycoprotein
   862   C1416969:MYELIN-ASSOCIATED GLYCOPROTEIN [Gene or Genome]
   760   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   760   C0026969:Myelin [Tissue]
   760   C0026973:Myelin [Cell Component]
   760   C0205263:Induced [Functional Concept]
   760   C0332281:Associated [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.474: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.475: 44:909916.[CrossRef][Medline] Hong, K., M. 

Phrase: "44"

Phrase: ":"

Phrase: "909916."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hong,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.476: Nishiyama, J. 

Phrase: "Nishiyama,"

Phrase: "J."
Processing 00000000.tx.477: Henley, M. 

Phrase: "Henley,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.478: Tessier-Lavigne, and M. 

Phrase: "Tessier-Lavigne,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.479: Poo. 

Phrase: "Poo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015733:poo [Body Substance]
Processing 00000000.tx.480: 2000. 

Phrase: "2000."
Processing 00000000.tx.481: Calcium signalling in the guidance of nerve growth by netrin-1. 

Phrase: "Calcium signalling in the guidance of nerve growth"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0600431:calcium signalling [Cell Function]
   744   C3537152:signalling [Biologic Function]
   711 E C1710082:Signal [Phenomenon or Process]

Phrase: "by netrin-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0258174:netrin-1 [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1334908:netrin 1 [Gene or Genome]
  1000   C1442814:Netrin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.482: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.483: 403:9398.[CrossRef][Medline] Hopker, V.H., D. 

Phrase: "403"

Phrase: ":"

Phrase: "9398."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hopker,"

Phrase: "V.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.484: Shewan, M. 

Phrase: "Shewan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: Tessier-Lavigne, M. 

Phrase: "Tessier-Lavigne,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.486: Poo, and C. 

Phrase: "Poo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015733:poo [Body Substance]

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.487: Holt. 

Phrase: "Holt."
Processing 00000000.tx.488: 1999. 

Phrase: "1999."
Processing 00000000.tx.489: Growth-cone attraction to netrin-1 is converted to repulsion by laminin-1. 

Phrase: "Growth-cone attraction to netrin-1"

Phrase: "is"

Phrase: "converted to repulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0683283:repulsion [Mental Process]

Phrase: "by laminin-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0908936:laminin-1 [Amino Acid, Peptide, or Protein]
   861   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.490: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.491: 401:6973.[CrossRef][Medline] Huber, A.B., A.L. 

Phrase: "401"

Phrase: ":"

Phrase: "6973."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Huber,"

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "A.L."
Processing 00000000.tx.492: Kolodkin, D.D. 

Phrase: "Kolodkin,"

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.493: Ginty, and J.F. 

Phrase: "Ginty,"

Phrase: "and"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.494: Cloutier. 

Phrase: "Cloutier."
Processing 00000000.tx.495: 2003. 

Phrase: "2003."
Processing 00000000.tx.496: Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance. 

Phrase: "Signaling at the growth cone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037083:Signaling [Cell Function]
   760   C3537152:signaling [Biologic Function]

Phrase: ":"

Phrase: "ligand-receptor complexes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1523873:receptor complex [Cell Component]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "the control of axon growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "guidance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150600:Guidance [Health Care Activity]
  1000   C1959633:Guidance [Clinical Attribute]
Processing 00000000.tx.497: Annu. 

Phrase: "Annu."
Processing 00000000.tx.498: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.499: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.500: 26:509563.[CrossRef][Medline] Kamiguchi, H., and F. 

Phrase: "26"

Phrase: ":"

Phrase: "509563."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kamiguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.501: Yoshihara. 

Phrase: "Yoshihara."
Processing 00000000.tx.502: 2001. 

Phrase: "2001."
Processing 00000000.tx.503: The role of endocytic L1 trafficking in polarized adhesion and migration of nerve growth cones. 

Phrase: "The role of endocytic L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "trafficking in polarized adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]
   770   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "migration of nerve growth cones."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.504: J. 

Phrase: "J."
Processing 00000000.tx.505: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.506: 21:91949203.[Abstract/Free FullText] Kuhn, T.B., C.V. 

Phrase: "21"

Phrase: ":"

Phrase: "91949203."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuhn,"

Phrase: "T.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "C.V."
Processing 00000000.tx.507: Williams, P. 

Phrase: "Williams,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.508: Dou, and S.B. 

Phrase: "Dou,"

Phrase: "and S.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.509: Kater. 

Phrase: "Kater."
Processing 00000000.tx.510: 1998. 

Phrase: "1998."
Processing 00000000.tx.511: Laminin directs growth cone navigation via two temporally and functionally distinct calcium signals. 

Phrase: "Laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "directs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "growth cone navigation via two temporally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827562:Navigation [Activity]

Phrase: "and"

Phrase: "functionally distinct calcium signals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.512: J. 

Phrase: "J."
Processing 00000000.tx.513: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.514: 18:184194.[Abstract/Free FullText] Kuwajima, G., A. 

Phrase: "18"

Phrase: ":"

Phrase: "184194."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuwajima,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.515: Futatsugi, M. 

Phrase: "Futatsugi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.516: Niinobe, S. 

Phrase: "Niinobe,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.517: Nakanishi, and K. 

Phrase: "Nakanishi,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.518: Mikoshiba. 

Phrase: "Mikoshiba."
Processing 00000000.tx.519: 1992. 

Phrase: "1992."
Processing 00000000.tx.520: Two types of ryanodine receptors in mouse brain: skeletal muscle type exclusively in Purkinje cells and cardiac muscle type in various neurons. 

Phrase: "Two types of ryanodine receptors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0332307:Types [Qualitative Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "in mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "skeletal muscle type exclusively in Purkinje cells"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   789   C1178808:Purkinje muscle cell [Cell]
   788   C1704336:Skeletal muscle cell [Cell]
   778   C0242692:Muscle, Skeletal [Tissue]
   778   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   774   C0449475:cells type [Intellectual Product]
   774   C0596981:Muscle Cells [Cell]
   757 E C0007634:Cell Type [Cell]
   748   C0026845:Muscle [Tissue]
   748   C0037253:skeletal [Body System]
   748   C0332307:Type [Qualitative Concept]
   748   C0521324:Skeletal [Spatial Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "cardiac muscle type in various neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0682689:neuron type [Cell]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.521: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.522: 9:11331142.[CrossRef][Medline] Lau, P.M., R.S. 

Phrase: "9"

Phrase: ":"

Phrase: "11331142."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lau,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.523: Zucker, and D. 

Phrase: "Zucker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.524: Bentley. 

Phrase: "Bentley."
Processing 00000000.tx.525: 1999. 

Phrase: "1999."
Processing 00000000.tx.526: Induction of filopodia by direct local elevation of intracellular calcium ion concentration. 

Phrase: "Induction of filopodia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by direct local elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439775:Elevation [Therapeutic or Preventive Procedure]
   827   C0702240:Elevation [Spatial Concept]

Phrase: "of intracellular calcium ion concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.527: J. 

Phrase: "J."
Processing 00000000.tx.528: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.529: 145:12651275.[Abstract/Free FullText] Letourneau, P.C., M.L. 

Phrase: "145"

Phrase: ":"

Phrase: "12651275."

Phrase: "[Abstract/Free FullText"

Phrase: "] Letourneau,"

Phrase: "P.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0030128:P-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1337110:P-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.530: Condic, and D.M. 

Phrase: "Condic,"

Phrase: "and"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.531: Snow. 

Phrase: "Snow."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037386:Snow [Natural Phenomenon or Process]
  1000   C1611690:Snow [Substance]
Processing 00000000.tx.532: 1994. 

Phrase: "1994."
Processing 00000000.tx.533: Interactions of developing neurons with the extracellular matrix. 

Phrase: "Interactions of developing neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "with the extracellular matrix."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015350:Extracellular Matrix [Tissue]
   861   C0521119:Extracellular [Cell Component]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.534: J. 

Phrase: "J."
Processing 00000000.tx.535: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.536: 14:915928.[Medline] Lev-Ram, V., H. 

Phrase: "14"

Phrase: ":"

Phrase: "915928."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lev-Ram,"

Phrase: "V.,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.537: Miyakawa, N. 

Phrase: "Miyakawa,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.538: Lasser-Ross, and W.N. 

Phrase: "Lasser-Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0331968:Ross [Health Care Related Organization]
   861   C2699100:Ross [Bird]

Phrase: "and"

Phrase: "W.N."
Processing 00000000.tx.539: Ross. 

Phrase: "Ross."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]
Processing 00000000.tx.540: 1992. 

Phrase: "1992."
Processing 00000000.tx.541: Calcium transients in cerebellar Purkinje neurons evoked by intracellular stimulation. 

Phrase: "Calcium transients in cerebellar Purkinje neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040704:Transients [Population Group]
   753   C0687129:Transients [Finding]
   719 E C0205374:Transient [Temporal Concept]

Phrase: "evoked by intracellular stimulation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1444748:Evoked [Qualitative Concept]
   770   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.542: J. 

Phrase: "J."
Processing 00000000.tx.543: Neurophysiol. 

Phrase: "Neurophysiol."
Processing 00000000.tx.544: 68:11671177.[Abstract/Free FullText] Lokuta, A.J., H. 

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "11671177."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lokuta,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.545: Komai, T.S. 

Phrase: "Komai,"

Phrase: "T.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.546: McDowell, and H.H. 

Phrase: "McDowell,"

Phrase: "and"

Phrase: "H.H."
Processing 00000000.tx.547: Valdivia. 

Phrase: "Valdivia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1204228:Valdivia [Plant]
Processing 00000000.tx.548: 2002. 

Phrase: "2002."
Processing 00000000.tx.549: Functional properties of ryanodine receptors from rat dorsal root ganglia. 

Phrase: "Functional properties of ryanodine receptors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "from rat dorsal root ganglia."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   923   C0017070:Dorsal Root Ganglia [Body Part, Organ, or Organ Component]
           Dorsal Root
   890 E C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   861   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   844   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   812   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   812   C0040452:Root [Body Part, Organ, or Organ Component]
   812   C0205095:Dorsal [Spatial Concept]
   812   C0242726:Root [Plant]
   812   C1318154:Root [Body Part, Organ, or Organ Component]
   812   C1705917:Root [Idea or Concept]
   779 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
Processing 00000000.tx.550: FEBS Lett. 

Phrase: "FEBS Lett."
Processing 00000000.tx.551: 511:9096.[CrossRef][Medline] Nakai, Y., and H. 

Phrase: "511"

Phrase: ":"

Phrase: "9096."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nakai,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.552: Kamiguchi. 

Phrase: "Kamiguchi."
Processing 00000000.tx.553: 2002. 

Phrase: "2002."
Processing 00000000.tx.554: Migration of nerve growth cones requires detergent-resistant membranes in a spatially defined and substrate-dependent manner. 

Phrase: "Migration of nerve growth cones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "requires"

Phrase: "detergent-resistant membranes in a spatially"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0025255:Membranes [Tissue]
   753   C0332325:Resistant [Functional Concept]
   753   C2827757:RESISTANT [Laboratory or Test Result]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "and"

Phrase: "substrate-dependent manner."
Processing 00000000.tx.555: J. 

Phrase: "J."
Processing 00000000.tx.556: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.557: 159:10971108.[Abstract/Free FullText] Neumann, S., F. 

Phrase: "159"

Phrase: ":"

Phrase: "10971108."

Phrase: "[Abstract/Free FullText"

Phrase: "] Neumann,"

Phrase: "S."

Phrase: ","

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.558: Bradke, M. 

Phrase: "Bradke,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.559: Tessier-Lavigne, and A.I. 

Phrase: "Tessier-Lavigne,"

Phrase: "and"

Phrase: "A.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.560: Basbaum. 

Phrase: "Basbaum."
Processing 00000000.tx.561: 2002. 

Phrase: "2002."
Processing 00000000.tx.562: Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. 

Phrase: "Regeneration of sensory axons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1621980:axon regeneration [Organ or Tissue Function]
   770   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "within the injured spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
   901   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   827   C0521329:Spinal [Spatial Concept]
   827   C1550235:Cord [Body Part, Organ, or Organ Component]
   827   C1552938:cord [Quantitative Concept]
   827   C1706500:Cord [Manufactured Object]

Phrase: "induced by intraganglionic cAMP elevation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C0205263:Induced [Functional Concept]
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]
Processing 00000000.tx.563: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.564: 34:885893.[CrossRef][Medline] Nishimura, K., F. 

Phrase: "34"

Phrase: ":"

Phrase: "885893."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nishimura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.565: Yoshihara, T. 

Phrase: "Yoshihara,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.566: Tojima, N. 

Phrase: "Tojima,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.567: Ooashi, W. 

Phrase: "Ooashi,"

Phrase: "W."
Processing 00000000.tx.568: Yoon, K. 

Phrase: "Yoon,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.569: Mikoshiba, V. 

Phrase: "Mikoshiba,"

Phrase: "V."
Processing 00000000.tx.570: Bennett, and H. 

Phrase: "Bennett,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.571: Kamiguchi. 

Phrase: "Kamiguchi."
Processing 00000000.tx.572: 2003. 

Phrase: "2003."
Processing 00000000.tx.573: L1-dependent neuritogenesis involves ankyrinB that mediates L1-CAM coupling with retrograde actin flow. 

Phrase: "L1-dependent neuritogenesis"

Phrase: "involves"

Phrase: "ankyrinB"

Phrase: "that"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "L1-CAM coupling with retrograde actin flow."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1948027:Coupling [Functional Concept]
Processing 00000000.tx.574: J. 

Phrase: "J."
Processing 00000000.tx.575: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.576: 163:10771088.[Abstract/Free FullText] Nishiyama, M., A. 

Phrase: "163"

Phrase: ":"

Phrase: "10771088."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nishiyama,"

Phrase: "M."

Phrase: ","

Phrase: "A."
Processing 00000000.tx.577: Hoshino, L. 

Phrase: "Hoshino,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.578: Tsai, J.R. 

Phrase: "Tsai,"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.579: Henley, Y. 

Phrase: "Henley,"

Phrase: "Y."
Processing 00000000.tx.580: Goshima, M. 

Phrase: "Goshima,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.581: Tessier-Lavigne, M.M. 

Phrase: "Tessier-Lavigne,"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.582: Poo, and K. 

Phrase: "Poo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015733:poo [Body Substance]

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.583: Hong. 

Phrase: "Hong."
Processing 00000000.tx.584: 2003. 

Phrase: "2003."
Processing 00000000.tx.585: Cyclic AMP/GMP-dependent modulation of Ca2+ channels sets the polarity of nerve growth-cone turning. 

Phrase: "Cyclic AMP/GMP-dependent modulation of Ca2+ channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443264:Modulation [Spatial Concept]

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "the polarity of nerve growth-cone turning."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596963:Polarity [Quantitative Concept]
Processing 00000000.tx.586: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.587: 423:990995.[CrossRef][Medline] Perrin, F.E., F.G. 

Phrase: "423"

Phrase: ":"

Phrase: "990995."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perrin,"

Phrase: "F.E.,"

Phrase: "F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.588: Rathjen, and E.T. 

Phrase: "Rathjen,"

Phrase: "and"

Phrase: "E.T."
Processing 00000000.tx.589: Stoeckli. 

Phrase: "Stoeckli."
Processing 00000000.tx.590: 2001. 

Phrase: "2001."
Processing 00000000.tx.591: Distinct subpopulations of sensory afferents require F11 or axonin-1 for growth to their target layers within the spinal cord of the chick. 

Phrase: "Distinct subpopulations of sensory afferents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1257890:Subpopulation [Population Group]

Phrase: "require"

Phrase: "F11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414498:F11 [Gene or Genome]
  1000   C1421650:F11 [Gene or Genome]

Phrase: "or"

Phrase: "axonin-1 for growth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0084710:Axonin-1 [Amino Acid, Peptide, or Protein]
   833   C1413560:AXONIN 1 [Gene or Genome]

Phrase: "to their target layers"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]

Phrase: "within the spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "of the chick."
Processing 00000000.tx.592: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.593: 30:707723.[CrossRef][Medline] Qiu, J., D. 

Phrase: "30"

Phrase: ":"

Phrase: "707723."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Qiu,"

Phrase: "J.,"

Phrase: "D."
Processing 00000000.tx.594: Cai, H. 

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.595: Dai, M. 

Phrase: "Dai,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683432:DAI [Intellectual Product]
  1000   C1424053:DAI [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.596: McAtee, P.N. 

Phrase: "McAtee,"

Phrase: "P.N."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.597: Hoffman, B.S. 

Phrase: "Hoffman,"

Phrase: "B.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.598: Bregman, and M.T. 

Phrase: "Bregman,"

Phrase: "and"

Phrase: "M.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.599: Filbin. 

Phrase: "Filbin."
Processing 00000000.tx.600: 2002. 

Phrase: "2002."
Processing 00000000.tx.601: Spinal axon regeneration induced by elevation of cyclic AMP. 

Phrase: "Spinal axon regeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1621980:axon regeneration [Organ or Tissue Function]
   827   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "induced by elevation of cyclic AMP."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C0439596:Cyclic [Temporal Concept]
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]
   753   C1511572:Cyclic [Temporal Concept]
Processing 00000000.tx.602: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.603: 34:895903.[CrossRef][Medline] Robles, E., A. 

Phrase: "34"

Phrase: ":"

Phrase: "895903."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Robles,"

Phrase: "E.,"

Phrase: "A."
Processing 00000000.tx.604: Huttenlocher, and T.M. 

Phrase: "Huttenlocher,"

Phrase: "and"

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.605: Gomez. 

Phrase: "Gomez."
Processing 00000000.tx.606: 2003. 

Phrase: "2003."
Processing 00000000.tx.607: Filopodial calcium transients regulate growth cone motility and guidance through local activation of calpain. 

Phrase: "Filopodial calcium transients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0040704:Transients [Population Group]
   827   C0687129:Transients [Finding]
   793 E C0205374:Transient [Temporal Concept]

Phrase: "regulate"

Phrase: "growth cone motility"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0007608:Motility [Cell Function]
   827   C0678835:Motility [Laboratory or Test Result]
   827   C1510470:Motility [Organism Function]
   755 E C1979933:Motile [Finding]
   734   C0596632:growth cone [Cell Component]

Phrase: "and"

Phrase: "guidance through local activation of calpain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150600:Guidance [Health Care Activity]
   753   C1959633:Guidance [Clinical Attribute]
Processing 00000000.tx.608: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.609: 38:597609.[CrossRef][Medline] Snider, W.D. 

Phrase: "38"

Phrase: ":"

Phrase: "597609."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Snider,"

Phrase: "W.D."
Processing 00000000.tx.610: 1994. 

Phrase: "1994."
Processing 00000000.tx.611: Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. 

Phrase: "Functions of the neurotrophins"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0542341:Functions [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "during nervous system development"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0598282:Nervous System Development [Organ or Tissue Function]
   901   C1744604:system development [Biologic Function]
   855   C1818230:nerve development [Organ or Tissue Function]
   852 E C0814002:Neural Development [Cell Function,Organism Function]
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]
   734   C0027763:Nervous System [Body System]
   734   C0422837:NERVOUS SYSTEM [Finding]
   734   C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "what the knockouts"

Phrase: "are"

Phrase: "teaching"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039401:Teaching [Educational Activity]
  1000   C0220924:teaching [Educational Activity]
  1000   C1548344:Teaching [Intellectual Product]

Phrase: "us."
Processing 00000000.tx.612: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.613: 77:627638.[CrossRef][Medline] Song, H.J., and M.M. 

Phrase: "77"

Phrase: ":"

Phrase: "627638."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "H.J.,"

Phrase: "and"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.614: Poo. 

Phrase: "Poo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015733:poo [Body Substance]
Processing 00000000.tx.615: 1999. 

Phrase: "1999."
Processing 00000000.tx.616: Signal transduction underlying growth cone guidance by diffusible factors. 

Phrase: "Signal transduction underlying growth cone guidance by diffusible factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150600:Guidance [Health Care Activity]
   742   C1959633:Guidance [Clinical Attribute]
Processing 00000000.tx.617: Curr. 

Phrase: "Curr."
Processing 00000000.tx.618: Opin. 

Phrase: "Opin."
Processing 00000000.tx.619: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.620: 9:355363.[CrossRef][Medline] Sydor, A.M., A.L. 

Phrase: "9"

Phrase: ":"

Phrase: "355363."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sydor,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "A.L."
Processing 00000000.tx.621: Su, F.S. 

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "F.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.622: Wang, A. 

Phrase: "Wang,"

Phrase: "A."
Processing 00000000.tx.623: Xu, and D.G. 

Phrase: "Xu,"

Phrase: "and"

Phrase: "D."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.624: Jay. 

Phrase: "Jay."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326402:Jay [Bird]
Processing 00000000.tx.625: 1996. 

Phrase: "1996."
Processing 00000000.tx.626: Talin and vinculin play distinct roles in filopodial motility in the neuronal growth cone. 

Phrase: "Talin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]

Phrase: "and"

Phrase: "vinculin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085175:Vinculin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336929:VINCULIN [Gene or Genome]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "distinct roles in filopodial motility"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "in the neuronal growth cone."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0596632:growth cone [Cell Component]
   901   C0814002:Neuronal Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0206428:Cone [Cell]
   827   C0220844:growth [Physiologic Function]
   827   C0330095:Cone [Plant]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2350017:Cone [Spatial Concept]
   827   C2911660:Growth [Activity]
Processing 00000000.tx.627: J. 

Phrase: "J."
Processing 00000000.tx.628: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.629: 134:11971207.[Abstract] Takei, K., R.M. 

Phrase: "134"

Phrase: ":"

Phrase: "11971207."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Takei,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.630: Shin, T. 

Phrase: "Shin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230444:Shin [Body Location or Region]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.631: Inoue, K. 

Phrase: "Inoue,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.632: Kato, and K. 

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.633: Mikoshiba. 

Phrase: "Mikoshiba."
Processing 00000000.tx.634: 1998. 

Phrase: "1998."
Processing 00000000.tx.635: Regulation of nerve growth mediated by inositol 1,4,5-trisphosphate receptors in growth cones. 

Phrase: "Regulation of nerve growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C1160191:regulation of growth [Organism Function]
           growth regulation
   791   C0598959:neural regulation [Organ or Tissue Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "mediated by inositol 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "4,"

Phrase: "5-trisphosphate receptors in growth cones."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0596632:Growth Cones [Cell Component]
   799   C0206428:Cones [Cell]
   766 E C0330095:Cone [Plant]
   766 E C2350017:Cone [Spatial Concept]
Processing 00000000.tx.636: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.637: 282:17051708.[Abstract/Free FullText] Takeichi, M. 

Phrase: "282"

Phrase: ":"

Phrase: "17051708."

Phrase: "[Abstract/Free FullText"

Phrase: "] Takeichi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.638: 1991. 

Phrase: "1991."
Processing 00000000.tx.639: Cadherin cell adhesion receptors as a morphogenetic regulator. 

Phrase: "Cadherin cell adhesion receptors as a morphogenetic regulator."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0300500:adhesion receptors [Amino Acid, Peptide, or Protein,Receptor]
   750   C1514760:Receptor Cell [Cell]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.640: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.641: 251:14511455.[Medline] Tang, F., E.W. 

Phrase: "251"

Phrase: ":"

Phrase: "14511455."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tang,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "E.W."
Processing 00000000.tx.642: Dent, and K. 

Phrase: "Dent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880278:DENT [Event]

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.643: Kalil. 

Phrase: "Kalil."
Processing 00000000.tx.644: 2003. 

Phrase: "2003."
Processing 00000000.tx.645: Spontaneous calcium transients in developing cortical neurons regulate axon outgrowth. 

Phrase: "Spontaneous calcium transients in developing cortical neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040704:Transients [Population Group]
   748   C0687129:Transients [Finding]
   714 E C0205374:Transient [Temporal Concept]

Phrase: "regulate"

Phrase: "axon outgrowth."
Processing 00000000.tx.646: J. 

Phrase: "J."
Processing 00000000.tx.647: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.648: 23:927936.[Medline] Tessier-Lavigne, M., and C.S. 

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "927936."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tessier-Lavigne,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "C.S."
Processing 00000000.tx.649: Goodman. 

Phrase: "Goodman."
Processing 00000000.tx.650: 1996. 

Phrase: "1996."
Processing 00000000.tx.651: The molecular biology of axon guidance. 

Phrase: "The molecular biology of axon guidance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   753   C0005532:Biology [Biomedical Occupation or Discipline]
   753   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.652: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.653: 274:11231133.[Abstract/Free FullText] Valdivia, H.H., J.H. 

Phrase: "274"

Phrase: ":"

Phrase: "11231133."

Phrase: "[Abstract/Free FullText"

Phrase: "] Valdivia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1204228:Valdivia [Plant]

Phrase: "H.H.,"

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.654: Kaplan, G.C. 

Phrase: "Kaplan,"

Phrase: "G.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]
Processing 00000000.tx.655: Ellis-Davies, and W.J. 

Phrase: "Ellis-Davies,"

Phrase: "and"

Phrase: "W.J."
Processing 00000000.tx.656: Lederer. 

Phrase: "Lederer."
Processing 00000000.tx.657: 1995. 

Phrase: "1995."
Processing 00000000.tx.658: Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation. 

Phrase: "Rapid adaptation of cardiac ryanodine receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0000934:adaptation [Organism Function]
   753   C0392673:Adaptation [Biologic Function]

Phrase: ":"

Phrase: "modulation by Mg2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.659: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.660: 267:19972000.[Medline] Wehrens, X.H., and A.R. 

Phrase: "267"

Phrase: ":"

Phrase: "19972000."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wehrens,"

Phrase: "X.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "A.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.661: Marks. 

Phrase: "Marks."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]
Processing 00000000.tx.662: 2003. 

Phrase: "2003."
Processing 00000000.tx.663: Altered function and regulation of cardiac ryanodine receptors in cardiac disease. 

Phrase: "Altered function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "regulation of cardiac ryanodine receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in cardiac disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018799:Disease, Cardiac [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   861   C1522601:Cardiac [Spatial Concept]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.664: Trends Biochem. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.665: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.666: 28:671678.[CrossRef][Medline] Wen, Z., C. 

Phrase: "28"

Phrase: ":"

Phrase: "671678."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "Z.,"

Phrase: "C."
Processing 00000000.tx.667: Guirland, G.L. 

Phrase: "Guirland,"

Phrase: "G.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439294:g l [Quantitative Concept]
Processing 00000000.tx.668: Ming, and J.Q. 

Phrase: "Ming,"

Phrase: "and"

Phrase: "J.Q."
Processing 00000000.tx.669: Zheng. 

Phrase: "Zheng."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]
Processing 00000000.tx.670: 2004. 

Phrase: "2004."
Processing 00000000.tx.671: A CaMKII/calcineurin switch controls the direction of Ca2+-dependent growth cone guidance. 

Phrase: "A CaMKII/calcineurin switch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707719:Switch [Manufactured Object]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the direction of Ca2+-dependent growth cone guidance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449738:Direction [Spatial Concept]
Processing 00000000.tx.672: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.673: 43:835846.[CrossRef][Medline] Yoshida, A., A. 

Phrase: "43"

Phrase: ":"

Phrase: "835846."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yoshida,"

Phrase: "A.,"

Phrase: "A."
Processing 00000000.tx.674: Ogura, T. 

Phrase: "Ogura,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.675: Imagawa, M. 

Phrase: "Imagawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.676: Shigekawa, and M. 

Phrase: "Shigekawa,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.677: Takahashi. 

Phrase: "Takahashi."
Processing 00000000.tx.678: 1992. 

Phrase: "1992."
Processing 00000000.tx.679: Cyclic AMP-dependent phosphorylation of the rat brain ryanodine receptor. 

Phrase: "Cyclic AMP-dependent phosphorylation of the rat brain ryanodine receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1157225:AMP phosphorylation [Molecular Function]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.680: J. 

Phrase: "J."
Processing 00000000.tx.681: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.682: 12:10941100.[Abstract] Zheng, J.Q. 

Phrase: "12"

Phrase: ":"

Phrase: "10941100."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "J.Q."
Processing 00000000.tx.683: 2000. 

Phrase: "2000."
Processing 00000000.tx.684: Turning of nerve growth cones induced by localized increases in intracellular calcium ions. 

Phrase: "Turning of nerve growth cones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0541749:turning [Finding]

Phrase: "induced by localized increases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205263:Induced [Functional Concept]
   770   C0392752:Localized [Spatial Concept]
   770   C0442805:increases [Functional Concept]

Phrase: "in intracellular calcium ions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0596235:calcium ions [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0022023:Ions [Element, Ion, or Isotope]
   793 E C1700702:ION [Functional Concept]
Processing 00000000.tx.685: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.686: 403:8993.[CrossRef][Medline] Zucchi, R., and S. 

Phrase: "403"

Phrase: ":"

Phrase: "8993."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zucchi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.687: Ronca-Testoni. 

Phrase: "Ronca-Testoni."
Processing 00000000.tx.688: 1997. 

Phrase: "1997."
Processing 00000000.tx.689: The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. 

Phrase: "The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1753335:ryanodine receptor [Molecular Function]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ":"

Phrase: "modulation by endogenous effectors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443264:Modulation [Spatial Concept]

Phrase: "drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "disease states."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0012634:Disease [Disease or Syndrome]
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.690: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.691: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.692: 49:151.[Abstract/Free FullText] Related Article Calcium, direct from the source Rabiya S. 

Phrase: "49"

Phrase: ":"

Phrase: "151."

Phrase: "[Abstract/Free FullText"

Phrase: "] Related Article Calcium,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "direct from the source Rabiya S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439851:Direct [Qualitative Concept]
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]
   753   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.693: Tuma J. 

Phrase: "Tuma J."
Processing 00000000.tx.694: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.695: 2005 170: 1014. 

Phrase: "2005 170"

Phrase: ":"

Phrase: "1014."
Processing 00000000.tx.696: [Full Text] This Article Abstract PDF (Full Text) Alert me when this article is cited Citation Map Services Alert me to new content in the JCB Download to citation manager Google Scholar Articles by Ooashi, N. 

Phrase: "[Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1527021:Text [Intellectual Product]
   861   C1554111:Text [Idea or Concept]
   861   C1705606:Text [Intellectual Product]
   861   C3541382:Text [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract PDF (Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: ")"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205314:New [Temporal Concept]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "in the JCB Download"

Phrase: "to citation manager Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1706852:Article [Intellectual Product]

Phrase: "by Ooashi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.697: Articles by Kamiguchi, H. 

Phrase: "Articles by Kamiguchi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.698: Articles citing this Article PubMed PubMed Citation Articles by Ooashi, N. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Ooashi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.699: Articles by Kamiguchi, H. 

Phrase: "Articles by Kamiguchi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.700: Related Collections Related Article Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Phrase: "Related Collections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0600644:Collections [Intellectual Product]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   777 E C1516695:Collected [Idea or Concept]

Phrase: "Related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "Article Home | Help | Feedback | Subscriptions | Archive | Search | Table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0039224:Table [Manufactured Object]
   793   C1706073:Table [Medical Device]
   793   C1706074:Table [Intellectual Product]

Phrase: "of Contents"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0456205:Contents [Conceptual Entity]
  1000   C1552853:contents [Idea or Concept]
   966 E C0423896:Content [Mental Process]

